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Abstract	  	   Uncontrolled	   inflammation	   contributes	   to	   a	   number	   of	   autoinflammatory	  pathological	  conditions,	  and	  is	  a	  significant	  factor	  in	  a	  number	  of	  other	  areas	  such	  as	   atherosclerosis	   the	   leading	   cause	   of	   death	   in	   the	   developed	   world.	   The	  inflammatory	   response	   is	   very	   tightly	   regulated,	   and	   controlled	   at	   its	   apex	   by	  Interleukin-­‐1β,	   a	   key	   proinflammatory	   cytokine.	   This	   key	   initiator	   provides	   an	  ideal	  target	  for	  therapeutic	  intervention,	  yet	  many	  aspects	  of	  its	  biology	  are	  poorly	  understood,	   including	   its	   novel	   release	   mechanism.	   Mammalian	   in	   vitro	   studies	  have	   demonstrated	   IL-­‐1β	   is	   processed	   by	   a	   protein	   complex	   called	   the	  inflammasome	  and	  that	  this	  processing	  is	  linked	  to	  release	  via	  membrane-­‐derived	  microvesicles	  from	  the	  cell	  surface.	  However,	  it	  has	  not	  yet	  been	  possible	  to	  show	  the	  functional	  release	  of	  IL-­‐1β	  microvesicles	  in	  vitro,	  determine	  the	  mechanism	  of	  release	   and	   how	   it	   is	   linked	   to	   processing	   and	   the	   biological	   function	   of	   these	  vesicles	   upon	   downstream	   cells.	  We	   hypothesise	   that	   components	   of	   the	   ESCRT	  complex	   are	   responsible	   for	   IL-­‐1β	   secretion;	   however,	   the	   tools	   to	   test	   this	  hypothesis	  in	  vitro	  have	  not	  yet	  been	  developed.	  IL-­‐1β	   structure	   is	   highly	   conserved	   between	   zebrafish	   and	  humans	   based	  on	   structure	   prediction	   software,	   which	   shows	   zebrafish	   IL-­‐1β	   shares	   the	   same	  secondary	   and	   tertiary	   structural	   elements.	   Zebrafish	   IL-­‐1β	  mRNA	   is	   induced	   in	  response	  to	  injury	  and	  the	  inflammatory	  response	  is	  downregulated	  in	  response	  to	  treatment	  with	  IL-­‐1β	  pathway	  inhibitors.	  To	  investigate	  IL-­‐1β	  processing	  in	  vivo,	  I	  have	  tested	  a	  FRET	  based	  reporter	  for	  caspase-­‐3	  activation	  and	  characterised	  the	  use	  of	  such	  a	  reporter	  in	  the	  zebrafish	  as	  a	  proof	  of	  concept.	  I	  have	  also	  designed	  a	  version	  of	  this	  reporter	  specific	  to	  caspase-­‐1	  activation.	  	  Alongside	   the	  work	  on	  an	   inflammasome	  reporter,	   I	  also	  show	  the	   first	   in	  vivo	   evidence	   of	   IL-­‐1β	   secretion	   from	   inflammatory	   cells	   in	   response	   to	   injury	  using	  a	  macrophage	  specific	  IL-­‐1β	  fusion	  reporter.	  In	  this	  thesis	  I	  demonstrate	  the	  utility	  of	  the	  zebrafish	  as	  a	  model	  of	  IL-­‐1β	  biology	  with	   regards	   to	   induction	  of	   IL-­‐1β	   signaling	   and	   the	   susceptibility	   of	   the	  zebrafish	  innate	  immue	  response	  to	  treatment	  with	  IL-­‐1β	  pathway	  inhibitors,	  and	  I	  present	   the	   first	   evidence	  of	  putative	   IL-­‐1β	   containing	  microvesicle	   release	   from	  macrophages	  in	  vivo.	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Chapter	  1:	  Introduction	  
1.1	  Evolution	  of	  the	  Immune	  response	  The	  evolution	  of	  multicellular	  life	  presented	  many	  challenges,	  perhaps	  foremost	  of	  these	   was	   competition	   and	   interaction	   with	   more	   primitive,	   pathogenic	  microorganisms,	   leading	   to	   the	   evolution	   of	   immunity	   as	   a	   mechanism	   to	  distinguish	  self	  from	  non-­‐self	  and	  to	  combat	  invading	  microorganisms.	  The	  earliest	  example	  of	   invertebrate	   immunity	  was	  documented	  by	  Metchnikoff	   in	  1882	  who	  described	  the	  attempted	  phagocytosis	  of	  a	  rose	  thorn	  puncturing	  a	  starfish	  by	  cells	  which	  were	  later	  termed	  coelomocytes	  (reviewed	  in	  Beck	  and	  Habicht,	  1996).	  Since	  then,	  primitive	  immune	  responses	  have	  been	  observed	  in	  a	  variety	  of	  invertebrate	   organisms	   in	   the	   study	   of	   immunity	   and	   evolution.	  Hydra	   has	   been	  shown	   to	   mount	   a	   potent	   antimicrobial	   response	   regulated	   by	   neuronal	   cells	  (Kasahara	  &	  Bosch	  2003),	  and	  genome	  data-­‐mining	  has	  permitted	  the	  discovery	  of	  pattern	   recognition	   receptors	   (PRRs)	   in	   other	  members	  of	   the	   cnidarian	   lineage.	  These	   PRRs	   use	   leucine	   rich	   repeats	   (LRRs)	   as	   the	   basis	   of	   their	   pattern	  recognition	  and	  were	  discovered	  as	  homologues	  for	  Toll	  like	  receptors	  (TLR)	  and	  Interleukin	   1	   receptors	   (IL-­‐1R)	   (DJ	   Miller	   et	   al.	   2007).	   These	   receptors	   link	   to	  innate	   immunity	   through	   the	   NF-­‐κB	   pathway,	   which	   activates	   transcription	   of	  immune	   related	  genes	  and	  was	  also	   found	   in	   cnidarian	  genomes	   (DJ	  Miller	   et	   al.	  2007;	  J.	  Sullivan	  et	  al.	  2007).	  The	  Toll	  pathway	  has	  been	  linked	  to	  development	  in	  a	  number	   of	   organisms,	   such	   as	  drosophila,	   but	   in	  mammalian	   lineages	   acts	   as	   an	  activator	  of	  immunity	  (Medzhitov	  et	  al.	  1997).	  The	  evolution	  of	  the	  Toll	  pathway,	  has	  been	   implicated	  as	  occurring	  after	  the	  evolution	  of	  sponges	  (Hemmrich	  et	  al.	  2007).	  LRRs	  as	  a	  mechanism	  of	  pathogen	  recognition	  are	  also	  present	  in	  plants	  to	  a	  great	  extent,	  demonstrating	  the	  evolution	  of	  these	  components	  very	  early	  on	  (DA	  Jones	  &	  D.	  Takemoto	  2004;	  Nürnberger	  et	  al.	  2004)	  Sensing	   of	   pathogens	   and	   non-­‐self	   material	   leads	   to	   the	   production	   of	  antimicrobial	  compounds	  and	  activation	  of	  phagocytosing	  cells,	  as	  those	  described	  by	  Metchnikoff	  in	  starfish	  but	  also	  present	  in	  insects	  (Lanot	  et	  al.	  2001),	  implying	  their	   evolution	   before	   the	   divergence	   of	   these	   lineages.	   In	   horseshoe	   crabs,	   this	  response	  is	  also	  potentiated	  by	  the	  precursors	  of	  the	  complement	  system	  (Y.	  Zhu	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et	  al.	  2005)	  which	  later	  developed	  to	  regulate	  the	  interaction	  between	  innate	  and	  adaptive	  immunity	  (Carroll	  1998).	  As	  immune	  systems	  evolved,	  so	  did	  pathogens,	  and	  LRRs	  as	  a	  mechanism	  of	  pathogen	   recognition	   have	   been	   suggested	   as	   evolutionarily	   burdensome	   due	   to	  the	  necessity	  of	  maintaining	  a	  large	  pattern	  recognition	  “library”	  (Pancer	  &	  Cooper	  2006).	  This	  difficulty	  was	  surmounted	  by	  the	  evolution	  of	  a	  family	  of	  VLR	  proteins	  in	   sea	   lampreys	   which	   were	   capable	   of	   rapid	   rearrangement	   to	   generate	   a	   vast	  array	   of	   combinations	   for	   improved	   pathogen	   sensitivity	   (Pancer	   et	   al.	   2004),	  alongside	  the	  evolution	  of	  the	  first	  adaptive	  immune	  cells;	  lymphocytes	  (Shintani	  &	  Terzic	   2000).	   These	   were	   the	   precursor	   to	   more	   advanced	   immunoglobulin	  domain	   based	   antibodies	  which	   first	   evolved	   in	   jawed	   fish,	   and	   the	   evolution	   of	  varied	   lymphocyte	   populations	   (Kaufman	   2002),	   however,	   immunoglobulin	  containing	  proteins	  were	  also	  implicated	  in	  earlier	   lamprey	  immunity	  (Fujii	  et	  al.	  1979).	  We	   can	   see	   that	   as	   organisms	   gained	   complexity,	   so	   did	   their	   immune	  systems,	  as	   layers	  of	  additional	  defense	  were	  added	  to	  protect	  against	  pathogens	  (Flajnik	   &	   Du	   Pasquier	   2004).	   The	   most	   “modern”	   development	   in	   immunity,	  Immunoglobulin	   genes,	   are	   under	   fierce	   selection	   pressure	   in	   response	   to	  pathogen	  evolution,	  as	  evidenced	  by	  the	  differences	  observed	  between	  mouse	  and	  human	   immune	  genes	   (Hughes	  1997).	  However,	   the	  more	   evolutionarily	   ancient	  immune	  pathways	   remain	  more	   conserved	   as	  demonstrated	  by	   the	   role	   of	   PRRs	  and	  phagocytosis.	  However,	  despite	  their	  useful	  role	  in	  host	  defense,	  the	  release	  of	  antimicrobial	   compounds	   and	   the	   activation	   of	   immune	   cells	   is	   potentially	  dangerous	   for	   the	   host	   organism	   and	   therefore	   mechanisms	   of	   regulation,	   and	  signalling	  have	  evolved	  to	  ensure	  tight	  control	  of	  these	  systems.	  Cytokines	  are	  an	  evolutionarily	   ancient	  mechanism	   to	   recruit	   immune	   cells	   and	   correctly	   activate	  the	  host	  response	  (Beck	  &	  Habicht	  1991a);	  key	  amongst	  these	  is	  the	  interleukin	  1	  (IL-­‐1)	  family.	  These	  genes	  are	  similarly	  ancient,	  yet	  retain	  a	  conserved	  function:	  IL-­‐1	  like	  proteins	  have	  been	  identified	  in	  starfish	  and	  tunicates	  and	  have	  furthermore	  been	  able	  to	  elicit	  an	  IL-­‐1β	  like	  response	  in	  murine	  fibroblasts	  and	  human	  cell	  lines	  (Beck	  &	  Habicht	  1991b).	  Human	  IL-­‐1	  itself	  was	  first	  discovered	  as	  a	  “leukocytic	  pyrogen”	  identified	  by	   its	  pleiotropic	  effects	  and	  was	   later	   found	  to	  consist	  of	   two	  separate	  proteins,	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IL-­‐1α	  and	  IL-­‐1β.	   IL-­‐1α	  has	  been	  described	  as	  an	   intracellular	  and	   local	  mediator,	  whereas	  IL-­‐1β	  has	  instead	  been	  designated	  as	  a	  more	  general,	  systemic	  mediator	  (Dinarello	  1996)	  and	  has	  since	  been	  described	  as	  a	  “gatekeeper	  of	   inflammation”	  (Dinarello	   2011a)	   due	   to	   its	   apical	   role	   in	   the	   initial	   stages	   of	   the	   inflammatory	  response.	  	   	  
1.2	  Summary	  of	  IL-­‐1β 	  synthesis	  and	  release	  As	   a	   key	   regulator	   of	   immunity,	   IL-­‐1β	   release	  must	   be	   strictly	   controlled,	  and	   over	   the	   course	   of	   evolution,	   numerous	   adaptations	   have	   provided	   tight	  control	   of	   the	   IL-­‐1β	   pathway.	   On	   a	   basic	   level,	   the	   release	   of	   IL-­‐1β	   from	   innate	  immune	   cells,	   such	   as	   macrophages,	   has	   numerous	   distinct	   controls,	   each	  requiring	  a	  potentially	  differing	  external	  signal	  to	  activate.	  These	  control	  the	  action	  of	   IL-­‐1β	   at	   the	   transcriptional	   level	   as	   well	   as	   the	   functional	   level.	   The	   IL-­‐1β	  message	  is	  transcribed	  and	  stabilised	  upon	  the	  reception	  of	  a	  pathogen	  or	  damage	  associated	  molecular	   pattern	   (PAMP	   or	  DAMP)	   by	   pattern	   recognition	   receptors	  on	  the	  cell	  surface.	  This	  signal	  is	  transduced	  through	  the	  NF-­‐κB	  signalling	  pathway	  resulting	  in	  the	  induction	  of	  IL-­‐1β	  transcription	  as	  the	  inactive	  propeptide	  pro-­‐IL-­‐1β.	  Pro-­‐IL-­‐1β	  is	  converted	  into	  an	  active	  cytokine	  through	  the	  action	  of	  caspase-­‐1	  which	   itself	   is	  proteolytically	  activated	  via	   the	   reception	  of	   secondary	  PAMP	  and	  DAMP	   signalling	   through	   intracellular	   PRRs	   making	   up	   complexes	   termed	  inflammasomes.	  IL-­‐1β	  is	  then	  packaged	  and	  released	  from	  the	  cell	  via	  an	  unknown	  secretion	  mechanism,	  not	  dependent	  on	  the	  traditional	  ER/Golgi	  release	  pathway.	  IL-­‐1β	   is	   regulated	   at	   transcription,	   translation,	   post	   translational	   and	   release	  pathways	   sensitive	   to	   a	   variety	   of	   stimuli	   and	   under	   a	   complex	   set	   of	   controls	  (Figure	  1.1).	  
1.3	  Pro-­‐IL-­‐1β 	  induction	  
1.3.1	  Pattern	  recognition	  in	  IL-­‐1β 	  induction	  IL-­‐1β	   is	   released	   by	  monocyte	   and	  myeloid	   lineage	   cells	   (Kominato	   et	   al.	  1995)	   in	   response	   to	   external	   stimuli,	   notably	   pathogen	   associated	   molecular	  patterns	  (PAMPS),	  as	  well	  as	  injury	  and	  other	  inflammation	  inducing	  stimuli	  such	  as	  other	  cytokines	  and	  stress	  factors	  (see	  (Dinarello	  2009a)	  for	  more	  detail)	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Figure	   1.1.	   IL-­‐1β	   signalling	   is	   subject	   to	   tight	   regulation	   on	   a	   number	   of	  
levels.	   IL-­‐1β	   is	   induced	  in	  response	  to	  a	  number	  of	   inflammatory	  stimuli,	  via	  the	  canonical	   NF-­‐κB	   pathway,	   and	   expressed	   from	   a	   promoter	   architecture	   “poised”	  for	   a	   rapid	   response.	   Both	   the	   mRNA	   and	   pro-­‐peptide	   of	   IL-­‐1β	   are	   subject	   to	  regulated	   turnover	   and	   degradation	   and	   inflammatory	   stimuli	   are	   necessary	   for	  stability.	  IL-­‐1β	  processing	  is	  mediated	  by	  caspase-­‐1,	  itself	  subject	  to	  activation	  by	  inflammasome	   complexes	   responsive	   to	   varied	   stimuli.	   Inflammasome	   action	   is	  coupled	   to	   IL-­‐1β	   release	   by	   a	   number	   of	   pathways	   sensitive	   to	   inflammatory	  signalling,	  and	  signal	  sensitivity	  is	  controlled	  by	  downstream	  decoy	  receptors	  and	  an	  endogenous	  antagonist.	  	  activating	  TLR	  receptors	  on	  the	  cell	  surface.	  Chromatin	  at	  the	  IL-­‐1β	  gene	  locus	  in	  IL-­‐1β	  producing	  cells	  exists	  in	  an	  “open	  and	  ready”	  arrangement	  due	  to	  the	  permanent	  binding	  of	  a	  transcription	  factor	  complex	  to	  promoter	  sites	  on	  the	  gene	  (M.	  Liang	  et	  al.	  2006;	  Unlu	  et	  al.	  2007),	  limiting	  the	  amount	  of	  time	  needed	  to	  initiate	  transcription	  on	  the	  reception	  of	  an	  inflammatory	  stimulus.	  IL-­‐1β	  transcription	  is	  triggered	  by	  the	  activation	  of	  NF-­‐κB	  and	  its	  subsequent	  translocation	  to	  the	  nucleus	  following	  reception	  of	  Toll	  like	  receptor	  (TLR)	  ligands	  by	  TLRs	  on	  the	  cell	  surface	  (Sabroe	  et	  al.	  2008),	  or	  in	  fact	  by	  IL-­‐1β	  itself	  (Dinarello	  et	  al.	  1987)	  (Figure	  1.2).	  
1.3.2	  NF-­‐κB	  complexes	  and	  transcriptional	  control	  IL-­‐1β	  transcription	  is	  a	  product	  of	  active	  NF-­‐κB	  binding	  to	  NF-­‐κB	  response	  elements	  upstream	  of	  the	  IL-­‐1β	  coding	  sequence,	  however,	  because	  of	  the	  potency	  of	   genes	   potentially	   activated	   by	   NF-­‐κB,	   this	   activation	   itself	   strictly	   controlled.	  Cytosolic	  NF-­‐κB	  is	  a	  multimeric	  protein	  complex	  composed	  of	  IκB	  and	  two	  NF-­‐κB	  protein	   subunits:	   the	   p50	   or	   p52	   subunit,	   and	   the	   p65	   subunit,	   RelA	   (Baeuerle	  1988).	   These	   subunits	   all	   contain	   a	   protein	   domain	   called	   the	   Rel	   homology	  domain	  (RHD),	  containing	  both	  immunoglobμlin	  like	  folds	  and	  the	  IκB	  interaction	  sites.	   However,	   on	   RelA,	   the	   DNA	   binding	   sites	   are	   present	   on	   the	   IPT	   domain	  (immunoglobulin-­‐like,	  Plexin	  and	  transcription	  factor	  domain)	  (Aravind	  &	  Koonin	  1999).	  In	  its	  inactive	  state,	  the	  nuclear	  localisation	  signals	  present	  on	  NF-­‐κB	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Figure	  1.2.	  IL-­‐1β	  transcription	  induction	  in	  response	  to	  Pathogen	  associated	  
Molecular	  Patterns	  (PAMPS).	  IL-­‐1β	  is	  induced	  in	  response	  to	  activation	  of	  TLR	  receptors	  on	  the	  cell	  surface	  by	  PAMP	  ligands.	  The	  signal	  is	  transduced	  through	  the	  canonical	  NF-­‐κB	  pathway	  where	  it	  induces	  IL-­‐1β	  transcription	  from	  a	  rapid-­‐response	  promoter	  architecture.	  IL-­‐1β	  is	  also	  controlled	  on	  an	  mRNA	  stability	  level	  via	  instability	  elements	  in	  the	  3’	  UTR	  and	  potential	  internal	  RNAse	  sites;	  message	  stability	  is	  dependent	  on	  the	  continued	  presence	  of	  inflammatory	  stimuli.	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subunits	  are	  masked	  by	  the	  binding	  of	   IκB	  to	   the	  complex	   in	  a	  1:1	  manner	  using	  the	   ankyrin	   repeats	   present	   on	   IκB	   and	   the	   RHD	   (Jacobs	   &	   S.	   Harrison	   1998).	  Multiple	  modes	  of	  activation	  exist	  for	  NF-­‐κB,	  the	  foremost	  being	  the	  kinase	  cascade	  culminating	   in	   the	   phosphorylation	   of	   IκB	   by	   IKK	   (IκB	   kinase).	   This	  phosphorylation	  prevents	  IκB	  binding	  to	  NF-­‐κB	  and	  exposes	  the	  PEST	  (sequences	  rich	  in	  Proline,	  Glutamic	  acid,	  Serine	  and	  Threonine	  residues),	  sites	  present	  on	  IκB	  (Shumway	   et	   al.	   1999)	   and	   allows	   IκB	   to	   be	   ubiquinated,	   which	   targets	   IκB	   for	  degradation	  by	  the	  proteosome.	  With	  IκB	  unbound	  and	  degraded,	  the	  nuclear	  localisation	  signals	  on	  NF-­‐κB	  become	   exposed	   and	   the	   protein	   is	   shuttled	   to	   the	   nucleus	   (Carlotti	   et	   al.	   2000)	  where	  it	  can	  bind	  NF-­‐κB	  response	  elements	  and	  start	  the	  transcription	  of	  IL-­‐1β	  .	  IκB	   itself	   is	   degraded	   by	   a	   the	   IKK	   complex,	   consisting	   of	   two	   effector	  kinases	   IKKα	   and	   IKKβ	   (DiDonato	   et	   al.	   1997;	   Mercurio	   et	   al.	   1997);	   and	   the	  regulatory	  subunit	  IKKγ  (DiDonato	  et	  al.	  1997;	  Mercurio	  et	  al.	  1997;	  Rothwarf	  et	  al.	  1998),	  which	  itself	   is	  regulated	  by	  NIK	  (NF-­‐κB	  inducing	  kinase)	  (Regnier	  et	  al.	  1997).	  NIK	  function	  is	  mediated	  by	  further	  factors,	  dependent	  on	  the	  nature	  of	  the	  stimuli	   in	  question.	  The	  most	   common	   in	   the	   study	  of	   IL-­‐1β	  biology	   is	  MyD88,	   a	  signal	   transducer	   and	   TLR	   adaptor,	   in	   this	   context	   specifically	   TLR4,	   which	   is	  responsible	   for	   detecting	   bacterial	   LPS	   (lipopolysaccharide).	   MyD88	   transduces	  these	  signals	   to	   IRAKs	  (interleukin-­‐1	  receptor	  associated	  kinases);	  which	  are	   the	  first	  step	  of	  this	  phosphorylation	  cascade	  (Croston	  et	  al.	  1995),	  or	  are	  able	  to	  bind	  to	  IKK	  directly	  (Cooke	  et	  al.	  2001).	  	  
1.3.3	  Translational	  control	  of	  IL-­‐1β	  Pro-­‐IL-­‐1β	  production	   is	  under	   further	   control	   at	   the	  mRNA	  stability	   level.	  The	   production	   of	   pro-­‐IL-­‐1β	  mRNA	   is	   induced	  without	   further	   protein	   synthesis	  and	   adhesion	   stimuli	   are	   sufficient	   for	   this	   response	   (Schindler	   et	   al.	   1990),	  however,	  in	  response	  to	  LPS,	  a	  rapid	  increase,	  followed	  by	  a	  rapid	  degradation	  of	  IL-­‐1β	  mRNA	  was	  described	  (Fenton	  et	  al.	  1987).	  Conversely	  low	  level	  induction	  of	  IL-­‐1β	  transcription	  by	  phorbol	  12-­‐myristate	  13-­‐acetate	  (PMA)	  resulted	  in	  a	  more	  stable	  message,	  indicating	  more	  than	  one	  pathway	  for	  regulation	  of	  mRNA	  stability	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(Fenton	  et	  al.	  1988).	  The	  suggested	  mechanisms	  behind	  the	  control	  of	  IL-­‐1β	  mRNA	  translation	  differ	  and	  multiple	  mechanisms	  have	  been	  proposed.	  Bufler	   et	   al.	   (2004)	   propose	   the	   involvement	   of	   instability	   elements	  detected	   by	   homology	   to	   described	   elements	   in	   the	   coding	   sequence	   of	   IL-­‐1F7,	  although	   alignment	   data	   presented	   in	   this	   study	   was	   not	   compelling.	   However,	  similar	  elements	  were	  found	  in	  other	  proteins	  (Tierney	  &	  Medcalf	  2001).	  The	   3’	   UTR	   region	   of	   IL-­‐1β	   mRNA	   has	   been	   implicated	   in	   the	   speed	   of	  ribosomal	   translation	  of	   the	  mRNA	  where	  downstream	  binding	  of	   a	  protein	  may	  inhibit	   ribosome	   velocity	   (Kaspar	   &	   Gehrke	   1994).	   This	   instability	   and	  translational	  control	  is	  regulated	  by	  TLR	  ligands,	  the	  most	  common	  experimentally	  used	  is	  bacterial	  LPS,	  a	  ligand	  of	  TLR4.	  Binding	  of	  this	  ligand	  increases	  the	  stability	  of	  IL-­‐1β	  mRNA	  and	  allows	  more	  pro-­‐IL-­‐1β	  to	  be	  produced	  (Bufler	  et	  al.	  2004).	  	  More	   recently,	   the	   involvement	   of	   an	   RNase,	   MCPIP,	   a	   product	   of	   the	  
ZC3H12A	   gene,	   has	   been	   implicated	   in	   the	   transcriptional	   control	   of	   IL-­‐1β	   by	  premature	  degradation	  of	  the	  IL-­‐1β	  message	  (Mizgalska	  et	  al.	  2009).	  Induction	  of	  the	   ZC3H12A	   gene	   was	   later	   shown	   to	   be	   a	   result	   of	   IL-­‐1β	   stimulation	   itself,	  suggesting	  a	  negative	  feedback	  control	  mechanism	  for	  IL-­‐1β	  translation	  (Kasza	  et	  al.	  2010).	  Altering	   IL-­‐1β	   stability	   at	   the	   message	   level	   could	   provide	   cells	   with	   an	  additional	   layer	   of	   control	   over	   IL-­‐1β	   signalling	   and	   allow	   the	   removal	   of	   excess	  transcripts	  in	  the	  event	  of	  a	  transient	  inflammatory	  insult,	  mRNA	  could	  be	  rapidly	  degraded	  without	  initiating	  protein	  translation.	  
1.4	  Post-­‐Translational	  processing.	  
1.4.1	  NLRs	  and	  Inflammasomes	  In	   mammalian	   cells,	   IL-­‐1β	   is	   released	   from	   cells	   as	   a	   mature	   cytokine	  following	   its	   conversion	   from	   pro-­‐IL-­‐1β	   by	   proteolytic	   cleavage;	   separating	   the	  bioactive	   IL-­‐1β	   subunit	   from	   the	   pro-­‐domain.	   This	   action	   is	   performed	   by	   the	  Interleukin	  1	  converting	  enzyme	  now	  known	  as	  caspase-­‐1	  (DK	  Miller	  et	  al.	  1993).	  Although	   in	   this	  process	  caspase-­‐1	   is	  essential	   for	   the	  release	  of	  mature	   IL-­‐1β,	   it	  has	   also	  been	   linked	   to	   the	  processing	  of	   at	   least	  77	  other	   extracellular	  proteins	  involved	  in	  initiating	  and	  recovering	  from	  inflammatory	  processes	  (M.	  Keller	  et	  al.	  2008)	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Figure	   1.3.	   Inflammasomes	   are	   mediators	   of	   IL-­‐1β	   processing	   and	   share	  
common	  domain	  architectures.	  IL-­‐1β	  	  is	  processed	  by	  caspase-­‐1,	  which	  in	  turn	  is	  activated	  by	   inflammasome	  complexes.	   Inflammasomes	  are	   responsive	   to	  a	  wide	  range	  of	  stimuli,	  via	  activation	  of	  different	  Pattern	  Recognition	  Receptors	  (PRRs).	  Different	   PRRs	   oligomerise	   into	   different	   inflammasomes	   with	   a	   unique	   set	   of	  ligands.	  Inflammasomes	  bind	  caspase-­‐1	  via	  a	  caspase	  recruitment	  domain	  (CARD)	  present	  either	  on	   the	  PRR	  protein,	  or	  via	  apoptosis-­‐associated	  speck-­‐like	  protein	  containing	  a	  CARD	  (ASC),	  an	  adaptor	  protein.	  Displayed	  are	  NLRP,	  NLRC	  and	  AIM	  inflammasomes.	  (adapted	  from	  Rathinam	  et	  al,.(2012))	  	  	   	  
10	  
	   Caspase-­‐1	  itself	  is	  produced	  as	  a	  pro-­‐peptide	  and	  is	  proteolytically	  activated	  (Ayala	  et	  al.	  1994)	  by	  an	  autocatalytic	  method	  (K.	  Wilson	  et	  al.	  1994)	  following	  the	  reception	   of	   a	   secondary	   inflammatory	   signal,	   a	   PAMP	   or	   DAMP,	   often	   distinct	  from	  the	  stimulus	  necessary	  for	  the	  induction	  of	  IL-­‐1β,	  such	  as	  the	  ATP	  mediated	  IL-­‐1β	   response	   in	   LPS	   primed	   monocytes	   (MacKenzie	   et	   al.	   2001).	   Hereby,	   the	  release	  of	  mature	   IL-­‐1β	  requires	  a	  secondary	  stimulus	  and	  an	  additional	   layer	  of	  regulatory	  control.	  This	   secondary	  signal	   initiates	   the	  assembly	  and	  activation	  of	  the	  large	  multiprotein	  complex	  known	  as	  the	  Inflammasome,	  whose	  function	  is	  to	  produce	  mature	   IL-­‐1 β	   through	   the	   activation	   of	   Caspase-­‐1	   (P.	   Li	   et	   al.	   1995;	   B.	  Miller	  et	  al.	  1995)	  (Figure	  1.3)	  	   A	  number	  of	  proteins	  are	  necessary	   for	   the	   function	  of	   an	   inflammasome,	  but	   key	   to	   these	   are	   a	   number	   of	   protein	   domains.	   At	   the	   most	   basic	   level,	   to	  perform	  the	  function	  of	  an	  inflammasome,	  a	  caspase	  recruitment	  domain	  (CARD)	  able	  to	  interact	  with	  the	  CARD	  domain	  of	  caspase-­‐1,	  and	  a	  PRR	  capable	  of	  sensing	  an	  inflammatory	  stimulus	  are	  necessary	  (Martinon	  et	  al.	  2002;	  Franchi	  et	  al.	  2006).	  Inflammasome	   PRRs	   take	   the	   form	   of	   Nod	   like	   receptors	   or	   NLR	   proteins,	  containing	   LRR	   domains	   for	   pattern	   recognition.	   NLRs	   have	   a	   number	   of	   other	  features	   exemplified	   in	   the	   most	   characterised,	   and	   perhaps	   the	   most	   complex	  inflammasome	  based	  on	   the	  NACHT,	  LRR	  and	  PYD	  domains-­‐containing	  protein	  3	  (NLRP3).	   In	  an	  NLRP3	   inflammasome,	  NLRP3	  acts	  as	   the	  primary	  PRR	  and	  has	  a	  multidomain	  structure	  (Martinon	  et	  al.	  2002);	  the	  LRR	  domain	  acts	  as	  the	  sensor	  for	  inflammatory	  stimuli,	  the	  NACHT	  domain	  is	  responsible	  for	  oligomerisation	  of	  NLRP3	  proteins,	  and	  the	  Pyrin	  domain	  is	  indirectly	  responsible	  for	  the	  recruitment	  of	   caspase-­‐1	   via	   the	   presence	   of	   an	   adaptor	   protein	   (ASC),	   itself	   composed	   of	   a	  Pyrin	   domain	   and	   a	   CARD	   domain.	   NLRP3	   inflammasomes	   are	   responsive	   to	   a	  wide	  array	  of	  stimuli	  (Rathinam	  et	  al.	  2012).	  	   Other	   inflammasome	   complexes,	  making	   use	   of	   differing	   arrangements	   of	  these	   domains	   have	   been	   described.	  NLRP	  proteins,	   like	  NLRP3,	   rely	   on	  ASC	   for	  caspase	  recruitment,	  whereas	  NLRC	  proteins	  have	  a	  CARD	  domain	  of	  their	  own	  in	  lieu	  of	  a	  Pyrin,	  thereby	  not	  requiring	  ASC	  (Mariathasan	  et	  al.	  2004).	  Inflammasome	  PRRs	  do	  not	  always	  take	  the	  form	  of	  a	  Leucine	  rich	  repeat	  as	  in	  NOD	  like	  proteins	  (NLRs)	  of	  the	  NLRP	  and	  NLRC	  families.	  AIM2	  inflammasomes,	  composed	  of	  a	  Pyrin	  domain	  and	  a	  HIN	  domain,	  instead	  detect	  double	  stranded	  DNA	  by	  binding	  directly	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via	   their	   HIN	   domain.	   Although	   AIM2	   inflammasomes	   have	   a	   limited	   ability	   to	  recognise	   self-­‐DNA,	   the	   presence	   of	   double	   stranded	  DNA	   in	   the	   cytosol	   is	  most	  often	  a	  sign	  of	  bacterial	  or	  viral	  infection.	  	   Although	   Inflammasome	   PRR	   proteins	   containing	   pyrin	   domains,	   such	   as	  NLRP	   and	   AIM	   based	   inflammasomes,	   require	   apoptosis-­‐associated	   speck-­‐like	  protein	  containing	  a	  CARD	  (ASC)	  for	  their	  function	  (Hornung	  et	  al.	  2008;	  Hornung	  et	   al.	   2009).	   ASC	   is	   also	   capable	   of	   potentiating	   the	   response	   of	   NLRC	  inflammasomes,	  which	  can	  mediate	  caspase-­‐1	  activation	  through	  their	  own	  CARD	  domain,	   but	   show	   a	   decrease	   in	   IL-­‐1β	   production	   in	   ASC-­‐/-­‐	   cells	   demonstrating	  that	   caspase-­‐1	   is	   activated	   more	   effectively	   in	   the	   presence	   of	   ASC	   in	   these	  inflammasomes	  (Miao	  et	  al.	  2006).	  	   The	   precise	   mechanism	   of	   activation	   of	   inflammasomes	   is	   poorly	  characterised.	   The	   activation	   of	   NLRC4	   inflammasomes	   through	   direct	   detection	  and	  binding	  of	  bacterial	  flagellin	  by	  the	  NAIP	  protein	  family	  and	  interaction	  of	  this	  protein	  with	  NLRC4	  has	  been	  demonstrated	  (Kofoed	  &	  Vance	  2011;	  Y.	  Zhao	  et	  al.	  2011),	   as	   has	   the	   ability	   of	   AIM2	   inflammasomes	   to	   bind	   directly	   to	   dsDNA	  (Hornung	  et	  al.	  2009;	  Bürckstümmer	  et	  al.	  2009).	  However,	   the	  activation	  of	   the	  archetypal	  NLRP3	  inflammasome	  (Jin	  &	  Flavell	  2010)	  remains	  to	  be	  understood.	  	  NLRP3	  is	  present	  as	  a	  multimeric	  protein	  in	  the	  cytoplasm	  of	  immune	  cells,	  it	   oligomerises	   through	   an	   LRR	   domain,	   with	   assembly	   into	   the	   inflammasome	  based	   on	   a	   pyrin	   domain	   interaction	   with	   ASC.	   The	   sensory,	   and	   presumably	  activation	  functions	  of	  NLRP3	  are	  performed	  by	  a	  NACHT	  domain.	  However,	  it	  has	  also	  been	  shown	  that	  the	  pyrin	  domain	  of	  NLRP3	  can	  itself	  inhibit	  inflammasome	  function,	  so	  perhaps	  inflammasome	  activation	  results	  in	  the	  change	  or	  removal	  of	  this	  domain	  from	  caspase-­‐1	  (Chae	  et	  al.	  2006).	  NLRP3	  is	  essential	  for	  the	  primary	  IL-­‐1β	  release	  pathway	  of	  IL-­‐1β	  from	  macrophages	  (Sutterwala,	  Ogura,	  Zamboni,	  et	  al.	  2006;	  Sutterwala,	  Ogura,	  Szczepanik,	  et	  al.	  2006)	  and	  it	  seems	  that	  mature	  IL-­‐1β	  also	  depends	  on	  the	  presence	  of	  ASC	  to	  be	  released	  (Pelegrín	  et	  al.	  2008).	  The	  NLRP3	  inflammasome	  is	  assembled	  in	  response	  to	  pathogen	  stimulation,	  as	  shown	  by	   the	   nuclear	   distribution	   of	   ASC	   until	   stimulation	   with	   PAMPs	   (Bryan	   &	  Dorfleutner	  2009);	  at	  which	  point	  ASC	  is	  shuttled	  to	  the	  cytoplasm	  and	  associates	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into	  aggregate	  complexes	  with	  Caspase-­‐1,	  some	  near	  the	  cell	  surface	  at	  possible	  IL-­‐1β	  release	  sites	  (Pelegrín	  &	  Surprenant	  2009b).	  	   NLRP3	  inflammasomes	  assemble	  and	  activate	  in	  response	  to	  a	  broad	  range	  of	  stimuli,	  ranging	  from	  bacterial	  and	  viral	  pathogens	  (Meixenberger	  et	  al.	  2010;	  S.	  Kim	   &	   Bauernfeind	   2010;	   I.	   Allen	   et	   al.	   2009),	   to	   danger	   signals	   such	   as	   silica,	  asbestos	  and	  uric	  acid	  crystals	  (Gasse	  et	  al.	  2009;	  Dostert	  et	  al.	  2008;	  Hornung	  et	  al.	  2008),	  and	  such	  a	  wide	  assortment	  of	  mechanisms	  implies	  that	  NLRP3	  does	  not	  directly	  sense	  these	  stimuli.	  Instead,	  three	  potential	  mechanisms	  for	  this	  activation	  have	  been	  proposed	  (Jin	  &	  Flavell	  2010).	  NLRP3	  inflammasomes	  can	  be	  activated	  directly	  by	  potassium	  efflux	  from	  the	  cell	  (Pétrilli	  et	  al.	  2007),	  by	  reactive	  oxygen	  species	   (ROS)	   produced	   from	   mitochondria	   (Cruz	   et	   al.	   2007)	   and	   by	   the	  disruption	   of	   phagolysosomes	   by	   crystalline	   compounds	   (Hornung	   et	   al.	   2008).	  Interestingly,	  both	  K+	  efflux	  and	  ROS	  production	  can	  be	  linked	  to	  the	  detection	  of	  extracellular	  ATP	  by	  the	  P2X7	  receptor	  (Pelegrín	  &	  Surprenant	  2009b)(Cruz	  et	  al.	  2007;	  Pétrilli	  et	  al.	  2007).	  Blocking	  the	  P2X7	  receptor	  with	  a	  selective	  antagonist	  in	  an	   inflammatory	  macrophage	   subtype	   (M1)	   (Scotton	   et	   al.	   2005;	  Martinez	   et	   al.	  2006)	   prevents	   NLRP3	   activation	   through	   the	   other	   methods,	   not	   just	   the	   ATP	  dependant	   pathway,	   but	   the	   mechanisms	   were	   unclear	   (Pablo	   Pelegrin	   &	  Annmarie	  Surprenant	  2009a).	  	  
1.4.2	  Non-­‐caspase-­‐1	  mediated	  mechanisms	  of	  IL-­‐1β	  processing.	  Although	   caspase-­‐1	   is	   the	   primary	   mediator	   of	   IL-­‐1β	   processing,	   other	  mechanisms	   of	   IL-­‐1β	   cleavage	   have	   been	   described.	   Mice	   deficient	   in	   caspase-­‐1	  were	   still	   capable	   of	   developing	   arthritic	   symptoms,	   and	   mature	   IL-­‐1β	   was	  recovered	   from	   synovial	   joints	   and	   inflammatory	   lesions	   (Guma	   et	   al.	   2009)	  (Joosten	   &	   Netea	   2009).	   Elastase	   and	   chymase	   activity	   has	   been	   proposed	   as	   a	  mechanism	  for	  cleavage,	  inhibition	  of	  which	  lessened	  arthritic	  symptoms	  (Guma	  et	  al.	  2009).	  Caspase-­‐1	  deficient	  mice	  were	  also	  capable	  of	  producing	  a	  bioactive	  IL-­‐1β	   in	   response	   to	   turpentine	   treatment	   (Fantuzzi	   et	   al.	   1997).	   IL-­‐1β	   cleavage	  resulting	  in	  a	  molecule	  with	  30%	  bioactivity	  of	  mature	  IL-­‐1β	  was	  reported	  due	  to	  granzyme	  A	  mediated	  cleavage	  (Irmler	  et	  al.	  1995),	  and	  Matrix	  Metalloproteinase	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mediated	  cleavage	  was	  observed	  for	  MMP2,	  3	  and	  9	  (Schönbeck	  et	  al.	  1998).	  Other	  caspases	   have	   also	   been	   implicated	   in	   the	   processing	   of	   IL-­‐1β, which	   is	   also	  cleaved	  at	  the	  caspase-­‐1	  cleavage	  site	  by	  caspase-­‐8	  (Maelfait	  et	  al.	  2008).	  Bacterial	   proteins	   have	   also	   been	   implied	   in	   IL-­‐1β	   cleavage,	   with	   the	  suggestion	  that	  this	  is	  an	  attempt	  to	  maintain	  an	  inflammatory	  niche	  in	  C.	  albicans	  and	  S.	  aureus	  infection,	  however	  it	  was	  also	  shown	  that	  these	  varying	  forms	  of	  IL-­‐1β	  cleavage	  were	  less	  bioactive	  than	  caspase-­‐1	  processed	  IL-­‐1β	  and	  that	  this	  was	  a	  function	  of	  the	  increased	  size	  of	  the	  molecule	  (R.	  Black	  et	  al.	  1988;	  Schönbeck	  et	  al.	  1998).	  Extracellular	  processing	  mechanisms	  have	  been	  proposed	  as	  a	  route	  for	  the	  production	   of	   mature	   IL-­‐1β	   cytokine	   post	   pyroptosis	   by	   cells	   in	   inflammatory	  lesions,	  a	  mechanism	  possibly	  subverted	  by	  bacterial	  processing.	  	  
1.4.3	  P2X7	  receptor	  function.	  Rapid	  release	  of	  IL-­‐1β	  from	  innate	  immune	  cells	  is	  triggered	  by	  reception	  of	  an	  exogenous	  ATP	  danger	  signal	  by	  the	  P2X7	  receptor	  on	  the	  cell	  surface	  (Sanz	  &	  Di	  Virgilio	  2000).	  The	  P2X7	  receptor	   is	  a	  purinergic	   receptor	   that	   forms	  a	  cation	  pore	  on	  binding	  extracellular	  ATP	  signal	  (Perregaux	  &	  Gabels	  1994;	  Rassendren	  et	  al.	  1997).	  In	  this	  context,	  receptor	  activation	  leads	  to	  the	  efflux	  of	  K+	  ions	  from	  the	  cell	   (Surprenant	   et	   al.	   1996),	   but	   is	   also	   coupled	   to	   the	  much	   larger	   pannexin-­‐1	  channel,	   which	   it	   can	   activate	   to	   make	   the	   cell	   membrane	   permeable	   to	   much	  larger	  sized	  molecules	  of	  up	  to	  900Da	  (Ferrari	  et	  al.	  2006;	  Pelegrín	  &	  Surprenant	  2006;	   Pétrilli	   et	   al.	   2007;	   Pelegrín	   et	   al.	   2008).	   Pelegrin	   and	   Surprenant	   (2006)	  posit	   that	   since	   a	   pannexin-­‐1	   siRNA	   knockdown	   inhibits	   IL-­‐1β	   processing,	   the	  cation	  efflux	  is	  not	  itself	  responsible	  for	  the	  activation	  of	  the	  NLRP3	  inflammasome	  and	   that	   the	  pannexin	   channel	  may	  offer	   a	  novel	  way	   that	   extracellular	  ATP	   can	  enter	  the	  cell	  and	  activate	  IL-­‐1β	  processing	  by	  a	  more	  direct	  method.	  Nevertheless,	  it	  is	  also	  clear	  that	  pannexin-­‐1	  is	  essential	  for	  the	  activation	  of	  the	  inflammasome	  through	  recruitment	  by	  P2X7	  (Kanneganti	  et	  al.	  2007;	  Locovei	  et	  al.	  2007).	  It	  has	  now	   been	   suggested	   that	   pannexin-­‐1	   itself	   is	   activated	   by	   high	   extracellular	  concentrations	  of	  K+,	  and	   that	   the	  presence	  of	   these	  cations	  outside	   the	  cell	   in	  a	  locally	  high	  concentration	  is	  responsible	  for	  the	  activation	  the	  channel	  (Silverman	  &	  Vaccari	  2009).	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  An	   interesting	   development	   is	   the	   proposition	   of	   novel	   mechanisms	   of	  inflammasome	   control;	   Pelegrin	   and	   Surprenant	   (2009a)	   have	   shown	   that	   the	  inflammasome	   is	   inhibited	   in	   the	   M2,	   or	   resolution	   type,	   macrophage	   by	   ATP	  acting	  independently	  of	  the	  P2X7	  receptor.	  This	  process	  occurs	  through	  the	  direct	  reduction	  of	  ROS	  production,	  and	   the	  rearrangement	  of	   the	  cell’s	  cytoskeleton	   to	  confine	  inflammasome	  components	  and	  restrict	  the	  formation	  of	  the	  complex.	  This	  gives	   an	   indication	   that	   perhaps	   IL-­‐1β	   release	   can	   be	   controlled	   in	   M1	  macrophages	  through	  the	  manipulation	  of	  these	  same	  mechanisms.	  	  
1.5	  IL-­‐1β	  release	  Numerous	   mechanisms	   for	   the	   release	   of	   IL-­‐1β	   from	   immune	   cells	   have	  been	  described,	  and	  although	  these	  mechanisms	  may	  not	  be	  entirely	  IL-­‐1β	  specific,	  these	  highlight	  the	  evolutionary	  importance	  of	  the	  control	  of	  IL-­‐1β	  signalling.	  It	  has	  been	  proposed	  that	  these	  mechanisms	  occupy	  a	  “spectrum”	  of	  release	  dependent	  on	  the	  severity	  of	  stimuli	  that	  the	  immune	  cells	  experience	  with	  low	  level	  continual	  release	   a	   feature	  of	   local	   inflammation,	   protected	   release	   a	   response	   to	   stronger	  stimuli	  with	  the	  most	  severe	  inflammatory	  insults	  resulting	  in	  a	  “terminal”	  release	  of	  IL-­‐1β.	  Furthermore,	  it	  is	  also	  likely	  that	  more	  than	  one	  of	  these	  mechanisms	  can	  be	  engaged	  in	  response	  to	  a	  stimulus	  (López-­‐Castejón	  &	  Brough	  2011),	  and	  it	  must	  be	  made	  clear	   that	   in	  vitro	   studies	  of	   IL-­‐1β	  release	  may	  not	  accurately	   represent	  this	  full	  spectrum	  by	  concentrating	  on	  a	  specific	  stimulus	  rather	  than	  considering	  the	  whole	  cell	  microenvironment	  in	  its	  totality.	  
1.5.1	  Low	  level	  release	  mechanisms	  Early	  in	  the	  history	  of	  IL-­‐1β	  research	  it	  was	  shown	  that	  IL-­‐1β	  lacks	  a	  signal	  peptide	  or	   leader	   sequence	   required	   for	   its	   release	   via	   conventional	   protein	   secretion	  pathways	  (Auron	  &	  Webb	  1984),	  and	  that	  IL-­‐1β	  was	  processed	  prior	  to	  its	  release	  from	  the	  cell	  (Auron	  et	  al.	  1987).	  IL-­‐1β	  release	  from	  monocytes	  was	  shown	  to	  be	  independent	   of	   cell	   death	   and	   insensitive	   to	   inhibition	   by	   golgi/ER	   pathway	  inhibitors	   (Rubartelli	   et	   al.	   1990),	   and	   these	   data	   pointed	   to	   a	   novel	   secretory	  pathway	  for	  IL-­‐1β.	  Rubartelli	  et	  al.	  (1990)	  demonstrated	  that	  IL-­‐1β	  was	  contained	  within	  monocyte	  fractions	  resistant	  to	  trypsin	  degradation	  unless	  first	  treated	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with	  detergent,	  providing	  evidence	  that	  IL-­‐1β	  was	  present	  in	  intracellular	  vesicles,	  later	   shown	   to	   be	   endolysosomes	   (Andrei	   et	   al.	   1999).	   These	   IL-­‐1β	   containing	  endolysosomal	   bodies	   are	   targeted	   for	   degradation	   via	   the	   autophagy	   pathway,	  disruption	   of	   which	   results	   in	   an	   increase	   in	   IL-­‐1β	   secretion	   from	   the	   cell,	   a	  mechanism	   suggested	   as	   a	   limit	   to	   secretion	   of	   the	   cytokine	   (Saitoh	   et	   al.	   2008;	  Harris	  et	  al.	  2011).	   It	  has	  been	  hypothesized	  that	  IL-­‐1β	   is	  constantly	  turned	  over	  within	  the	  cell,	  and	  that	   this	  release	  pathway	  redirects	   this	   turnover	  to	  secretion	  under	  the	  appropriate	  stimuli,	  a	  mechanism	  termed	  “rescue	  and	  release”	  (López-­‐Castejón	  &	  Brough	  2011).	  Alongside	   this	  pathway,	   a	  direct	   transport	  mechanism	  for	   IL-­‐1β	   independent	  of	  secretory	   lysosomes	  has	  also	  been	  proposed	  (Brough	  &	  Rothwell	  2007)	  (Figure	  1.4).	  
1.5.2	  Pyroptosis	  as	  a	  mechanism	  for	  IL-­‐1β	  release	  IL-­‐1β	  has	  been	  demonstrated	  as	  a	  product	  of	  the	  inflammatory	  macrophage	  cell	   death	   pathway	   pyroptosis	   (Le	   Feuvre	   et	   al.	   2002;	   Bergsbaken	   et	   al.	   2010).	  Pyroptosis	   is	   an	   inflammatory	   programmed	   cell	   death,	   related	   to	   apoptosis	   but	  with	  key	  differences:	  like	  apoptosis,	  pyroptosis	  is	  mediated	  by	  caspases,	  though	  in	  this	  case,	  the	  inflammatory	  caspase-­‐1,	  is	  required	  for	  pyroptosis	  to	  occur	  (Hersh	  et	  al.	   1999).	   Unlike	   apoptosis,	  which	   does	   not	   trigger	   an	   inflammatory	   reaction	   by	  packaging	   cellular	  material	   into	   apoptotic	   bodies	   later	   phagocytosed	  by	   immune	  cells,	   pyroptosis	   is	   a	   pro-­‐inflammatory	   lysis	   of	   innate	   immune	   cells	   (Brennan	   &	  Cookson	   2000).	   Immune	   cells	   undergoing	   pyroptosis	   experience	   caspase-­‐1	  mediated	   membrane	   pore	   formation	   (Fink	   et	   al.	   2008)	   resulting	   in	   loss	   of	  membrane	  asymmetry	  demonstrated	  by	  dye	  uptake	  and	  phosphatidylserine	   (PS)	  flip	  on	  the	  cell	  surface,	  a	  process	  differing	  from	  apoptosis	  where	  PS	  flip	  is	  observed	  but	  membrane	  integrity	  is	  maintained	  (Brennan	  &	  Cookson	  2000).	  Pore	  formation	  allows	  osmotic	   lysis	  of	  macrophages	  as	  excess	  water	   crosses	   the	  membrane	   into	  the	   cell	   and	   results	   in	   the	   release	   of	   the	   cell	   contents	   into	   the	   cellular	   milieu,	  concurrently	  releasing	  large	  amounts	  of	  processed	  IL-­‐1β	  alongside	  other	  cytokines	  (Fink	  &	  Cookson	  2006).	   Pyroptosis	   is	   entirely	   caspase-­‐1	  dependent	   as	   inhibiting	  caspase-­‐1	   also	   inhibits	   this	   cell	   death	   pathway	   (Hersh	   et	   al.	   1999;	   Brennan	   &	  Cookson	   2000).	   Pyroptosis	   is	   independent	   of	   caspase-­‐3	   activation	   (Brennan	   &	  Cookson	   2000),	   and	   apoptotic	   pathways	   remain	  mechanistically	   independent	   of	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pyroptosis	   (P.	   Li	   et	   al.	   1995)	   delineating	   this	   as	   two	   separate	   pathways	   to	   cell	  death.	  	   Certain	   intracellular	  pathogens,	   such	  as	   legionella	   (L.	  Y.	  Gao	  &	  Abu	  Kwaik	  1999)	  and	  Yersinia	   (Bergsbaken	  &	  Cookson	  2007)	  can	  initiate	  a	  sterile,	  apoptotic	  cell	   death	   dependent	   upon	   caspase-­‐3	   in	   macrophages.	   However,	   this	   can	   be	  switched	  to	  a	  pyroptotic	  death	  if	  this	  infection	  is	  in	  pre-­‐activated	  rather	  than	  naïve	  cells	   (Bergsbaken	  &	  Cookson	  2007).	  Although	  pyroptosis	  has	  been	  described	   for	  sterile	   stimuli,	   such	   as	   prolonged	   P2X7	   receptor	   activation,	   pyroptosis	   has	  most	  commonly	   been	   detected	   in	   response	   to	   potent	   intracellular	   pathogens,	   such	   as	  
Yersinia,	  Legionella,	  Salmonella	   and	  anthrax	   toxin	   (Hersh	  et	   al.	   1999;	  L.	  Y.	  Gao	  &	  Abu	   Kwaik	   1999;	   Fink	   et	   al.	   2008)	   and	   this	   proposes	   an	   evolutionary	   basis	   for	  pyroptosis;	   as	   a	   number	   of	   these	   pathogens	   induce	   apoptosis	   in	   host	   cells	   as	   a	  possible	  mechanism	  for	  further	  infection,	  pyroptosis	  could	  act	  as	  a	  switch	  to	  warn	  nearby	   cells	   of	   this	   attempt	   to	   subvert	   cellular	   machinery.	   As	   such,	   pyroptosis	  sends	   a	   very	   “urgent”	   and	  potent	   signal	   to	   surrounding	   cells	  with	   the	   effectively	  uncontrolled	   release	   of	   normally	   strictly	   controlled,	   intracellular,	   pro-­‐inflammatory	   factors	  such	  as	  mature	   IL-­‐1β	  and	   tumour	  necrosis	   factor	  α	   (TNFα)	  (Bergsbaken	  et	  al.	  2010).	  	  
1.5.3	  Vesicular	  and	  endosomal	  release	  pathways	  Alongside	  rescue	  and	  release	  mechanisms,	  and	  the	  localised	  release	  of	  IL-­‐1β	  from	   inflammatory	   cell	   death,	   an	   interesting	   IL-­‐1β	   release	   mechanism	   via	   the	  membrane-­‐derived	   microvesicles	   from	   macrophages	   has	   been	   described.	   These	  vesicles	  contain	  both	  mature,	  biologically	  active	  IL-­‐1β	  as	  well	  the	  ability	  to	  process	  pro-­‐IL-­‐1β	   using	   packaged	   inflammasome	   components	   such	   as	   caspase-­‐1,	  suggesting	   that	   the	   site	   for	   the	   release	   of	   these	   vesicles	   is	   close	   to	   the	   site	   of	  inflammasome	  mediated	  caspase-­‐1	  activation,	  and	  that	  the	  release	  and	  processing	  pathways	   are	   likely	   related	   (Pelegrín	   &	   Surprenant	   2009b),	   Mackenzie	   et	   al.,	  (MacKenzie	   et	   al.	   2001)	  demonstrate	   that	   the	   release	  of	  microvesicles	   is	  distinct	  from	  cell	  lysis	  and	  is	  a	  very	  rapid	  process,	  however	  the	  mechanism	  by	  which	  these	  vesicles	   are	   packaged	   and	   released	   is	   unknown.	   This	   microvesicle	   based	   IL-­‐1β	  release	  pathway	  has	  also	  been	  demonstrated	  in	  microglia	  (Bianco	  et	  al.	  2005)	  and	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dendritic	  cells	  (Pizzirani	  et	  al.	  2007),	  and	  its	  presence	  in	  these	  cell	  types	  implies	  its	  functions	   as	   a	   release	   mechanism	   within	   tissues	   as	   well	   as	   in	   the	   bloodstream.	  Microvesicles	   are	   capable	   of	   releasing	   IL-­‐1β	   in	   response	   to	   ATP	   stimulation	   of	  P2X7	   receptors	   on	   their	   cell	   membranes	   (Pizzirani	   et	   al.	   2007),	   and	   that	   this	  mechanism	  is	  due	  to	  lysis	  of	  these	  vesicles	  (Bianco	  et	  al.	  2005).	  	  	   IL-­‐1β	   is	   also	   found	   within	   smaller	   membrane	   bound	   vesicles	   termed	  exosomes,	   first	   identified	   in	   murine	   macrophages	   by	   the	   presence	   of	  endolysosomal	  markers,	   such	   as	  LAMP1.	  These	   exosomes	   act	   as	   a	  mechanism	  of	  IL-­‐1β	   release	   with	   significantly	   different	   kinetics	   from	   membrane	   derived	  microvesicle	  release	  in	  terms	  of	  LPS	  priming	  (Qu	  et	  al.	  2007).	  Exosomal	  release	  of	  IL-­‐1β	  is	  highly	  dependent	  on	  the	  NLRP3	  inflammasome,	  however	  is	  paradoxically	  not	   dependent	   on	   caspase-­‐1,	   as	   it	   still	   occurs	   in	   macrophages	   derived	   from	  caspase-­‐1	  deficient	  mice	  (Qu	  et	  al.	  2009).	  Exosomes	  are	  significantly	  smaller	  than	  membrane	  microvesicles,	  being	  50-­‐80nm	  in	  diameter,	  rather	  than	  100-­‐600nm	  for	  microvesicles	  (Qu	  et	  al.	  2009).	  Vesicles	  and	  exosomes	  could	  be	  an	  evolutionary	  mechanism	  to	  deliver	  IL-­‐1β	  to	   sites	   of	   inflammation	   and	   overcome	   the	   limited	   half-­‐life	   of	   IL-­‐1β	   in	   the	  circulation	  (Kudo	  et	  al.	  1990),	  but	  also	  as	  a	  potential	  response	  to	  the	  potency	  of	  IL-­‐1β	  and	  the	  danger	  of	  unnecessary	  proinflammatory	  signalling	  and	  off	  target	  effects	  on	  surrounding	  cells.	  The	  potential	  benefit	  of	  release	  using	  vesicular	  bodies	  is	  that	  IL-­‐1β,	   and	   in	   fact	   other	   proteins	   co-­‐released	   with	   the	   vesicles	   are	   delivered	   to	  target	   cells	   at	   a	   high	   concentration.	   Such	   packaging	   avoids	   dilution	   within	   the	  extracellular	   environment	   (Hugel	   &	   Martínez	   2005)	   confers	   protection	   from	  degradation	   due	   to	   their	   membrane	   encapsulation.	   These	   mechanisms	   have	  therefore	  been	  termed	  “protected	  release”	  (López-­‐Castejón	  &	  Brough	  2011).	  	  
1.6	  Mechanisms	  of	  microvesicle	  formation	  and	  release.	  
1.6.1	  Phosphatidylserine	  signalling	  Preceding	   the	   release	   of	   IL-­‐1	   containing	   vesicles,	   a	   phosphatidylserine	  (Eisenberg	   et	   al.	   1990)	   flip	   from	   the	   internal	   to	   external	   membrane	   face	   is	  detectable	  on	  the	  surface	  of	  releasing	  cells	  (MacKenzie	  et	  al.	  2001),	  which	  may	  be	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related	  to	  the	  method	  of	  release	  and/or	  may	  provide	  a	  method	  for	  these	  vesicles	  to	  interact	   and	   “dock”	   with	   their	   target	   cells.	   This	   PS	   flip	   has	   been	   confirmed	   as	  dependent	  on	  P2X7	  receptor	  stimulation	  and	  extracellular	  calcium	  (Pizzirani	  et	  al.	  2007)	   defining	   these	   vesicles	   as	   distinct	   from	   the	   exosomes	   released	   during	  apoptosis	  and	  other	  processes	  (Aupeix	  et	  al.	  1997;	  Heijnen	  et	  al.	  1999)	  but	  related	  to	   other	   microvesicles	   produced	   in	   processes	   such	   as	   coagulant	   and	   healing	  activity	   (Dachary-­‐Prigent	   et	   al.	   1993;	   Satta	   et	   al.	   1994).	   Therefore	   this	   suggests	  that	   this	   pathway	   of	   IL-­‐1β	   release	  may	  well	   utilise	   a	   pre-­‐existing	  mechanism	   of	  vesicle	  release	  as	  opposed	  to	  one	  specifically	  evolved	  for	  the	  secretion	  IL-­‐1β.	  	  
1.6.2	  Membrane	  structure	  and	  vesicle	  formation	  Phosphatidyl	  serine	  is	  a	  membrane	  lipid	  that	  usually	  lies	  on	  the	  inner	  face	  of	   a	   lipid	   bilayer,	   providing	   an	   ideal	   signal	   to	   detect	   changes	   in	   cell	   state	   or	  signalling	  as	  a	  result	  of	  its	  relocation	  to	  the	  outer	  face	  of	  the	  membrane	  (Fadok	  et	  al.	  1992;	  Fadok	  et	  al.	  1993;	  S.	  Martin	  et	  al.	  1995).	  In	  order	  to	  control	  this	  process	  and	   maintain	   membrane	   asymmetry,	   cells	   have	   an	   ATP	   driven	   translocase,	   an	  active	  enzyme	  responsible	  for	  maintaining	  PS	  on	  the	  inner	  face	  of	  the	  membrane	  (Seigneuret	   1984).	   Loss	   of	  membrane	   asymmetry	   and	   thus	   PS	   externalisation	   is	  achieved	   through	   the	   activity	   of	   a	   Scramblase	   enzyme	   dependent	   on	   Ca2+	   influx	  into	  the	  cell	  for	  its	  activation	  (Stout	  et	  al.	  1996;	  Q.	  Zhou	  et	  al.	  1997).	  In	  red	  blood	  cells,	  the	  proposed	  mechanism	  for	  the	  release	  of	  these	  microvesicles	  following	  the	  loss	   of	   membrane	   asymmetry	   is	   the	   activation	   of	   calpain	   by	   increased	   Ca2+	  concentration,	   resulting	   in	   the	   calpain	   mediated	   cleavage	   of	   the	   underlying	  cytoskeletal	   structure	   (Zwaal	   &	   Schroit	   1997).	   Its	   been	   proposed	   that	   the	  increased	   cellular	   Ca2+	   concentration	   also	   results	   in	   the	   activation	   of	   enzymes	  responsible	   for	   the	   cleavage	   of	   PI(4,5)P2;	   a	   membrane	   lipid	   responsible	   for	  anchoring	  the	  underlying	  cytoskeleton	  to	  the	  plasma	  membrane,	  osmotic	  pressure	  then	   results	   in	   the	   separation	   of	   the	   membrane	   from	   the	   skeleton	   and	   the	  formation	  of	  a	  membrane	  bleb	   (H.	  Keller	  et	  al.	  2009).	   It	  has	  been	  suggested	   that	  this	  blebbing	  is	  a	  function	  of	  the	  release	  of	  IL-­‐1β	  in	  microparticles,	  however	  due	  to	  the	   timescale	   it	   occurs	   at;	   significantly	   later	   than	   the	   release	   of	  microvesicles,	   it	  may	  be	  a	  result	  of	  the	  cell’s	  ability	  to	  release	  microvesicles	  being	  overwhelmed,	  or	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that	   continuous	   exposure	   to	   ATP	   initiates	   blebbing	   to	   engulf	   macrophages	   and	  trigger	  a	  negative	   feedback	   response,	   thereby	  controlling	   inflammation	   (Marguet	  et	  al.	  1999;	  Verhoef	  &	  Estacion	  2003):	  vesicle	  shedding	  is	  visible	  within	  seconds	  of	  a	   secondary	   stimulus	   such	   as	   ATP,	   reception	   and	   the	   accompanied	   tethered	  blebbing	   from	   the	   plasma	   membrane	   takes	   place	   over	   the	   timescale	   of	   a	   few	  minutes.	   The	   two	   processes,	   though	   temporally	   linked,	   have	   been	   shown	   to	   be	  independent	  of	  each	  other.	  Blebbing	  is	  inducible	  upon	  maitotoxin	  (MTX)	  uptake	  or	  by	  non-­‐specific	  large	  pore	  opening	  following	  treatment	  with	  high	  concentrations	  of	  extracellμlar	  K+	  (Verhoef	  et	  al.	  2004),	  supporting	  the	  role	  of	  the	  P2X7	  receptor	  and	  extracellular	  K+	  in	  IL-­‐1β	  processing	  and	  release.	  	  
1.6.3	  Candidate	  microvesicle	  release	  proteins	  The	   release	   of	   membrane-­‐derived	   microvesicles	   remains	   poorly	  understood,	  and	  although	  specific	  proteins	  have	  been	   implicated	   in	   the	  pathway,	  the	   exact	  mechanism	   of	   release	   remains	   to	   be	   determined.	   Bianco	   et	   al.,	   (2009)	  propose	   a	   central	   role	   for	   sphingomyelinase	   in	   this	   release	   pathway,	   citing	   its	  importance	  in	  P2X7	  mediated	  IL-­‐1β	  release	  alongside	  previous	  data	  indicating	  the	  role	   of	   sphingomyelinase	   in	   the	   release	   of	   vesicles	   from	   artificial	   microspheres	  (Nurminen	   et	   al.	   2002),	   and	   its	   role	   in	   membrane	   blebbing	   during	   apoptosis	  (Tepper	   et	   al.	   2000;	   Lépine	   et	   al.	   2006).	   Bianco	   et	   al.,	   (2009)	   suggest	   that	  sphingomyelinase	  mediates	  vesicle	  release	  through	  altering	  membrane	  structure,	  however	  this	  provides	  no	  insight	  into	  the	  packaging	  of	  microvesicle	  contents.	  A	  novel	  binding	  partner	  of	   caspase-­‐1,	  Rab39a	  has	   also	  been	   implicated	   in	  the	  release	  of	  IL-­‐1β	  (C.	  Becker	  et	  al.	  2009).	  Rab39a	  is	  a	  member	  of	  the	  RAB	  GTPase	  family,	  members	  of	  which	  are	  responsible	   for	  membrane	  fusion	  and	  organisation	  (Stenmark	  et	  al.	  2001;	  Zerial	  &	  McBride	  2001).	  Becker	  et	  al.,	   (2009)	  have	  shown	  that	  Rab39a	   is	  required	  for	  IL-­‐1β	  secretion,	  and	  was	   induced	  by	  LPS	  stimulation,	  however	   it	  was	   unclear	  which	   of	   the	   IL-­‐1β	   secretion	   pathways	  Rab39a	   could	   be	  involved	  in.	  	   A	   potential	  mechanism	   for	   the	   release	   of	  microvesicles	   is	   the	   Endosomal	  Sorting	  complex	  required	  for	  Transport	  (ESCRT)	  complexes.	  ESCRT	  proteins	  have	  been	  shown	  to	  allow	  the	  budding	  of	  HIV	  virions	  from	  the	  surface	  of	  the	  cell	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(Garrus	  et	  al.	  2001;	  Demirov	  et	  al.	  2002;	  von	  Schwedler	  et	  al.	  2003;	  Morita	  et	  al.	  2011),	  a	  process	  shown	  to	  be	  similar	  to	  the	  release	  of	  membrane	  microvesicles	  (Gan	  &	  Gould	  2011).	  The	  importance	  of	  the	  ESCRT	  complexes	  has	  been	  shown	  in	  membrane	  scission	  in	  cytokinesis	  (Morita	  et	  al.	  2007;	  Dukes	  et	  al.	  2008)	  which	  also	  involve	  the	  same	  proteins	  as	  viral	  budding	  (Carlton	  &	  Martin-­‐Serrano	  2007).	  ESCRT	  III,	  the	  complex	  responsible	  for	  membrane	  scission,	  is	  capable	  of	  mediating	  the	  formation	  of	  intraluminal	  vesicles	  in	  an	  isolated	  system	  (Wollert	  et	  al.	  2009).	  The	  proposed	  mechanism	  behind	  this	  relies	  on	  the	  ability	  of	  the	  ESCRT	  III	  components,	  CHMP	  proteins,	  to	  self	  assemble	  into	  a	  helical	  structure	  in	  vitro	  through	  the	  formation	  of	  a	  spiral	  oligomer	  (Lata	  et	  al.	  2008).	  Interactions	  between	  these	  spiral	  oligomers	  and	  the	  membrane	  to	  which	  they	  bind	  proposes	  a	  mechanism	  by	  which	  the	  membrane	  could	  buckle,	  resulting	  in	  a	  vesicular	  “bud”	  (Lenz	  et	  al.	  2009;	  Henne	  et	  al.	  2011).	  This	  mechanism	  provides	  an	  ideal	  candidate	  pathway	  for	  the	  biogenesis	  and	  release	  of	  microvesicles	  from	  the	  surface	  of	  a	  plasma	  membrane	  and	  has	  been	  significantly	  better	  characterised	  than	  proposed	  sphingomyelinase	  pathways,	  for	  which	  mechanistic	  details	  are	  less	  clear.	  	  	  
1.7	  IL-­‐1β	  receptors	  and	  signal	  modulation	  
1.7.1	  IL-­‐1RI	  Evolution	   has	   adapted	   further	   regulation	   onto	   IL-­‐1β	   signalling	   with	   the	  strict	   regulation	   of	   IL-­‐1	   signals	   received	   by	   IL-­‐1β	   sensitive	   cells.	   IL-­‐1β	   has	   two	  distinct	  types	  of	  receptors,	  IL-­‐1R1	  and	  IL-­‐1R2,	  both	  with	  differing	  functions	  in	  IL-­‐1β	   sensitive	   cells.	   The	   IL-­‐1R1	   receptor	   is	   a	  member	   of	   the	   TIR	   domain	   receptor	  superfamily	   (Mitcham	  et	   al.	   1996;	  Y.	   Xu	   et	   al.	   2000),	   linked	   to	  TLR	  proteins	   and	  other	  Toll	  based	  receptors	  (Medzhitov	  et	  al.	  1997).	  Control	  over	   the	  efficiency	  of	  signal	   transduction	   by	   these	   receptors	   is	   provided	   through	   the	   existence	   of	  receptor	  subtypes	  that	  transduce	  signals	  less	  efficiently	  or	  not	  at	  all,	  acting	  as	  sinks	  for	  the	  IL-­‐1β	  present.	  	   IL-­‐1R1	  is	  the	  signal	  transducing	  IL-­‐1	  receptor	  and	  is	  a	  complex	  of	  two	  proteins,	  the	  receptor	  unit	  (J.	  Sims	  et	  al.	  1988;	  Vigers	  et	  al.	  1997)	  and	  the	  IL-­‐1	  receptor	  accessory	  protein	  (RAcP),	  which	  is	  necessary	  for	  signal	  transduction	  (Greenfeder	  et	  al.	  1995;	  Korherr	  et	  al.	  1997;	  Cullinan	  et	  al.	  1998),	  IL-­‐1RAcP	  is	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recruited	  to	  IL-­‐1R	  to	  form	  a	  receptor	  complex	  but	  does	  not	  directly	  contact	  IL-­‐1β	  (Casadio	   et	   al.	   2001).	   The	   IL-­‐1RI	   IL-­‐1β	   complex	   is	   also	   internalised	   by	   the	   cell	  (Qwarnstrom	  et	  al.	  1988)	  after	  ligand	  binding,	  reducing	  the	  capability	  of	  the	  cell	  to	  receive	  further	  signals	  (Figure	  1.5).	  	  
1.7.2	  IL-­‐1RII	  IL-­‐1RI	   signalling	   is	   tempered	   by	   another	   controlling	   factor	   in	   the	   form	  of	  the	  IL-­‐1RII	  receptor,	  which	   lacks	  the	  TIR	  domain	  present	  on	  IL-­‐1RI	  (Mcmahan	  et	  al.	   1991).	   IL-­‐1RII	   can	   be	   cleaved	   from	   the	   cell	   surface	   and	   released	   into	   the	  bloodstream	   though	   the	   actions	   of	   an	   aminopeptidase	   (Cui	   et	   al.	   2003).	   In	   both	  cases	  the	  functional	  role	  of	  this	  receptor	  is	  to	  act	  as	  an	  IL-­‐1β	  sink,	  sequestering	  the	  cytokine	   and	   reducing	   the	   amount	   of	   free	   IL-­‐1β	   that	   can	   reach	   and	   induce	   a	  response	  in	  IL-­‐1RI	  (Colotta	  et	  al.	  1993;	  Kollewe	  et	  al.	  2000;	  Neumann	  et	  al.	  2000).	  IL-­‐1RII	   can	  also	   sequester	   the	   IL-­‐1RAcP,	  necessary	   for	   IL-­‐1β	   signal	   transduction,	  preventing	   it	   forming	   functional	   complexes	   with	   IL-­‐1RI	   (Lang	   et	   al.	   1998;	  Malinowsky	  &	  Lundkvist	  1998).	  Soluble	  IL-­‐1RAcP	  also	  binds	  to	  the	  soluble	  variant	  of	   IL-­‐1RII,	   enhancing	   its	   binding	   properties	   and	   allowing	   it	   to	   sequester	   IL-­‐1β	  more	  effectively	  (D.	  Smith	  et	  al.	  2003).	  	  
1.7.3	  IL-­‐1Ra	  and	  Anakinra	  IL-­‐1	  receptor	  antagonist	  (RA)	  was	  discovered	  in	  a	  sequence	  search	  for	  IL-­‐1β	  matching	  genes	  (Eisenberg	  et	  al.	  1990),	  as	  such	  IL-­‐1RA	  is	  on	  the	  same	  genomic	  region	  as	  IL-­‐1α	  and	  IL-­‐1β,	  showing	  a	  common	  ancestry	  for	  this	  gene	  and	  indicating	  an	  evolution	  based	  on	  gene	  duplication	  (Nicklin	  &	  Weith	  1994).	  IL-­‐1RA	  is	  a	  natural	  competitive	  inhibitor	  (Schreuder	  et	  al.	  1997)	  of	  IL-­‐1β	  signalling	  as	  it	  binds	  to	  the	  same	  receptors	  but	  cannot	  initiate	  signalling	  due	  to	  its	  inhibition	  of	  IL-­‐1RAcP	  binding	  and	  blockage	  of	  the	  IL-­‐1RI	  complex	  formation	  during	  IL-­‐1β	  signalling	  (Greenfeder	  et	  al.	  1995).	  Recombinant	  IL-­‐1RA	  has	  been	  marketed	  under	  the	  name	  Anakinra,	  which	  has	  been	  approved	  for	  the	  treatment	  of	  rheumatoid	  arthritis	  (Bresnihan	  et	  al.	  1998;	  Jiang	  et	  al.	  2000;	  S.	  Cohen	  et	  al.	  2002;	  Mertens	  &	  Singh	  2009)	  and	  is	  being	  investigated	  for	  the	  treatment	  of	  other	  inflammatory	  conditions	  (So	  &	  De	  Smedt	  2007).	  Numerous	  studies	  have	  also	  been	  conducted	  on	  Anakinra	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Figure	   1.5.	   IL-­‐1β	   signalling	   is	   subject	   to	   control	   at	   the	   signalling	   level.	  The	  receptor	  for	  IL-­‐1β,	  IL-­‐1RI	  requires	  an	  accessory	  protein,	  IL-­‐1RAcP,	  to	  transduce	  a	  signal.	   Downstream	   genes	   are	   activated	   via	   NF-­‐κB	   signalling,	   which	   is	   both	  upstream	  and	  downstream	  of	  the	  IL-­‐1β	  pathway.	  Receptor	  signalling	  is	  regulated	  by	  decoy	  receptor	  IL-­‐1RII,	  in	  both	  membrane	  bound	  and	  soluble	  forms,	  incapable	  of	  transducing	  a	  signal	  and	  acting	  as	  sinks	  for	  both	  IL-­‐1β	  and	  IL-­‐1RAcP,	  IL-­‐1RAcP	  is	  also	   present	   on	   soluble	   receptors,	   enhancing	   IL-­‐1β	   binding.	   IL-­‐1β	   is	   further	  regulated	  by	  endogenous	  ligand	  IL-­‐1Ra,	  capable	  of	  binding	  IL-­‐1RI,	  but	  preventing	  binding	  of	  IL-­‐1RAcP.	  	   	  
24	  
safety	  (Nuki	  et	  al.	  2002;	  Fleischmann	  et	  al.	  2006),	  with	  possible	  side	  effects	  arising	  from	  the	  immunosuppressive	  effect	  of	  inhibiting	  inflammatory	  initiation.	  Anakinra	  has	  also	  been	  investigated	  in	  the	  treatment	  of	  heart	  disease,	  where	   inflammation	  plays	  an	  important	  role	  in	  the	  development	  of	  atherosclerotic	  plaques	  (Abbate	  et	  al.	  2008;	  Salloum	  et	  al.	  2009).	  However,	  its	  expense,	  short	  lifetime	  and	  intravenous	  delivery	  method	  leave	  a	  niche	  for	  alternative	  therapies.	  	  
1.8	  Investigating	  IL-­‐1β	  signalling	  and	  regulation.	  	  The	  evolutionary	  history	  and	  conservation	  of	  immune	  regulation,	  as	  well	  as	  the	  strict	  control	  of	  the	  IL-­‐1β	  pathway	  confirm	  its	  importance	  in	  inflammation.	  IL-­‐1β	  is	  under	  strict	  regulation	  at	  all	  pathway	  steps.	  IL-­‐1β	  is	  induced	  in	  response	  to	  a	  variety	   of	   stimuli,	   as	   a	   function	   of	   the	   modular	   TLR	   receptors	   ensuring	   its	  sensitivity	  to	  multiple	  types	  of	  inflammatory	  insult.	  In	  IL-­‐1β	  producing	  cells,	  the	  IL-­‐1β	  promoter	   is	  poised	   for	   transcription,	  allowing	  a	  quick	  response,	  but	   the	   IL-­‐1β	  message	  is	  subject	  to	  further	  controls	  based	  on	  its	  stability,	  and	  the	  resulting	  pro-­‐protein	   subject	   to	   similar	   controls	   and	   premature	   degradation.	   IL-­‐1β	   processing	  and	   secretion	   are	   linked,	   responsive	   to	   yet	   further	   stimuli	   and	   regulation	   in	   the	  form	  of	  the	  varied	  inflammasome	  complexes	  responsible	  for	  caspase-­‐1	  activation,	  and	   a	   concurrent	   spectrum	   of	   release.	   Control	   at	   the	   IL-­‐1	   receptor	   level	   has	  evolved	  an	  additional	  layer	  to	  modulate	  the	  IL-­‐1β	  signal	  through	  decoy	  receptors	  sequestering	  the	  IL-­‐1β	  signal	  (Figure	  1.6).	  The	  complexity	  of	  IL-­‐1β	  signalling	  demonstrates	  the	  importance	  of	  control	  of	  IL-­‐1β,	  itself	  described	  as	  a	  master	  switch	  of	  inflammation.	  Yet	  for	  its	  importance,	  key	  components	  of	   the	  pathway	  are	  not	  yet	  understood.	  The	  mechanisms	  behind	  inflammasome	   activation,	   its	   link	   to	   release,	   the	   release	  mechanisms	   themselves	  and	  the	  relation	  this	  release	  has	  to	  downstream	  reception	  of	  the	  IL-­‐1β	  signal	  has	  yet	  to	  be	  elucidated.	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Figure	   1.6.	   Downstream	   effects	   of	   IL-­‐1β	   signalling.	   IL-­‐1β	   has	   a	   pleiotropic	  spectrum	   of	   activity	   and	   is	   a	   key	   cytokine	   in	   the	   initiation	   of	   inflammation.	  Alongside	  its	  autoinflammatory	  role	  in	  the	  pathogenesis	  of	  atherosclerosis,	  a	  major	  contributor	   to	   mortality	   in	   the	   developed	   world	   (blue,	   adapted	   from	   Bujak	   &	  Frangogiannis	  (2009),	  it	  has	  a	  wide	  range	  of	  downstream	  effects	  in	  multiple	  other	  tissues	  (green,	  adapted	  from	  C	  Dinarello	  (2011)	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1.9	  Investigating	  the	  consequences	  of	  unregulated	  IL-­‐1β	  release	  
1.9.1	  Clinical	  relevance	  of	  IL-­‐1β 	  	   IL-­‐1β	  has	  been	  linked	  to	  the	  development	  of	  a	  number	  of	  diseases	  such	  as	  the	  development	  of	  plaques	  and	  cholesterol	  metabolism	  in	  atherosclerotic	  disease	  (Elhage	   et	   al.	   1998;	   Isoda	   et	   al.	   2004;	   Isoda	   et	   al.	   2005),	   as	  well	   as	   significantly	  contributing	   to	   the	   development	   of	   autoinflammatory	   and	   autoimmune	   diseases	  (Dinarello	  1996;	  Dinarello	  2009b)	  and	  neuronal	   injury	  (Relton	  &	  Rothwell	  1992;	  Boutin	   et	   al.	   2001;	   Allan	   et	   al.	   2005)	   (Figure	   1.6).	   IL-­‐1β	   signalling	   initiates	   a	  cascade	  response	  in	  target	  cells	  at	  the	  site	  of	  inflammation,	  multiplying	  the	  initial	  signal	  received	  by	  these	  first	  cells	  by	  orders	  of	  magnitude.	  This	  is	  a	  very	  powerful	  response	  to	  the	  initial	  infection	  as	  it	  quickly	  mobilises	  innate	  immunity	  in	  a	  large	  region	   of	   the	   surrounding	   tissue;	   naturally	   such	   a	   strong	   response	  must	   also	   be	  strictly	   controlled	   (Dinarello	   2009b).	   The	   prognosis	   of	   autoinflammatory	  conditions	   such	   as	   rheumatoid	   arthritis,	   cryopyrinopathy-­‐associated	   periodic	  syndrome	   and	   Adult	   onset	   stills	   disease	   have	   been	   improved	   by	   treatment	  with	  Anakinra,	  which	  has	  also	  shown	  promising	  results	  in	  the	  treatment	  of	  diabetes	  and	  ST	  elevated	  myocardial	  infarction	  (reviewed	  in	  Dinarello,	  2011).	  Although	   therapeutically	   it	  may	  be	  beneficial	   to	   inhibit	   IL-­‐1β	   signalling	   in	  its	   entirety,	   it	  may	   also	   be	   pragmatic	   to	   consider	   specifically	   targeting	   the	   IL-­‐1β	  release	   mechanism	   as	   a	   way	   to	   avoid	   systemic	   immunosuppression.	   One	   could	  hypothesise	   that	   allowing	   low	   level	   and	   terminal	   release	   events	   to	   proceed	  uninhibited	  could	  prove	  protective	  against	  infection	  and	  local	  inflammatory	  insult,	  however	   better	   control	   of	   the	   protected	   release	   pathway	   could	   result	   in	   the	  reduction	   of	   systemic	   inflammatory	   conditions,	   such	   as	   cardiovascular	   diseases,	  where	  microvesicles	  have	  been	  demonstrated	  as	  an	   important	   factor	  (Nomura	  et	  al.	  1995;	  Huber	  et	  al.	  2002).	  Nevertheless,	  the	  mechanisms	  involved	  in	  the	  release	  events	  described	  here	  are	   poorly	   characterised,	   and	   small	   molecule	   modulators	   of	   the	   microvesicle	  release	   pathway	   could	   prove	   an	   invaluable	   tool	   for	   therapeutic	   intervention	   in	  both	  inflammatory	  diseases	  and	  atherosclerosis.	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1.9.2	  IL-­‐1β	  pathway	  models.	  The	   current	   paradigm	   of	   IL-­‐1β	   function	   and	   release	   has	   largely	   been	  developed	  using	   in	  vitro	   tissue	   culture	  methods	   in	   cell	   lines	  or	  macrophage	   type	  cells	  in	  isolation.	  The	  use	  of	  cell	  monoculture	  techniques,	  in	  vitro	  study	  and	  lack	  of	  cellular	  microenvironment	  presents	  an	  artificial	  system	  for	  studying	  the	  release	  of	  IL-­‐1β	  from	  cells,	  hence	  examining	  the	  situation	  in	  vivo	  could	  provide	  very	  valuable	  insight	  into	  these	  pathways.	  It	  is	  difficult	  to	  determine	  how	  IL-­‐1β	  release	  operates	  in	   a	   living	   organism	   and	   how	   IL-­‐1β	   containing	   vesicles	   are	   trafficked	   to	   sites	   of	  inflammation	  based	  on	  cell	  culture	  methods	  and	  it	  is	  likely	  that	  significantly	  more	  detail	   about	   the	   nature	   of	   microvesicle	   signalling	   could	   be	   discovered	   in	   a	   live	  organism	  unconstrained	  by	  the	  limitations	  of	  cell	  culture,	  and	  that	  greater	  insight	  could	   be	   gained	   from	   the	   ability	   to	   track	   both	   the	   release	   and	   targeting	   of	  microvesicles	  with	  greater	  fidelity	  than	  possible	  in	  vitro.	  Currently	  there	  are	  no	  in	  
vivo	  models	  of	  IL-­‐1β	  release	  and	  signalling	  that	  would	  allow	  real-­‐time	  visualisation	  of	  the	  IL-­‐1β	  release	  process.	  
1.9.3	  Zebrafish	  as	  a	  model	  system.	  Current	  studies	  of	  IL-­‐1β	  in	  mouse	  and	  human	  macrophages	  are	   limited	  by	  their	  lack	  of	  interaction	  with	  the	  cellular	  milieu,	  and	  if	  we	  want	  to	  examine	  these	  interactions	   an	   in	   vivo	   model	   is	   the	   ideal	   tool.	   To	   visualise	   the	   secretion	   of	   a	  molecule	  in	  response	  to	  inflammatory	  insult	  would	  require	  and	  model	  amenable	  to	  genetic	  manipulation	  and	  to	  high	  power	  microscopy,	  requirements	  that	  are	  met	  by	  the	  zebrafish	  (Danio	  rerio).	  Zebrafish	  are	  transparent	  as	  larva	  (Kimmel	  1989),	  and	  their	  genetic	  tractability	  make	  them	  ideal	  for	  the	  expression	  of	  reporters	  based	  on	  the	  IL-­‐1β	  pathway.	  
1.9.3.1	  Zebrafish	  transgenesis	  tools	  The	  main	  tool	  in	  the	  arsenal	  of	  zebrafish	  transgenesis	  is	  the	  tol2	  transposon	  system,	   derived	   from	   the	   Medaka	   and	   allowing	   the	   efficient	   generation	   of	  transgenic	   lines	   (K.	   Kawakami	   et	   al.	   2004;	   Urasaki	   &	   Asakawa	   2008).	   Alongside	  this,	   the	   Gal4/UAS	   tools	   used	   in	   genetic	   studies	   of	   drosophila	   (Scheer	   1999;	   E.	  Scott	  et	  al.	  2007)	  have	  also	  been	  adapted	  to	  zebrafish	  to	  allow	  the	  tissue	  specific	  promotion	  of	  reporter	  lines	  (Asakawa	  &	  K.	  Kawakami	  2008)	  adding	  to	  the	  genetic	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amenability	  of	  zebrafish.	  Furthermore,	  zebrafish	  genes	  can	  be	  specifically	  knocked	  down	  using	  antisense	  technology	  such	  as	  morpholinos	  (Ekker	  2000;	  Nasevicius	  &	  Ekker	  2000;	  Draper	  et	  al.	  2001).	  
1.9.3.2	  Imaging	  in	  the	  zebrafish	  Zebrafish	  are	  amenable	  to	  genetic	  modification,	  which	  combined	  with	  their	  larval	   transparency	  make	   them	   ideal	   as	   an	   in	   vivo	   model.	   These	   advantages	   are	  perhaps	   best	   exemplified	   by	   the	   recent	   development	   of	   fluorescent	   calcium	  sensors,	  which	  have	  enabled	  the	  real	  time	  imaging	  of	  neuronal	  activation	  and	  brain	  activity	   on	   a	   single	   cell	   basis	   (Ahrens	   et	   al.	   2013;	   Muto	   et	   al.	   2013).	   Such	  breakthroughs	  are	  possible	  in	  this	  model	  specifically	  due	  to	  its	  amenability	  to	  live	  imaging	  and	  genetic	  manipulation	  and	  demonstrate	  the	  utility	  of	  the	  zebrafish	  as	  a	  platform	  for	  in	  vivo	  study.	  Furthermore,	  the	  small	  size	  and	  short	  generation	  time	  of	   zebrafish	   has	   also	   enabled	   the	   use	   of	   microCT	   for	   phenome	   screening	   of	   the	  whole	  organism	  to	  catalogue	  the	  characteristics	  of	  specific	  mutations	  (Cheng	  et	  al.	  2011).	  
1.9.3.3	  Zebrafish	  as	  disease	  models	  More	  relevant	  to	  the	  study	  of	  IL-­‐1β	  biology	  is	  the	  study	  of	  innate	  immunity	  in	   zebrafish	   (Meeker	  &	  Trede	   2008;	  Renshaw	  &	  Trede	   2012;	  Henry	   et	   al.	   2013)	  enabled	   by	   the	   characterisation	   of	   the	   various	   immune	   cell	   lineages	   during	  development	   and	   their	   behaviour.	   Zebrafish	   macrophages	   were	   initially	  characterised	  by	  their	  morphology	  and	  expression	  of	  early	  myeloid	  and	  leukocyte	  markers	  (Herbomel	  et	  al.	  1999;	  Herbomel	  et	  al.	  2001)	  and	  more	  recently,	  zebrafish	  macrophages	  have	  been	  fluorescently	  labelled	  using	  the	  mpeg1	  (Ellett	  et	  al.	  2010)	  and	   fms	   (Gray	   et	   al.	   2011)	   promoters.	   However	   even	   before	   these	   lines	   were	  developed	  it	  was	  possible	  to	  visualise	  microglia,	  a	  specialised	  macrophage	  subtype,	  using	   the	   APO-­‐E	   and	   pu.1	   transgenic	   markers	   (Peri	   &	   Nüsslein-­‐Volhard	   2008)	  enabling	  the	  characterisation	  of	  the	  highly	  dynamic	  microglial	  response	  to	  calcium	  signalling	  using	  the	  aforementioned	  GCaMP	  calcium	  sensor(Sieger	  et	  al.	  2012).	  	   Other	   innate	   immune	   cell	   types	   have	   also	   been	   characterised	   in	   the	  zebrafish.	  By	  using	  the	  zebrafish	  orthologue	  of	  Myeloid	  specific	  peroxidase	  (mpx),	  Lieschke	   et	   al.	   (2001)	   characterised	   embryonic	   neutrophils.	   The	   promoter	  involved	  was	  later	  used	  to	  generate	  the	  mpx:gfp	  neutrophil	  marker	  line	  (Renshaw	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et	   al.	   2006)	   later	   complemented	  by	   lines	  bearing	   the	   lyz	   promoter	   (CJ	  Hall	   et	   al.	  2007).	  Combined,	   these	   technologies	   have	   enabled	   the	   characterisation	   of	   the	  varying	   roles	   of	   neutrophils	   and	   macrophages	   in	   the	   innate	   immune	   response;	  such	   as	   their	   movement	   dynamics	   (Ellett	   et	   al.	   2010;	   Gray	   et	   al.	   2011);	  susceptibility	  to	  pharmacological	  manipulation	  (Loynes	  et	  al.	  2010)	  and	  induction	  of	   hypoxic	   signalling	   (Elks	   et	   al.	   2011);	   differing	   roles	   in	   phagocytosis	   (Colucci-­‐Guyon	  et	  al.	  2011);	  and	  their	  roles	  in	  wound	  healing	  (L.	  Li	  et	  al.	  2012);	  as	  well	  as	  the	   ability	   of	   these	   systems	   to	   be	   subverted	   into	   a	   trophic	   phenotype	   by	   the	  signalling	  molecules	  released	  during	  tumour	  initiation	  (Feng	  et	  al.	  2012).	  It	  has	  also	  been	  possible	  to	  characterise	  other	   immune	  components	   in	  the	  zebrafish;	  such	  as	  the	  definition	  of	  mast	  cells,	  a	  neutrophil	  subtype	  expressing	  the	  cpa5	  marker;	  and	  the	   identification	  of	  dendritic	  cells	  (Lugo-­‐Villarino	  et	  al.	  2010),	  eosinophils	   (Balla	   et	   al.	   2010)and	   T-­‐cells	   	   (Langenau	   et	   al.	   2004)	   from	   adult	  zebrafish.	  The	  pathways	  involved	  in	  the	  immune	  response,	  MyD88	  expression	  (CJ	  Hall	  et	  al.	  2009)	  chemokine	  signalling	  (Oehlers	  et	  al.	  2010),	  and	  PI3K	  activity	  have	  also	  been	  studied	  in	  the	  zebrafish.	  Novel	  imaging	  tools	  useful	  in	  the	  study	  of	  innate	  immunity	  include	  hydrogen	  peroxide	  sensors;	  which	  reveal	  the	  role	  of	  H202	  in	  the	  initiation	  of	  inflammation	  in	  response	  to	  injury	  (Niethammer	  et	  al.	  2009)	  and	  the	  role	   of	   H202	   signalling	   in	   tumour	   initiation	   (Feng	   et	   al.	   2010);	   and	   dynamic	  apoptosis	  sensors	  (Van	  Ham	  et	  al.	  2010)	  which	  could	  reveal	  the	  pathways	  involved	  in	   inflammation	   resolution	   and	   in	   the	   processes	   involved	   in	   membrane	  asymmetry.	  	  In	   trying	   to	   combat	   the	   growing	   threat	   of	   antibiotic	   resistance,	   and	   to	  further	  elucidate	  the	  pathways	  involved,	  a	  number	  of	  zebrafish	  models	  of	  infection	  have	   been	   established	   (C.	   Sullivan	   &	   C.	   Kim	   2008;	   A.	   Meijer	   &	   Spaink	   2011).	  Problematic,	   drug	   resistant	   bacteria	   such	   as	   S.	   aureus	   and	  M.	   turberculosis	   have	  been	  modelled	  in	  zebrafish	  using	  various	  strains	  of	  S.	  aureus	  (Prajsnar	  et	  al.	  2008;	  Prajsnar	  et	  al.	  2012)	  and	   the	  marine	  pathogen	  M.	  marinum	  (Tobin	  et	  al.	  2010;	  C.	  Yang	  et	  al.	  2012).	  E.	  coli	  (Colucci-­‐Guyon	  et	  al.	  2011)	  and	  S.	  enterica	  (Van	  der	  Sar	  et	  al.	  2006)	  have	  been	  used	  to	  study	  more	  general	  phagocytic	  and	  signal	  transduction	  pathway	   dynamics.	   Finally,	   zebrafish	   have	   also	   been	   used	   to	   study	   aquaculture	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pathogens,	   such	   as	   V.	   anguilarum	   (Z.	   Xu	   et	   al.	   2011).	   These	   models	   provide	   an	  insight	   into	  the	  mechanisms	   involved	   in	   the	  host	  response	  to	   infection	  and	  allow	  these	  processes	  to	  be	  visualised	  in	  vivo.	  	  Alongside	  their	  role	  in	  in	  infection	  models,	  zebrafish	  have	  also	  been	  used	  in	  the	   study	  of	   a	  number	  of	   other	  diseases	   (Lieschke	  &	  Currie	  2007),	   ranging	   from	  ototoxicity	   (Buck	   et	   al.	   2012)	   and	   epilepsy	   (Baxendale	   et	   al.	   2012)	   to	  muscular	  disease	  (Ingham	  2009)	  and	  atherosclerosis	  (Stoletov	  et	  al.	  2009).	  	   	  The	   zebrafish	   has	   been	   key	   to	   a	   number	   of	   advances	   that	   are	   in	   part	  impractical	   or	   uneconomical	   in	   other	   models,	   but	   a	   number	   of	   these	   advances,	  such	   as	   the	   aforementioned	   neuronal	   imaging	   (Ahrens	   et	   al.	   2013),	   are	   almost	  impossible	  in	  a	  model	  without	  the	  attributes	  of	  the	  zebrafish.	  The	  combination	  of	  genetic	   amenability	   and	   transparency	   during	   larval	   development	   enable	   the	  zebrafish	   to	  be	  used	  as	  a	  powerful	   tool	   for	   in	  vivo	   imaging,	  which	   is	  perhaps	   the	  greatest	   advantage	  of	   the	   zebrafish	  over	  mammalian	  models,	   and	  make	   it	   key	   in	  studying	  complex	  pathways	  for	  which	  in	  vivo	  imaging	  is	  necessary.	  
1.9.3.4	  Innate	  immune	  pathway	  conservation	  in	  the	  zebrafish	  The	  use	  of	  zebrafish	  as	  a	  tool	  to	  study	  IL-­‐1β	  biology	  is	  possible	  because	  of	  the	   high	   degree	   of	   homology	   between	   zebrafish	   and	   mammals.	   As	   discussed	  earlier,	   the	   evolution	   of	   the	   innate	   immune	   system	   predates	   vertebrate	  development	   and	   zebrafish	   have	   an	   extensive	   complement	   of	   innate	   immune	  genes.	   Zebrafish	   macrophages	   develop	   shortly	   after	   fertilisation	   and	   perform	   a	  phagocytosing	  role	  in	  zebrafish	  larva	  (Herbomel	  et	  al.	  1999;	  Herbomel	  et	  al.	  2001).	  Signalling	  and	  induction	  in	  the	  innate	  immune	  pathway	  are	  mediated	  by	  zebrafish	  homologues	  of	  TLR	  pattern	  recognition	  receptors	  (Jault	  et	  al.	  2004;	  A.	  Meijer	  et	  al.	  2004)	   through	   a	   conserved	  NF-­‐κB	   pathway	   including	  MyD88	   (Van	   der	   Sar	   et	   al.	  2006),	  NF-­‐κB	  (Correa	  et	  al.	  2004),	  and	  its	  activation	  pathway	  (reviewed	  by	  Stein	  et	  
al.,	  2007).	  Zebrafish	  inflammatory	  caspases	  have	  been	  described	  (Masumoto	  et	  al.	  2003;	  Eimon	  et	  al.	  2006),	  as	  well	  as	  ASC	  (Masumoto	  et	  al.	  2003;	  Y.	  Sun	  et	  al.	  2008)	  and	   inflammasome	   like	   proteins	   (Laing	   et	   al.	   2008).	   Zebrafish	   also	   show	  conservation	  of	  P2X7	  receptors	  in	  both	  structure	  and	  function	  (López-­‐Castejón,	  M.	  Young,	  et	  al.	  2007)	  and	  pannexin-­‐1	  (Prochnow	  et	  al.	  2009).	  IL-­‐1	  protein	  family	  and	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receptor	   family	   conservation	   has	   also	   been	   extensively	   described	   (Huising	   et	   al.	  2004),	   however,	   the	  present	   state	   of	   these	   receptors	   is	   complicated	  by	   errors	   in	  sequencing	  and	  genome	  assembly	  (see	  Chapter	  3).	  	  
1.20	  Project	  aims	  The	  zebrafish	   innate	   immune	  system	  shows	  a	  high	  degree	  of	  conservation	  with	  human	  immunity	  and	  should	  provide	  the	  ideal	  subject	  for	  the	  development	  of	  an	  in	  vivo	  model	  of	  IL-­‐1β	  biology.	  In	  IL-­‐1β	  research,	  there	  are	  a	  number	  of	  key	  questions	  relating	  to	  the	  IL-­‐1β	  pathway	   that	   remain	   unanswered.	   How	   is	   the	   processing	   of	   IL-­‐1β	   activated	   and	  how	  can	   this	  be	  modulated?	  What	   is	   the	  mechanism	  by	  which	   IL-­‐1β	   is	  packaged	  into	  vesicles,	  how	  is	  this	   linked	  to	  processing,	  how	  are	  these	  vesicles	  release	  and	  what	  regulatory	  steps	  are	  necessary?	  In	  addition	  how	  are	  IL-­‐1β	  containing	  vesicles	  transported	   to	   their	   site	   of	   action,	   which	   downstream	   signalling	   pathways	   are	  responsible	  for	  targeting	  them	  to	  IL-­‐1β	  sensitive	  cells	  and	  what	  triggers	  the	  release	  of	   their	   contents?	   And	   what	   are	   the	   key	   control	   points	   that	   may	   serve	   as	  therapeutic	  targets?	  The	   biogenesis	   and	   release	   of	   microvesicles	   is	   difficult	   to	   observe	   in	   cell	  culture,	  and	  the	  mechanisms	  behind	  these	  processes	  have	  not	  yet	  been	  described.	  The	  involvement	  of	  microvesicles	  has	  been	  described	  for	  a	  number	  of	  proteins	  as	  a	  non-­‐conventional	   mechanism	   of	   cellular	   release,	   implying	   the	   evolutionary	  conservation	  of	  the	  pathway	  machinery,	  and	  its	  significance	  as	  a	  biological	  process.	  Studying	  this	  pathway	   in	  vivo	   is	   the	   logical	  extension	  for	   its	  characterization,	  and	  would	  yield	  valuable	   insight	   into	  not	  only	   the	  mechanism	  as	  a	  whole,	  but	  how	   it	  pertains	  to	  IL-­‐1β.	  Inhibiting	  release	  could	  therefore	  become	  a	  valuable	  therapeutic	  tool	   in	   conditions	  where	   this	   pathway	   is	   responsible	   for	   the	   release	   of	   bioactive	  signals.	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My	   hypothesis	   is	   that	   microvesicular	   IL-­‐1β	   release	   and	   microvesicular	  biogenesis	  is	  dependent	  on	  the	  ESCRT	  pathway	  and	  that	  mechanisms	  linking	  this	  pathway	   to	   secretion	   rely	   on	   Rab	   adaptor	   proteins	   to	   link	   caspase-­‐1	   mediated	  processing	  to	  secretion.	  Furthermore	  I	  hypothesise	  that	  the	  release	  of	  IL-­‐1β	   from	  microvesicles	  is	  dependent	  on	  receptors	  on	  the	  surface	  of	  sensitive	  cells,	  and	  that	  this	   signalling	   is	   highly	   context	   dependent.	   Unfortunately	   the	   tools	   to	   test	   these	  hypotheses	  in	  vivo	  are	  currently	  unavailable.	  	  Thus,	   the	   aims	   of	   this	   thesis	   are	   primarily	   to	   develop	   a	   zebrafish	   in	   vivo	  model	  of	  IL-­‐1β	  biology.	  Specifically	  I	  aim	  to	  1. Validate	  the	  zebrafish	  as	  a	  viable	  model	  of	  the	  IL-­‐1β	  pathway	  through	  both	  bioinformatics	  analysis	  and	  through	   inhibition	  of	  components	  of	   the	   IL-­‐1β	  pathway.	  2. Develop	  a	  FRET	  based	  reporter	  of	  IL-­‐1β	  processing	  by	  measuring	  caspase-­‐1	  activation	   to	   enable	   spatial	   and	   temporal	   localisation	   of	   IL-­‐1β	   processing	  and	  its	  link	  to	  release	  3. Develop	  an	  in	  vivo	  reporter	  of	  IL-­‐1β secretion	  to	  allow	  visualisation	  of	  the	  release	  event	  and	  downstream	  signalling	  to	  sensitive	  cells.	  	  	   	  
	   33	  
Chapter	  2:	  Materials	  and	  Methods	  	  Unless	  otherwise	  stated,	  all	  reagents	  were	  purchased	  from	  Sigma-­‐Aldrich	  
2.1	  Buffers	  
20x	  saline	  sodium	  citrate	  buffer	  (SSC)	  	   3M	  sodium	  chloride	  300	  mM	  sodium	  citrate	  	   Adjusted	  to	  pH	  7	  with	  citric	  acid.	  
Hybridisation	  Buffers	  Wash	  hybridisation	  buffer:	  50%	  formamide	  5	  ×	  SSC	  0.1%	  Tween	  20	  adjusted	  to	  pH	  6	  with	  Citric	  acid.	  Pre-­‐hybridisation	  buffer:	  	   As	  wash-­‐hybridisation	  buffer,	  with	  the	  addition	  of	  	   50	  µg/ml	  heparin	  (Scientific	  Laboratory	  Supplies	  (SLS))	  	   500	  µg/ml	  tRNA	  Probe-­‐hybridisation	  buffer:	  	   Pre-­‐hybridisation	  buffer	  with	  the	  addition	  of	  	   1:200	  dilution	  of	  AP-­‐labelled	  probe	  in	  80%	  formamide	  
E3	  medium	  	   5	  mM	  sodium	  chloride	  	   170	  µM	  potassium	  chloride	  	   330 µM	  calcium	  chloride	  	   330	  µM MgSO4	  	   0.00005%	  methylene	  blue	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2.2	  Bioinformatic	  study	  
2.2.1	  Sequence	  Searching	  and	  Gene	  alignments	  BLAST	   searching	   was	   performed	   using	   the	   National	   Center	   for	   Biotechnology	  Information	   (NCBI)	   Basic	   Local	   Alignment	   Search	   Tool	   (BLAST)	   tool	  (http://blast.ncbi.nlm.nih.gov/)	  domains	  were	  delimited	  by	  the	  BLAST	  location	  of	  domains	  on	  query	  sequences.	  Protein	  alignments	  were	  performed	  using	  clustalW.	  Gene	   searching	   was	   performed	   using	   the	   Ensembl	   genome	   browser	  (http://www.ensembl.org/index.html)	  against	  Human	  or	  zebrafish	  genomes.	  Data	  were	  updated	  during	  the	  study	  to	  use	  the	  latest	  zebrafish	  genome	  assembly	  (Zv9).	  
2.2.2	  Zebrafish	  IL-­‐1β	  structure	  prediction	  The	  Zebrafish	  IL-­‐1β	  protein	  sequence	  (accession:	  NP_998009.1)	  was	  submitted	  to	  the	   Phyre	   (Kelley	   &	   Sternberg	   2009)	   (http://www.sbg.bio.ic.ac.uk/~phyre/),	  RaptorX	  (Peng	  &	  J.	  Xu	  2011;	  Källberg	  et	  al.	  2012)	  (http://raptorx.uchicago.edu/),	  I-­‐TASSER	   (Y.	   Zhang	   2008;	   A.	   Roy	   et	   al.	   2010)	  (http://zhanglab.ccmb.med.umich.edu/I-­‐TASSER/)	   and	   the	   UCL	   PsiPred	   Server	  (Buchan	   et	   al.	   2010)	   (http://bioinf.cs.ucl.ac.uk/).	   The	   resulting	   models	   were	  analysed	   by	   comparison	   with	   the	   human	   IL-­‐1β	   protein	   structure	   (accession	  AAA59135.1)	  and	  the	  nearest	  protein	  orthologues	  provided	  by	  each	  server.	  
2.3	  Functional	  study	  
2.3.1	  Whole	  mount	  in	  situ	  Hybridisation	  (WISH)	  probe	  synthesis	  An	   IL-­‐1β	   coding	   sequence	   containing	   vector	   (A	   kind	   gift	   of	   Sara	   Kohal,	  University	   of	   Sheffield)	   was	   linearised	   with	   a	   HindIII	   restriction	   digest.	   20µg	   of	  vector	  was	  mixed	  with	   20µl	   of	   New	   England	   Biolabs	   (NEB)	   restriction	   Buffer	   2,	  0.5µl	  HindIII	  (NEB)	  in	  a	  total	  volume	  of	  200µl	  of	  distilled	  water	  and	  incubated	  at	  37	  °C	  for	  3	  hours.	  The	  linearised	  DNA	  was	  phenol:chloroform	  precipitated:	  200µl	  of	  Phenol:Chloroform:Isoamyl	  Alcohol	  25:24:1	  Saturated	  with	  10	  mM	  Tris,	  pH	  8.0,	  1	   mM	   EDTA	   was	   added	   to	   the	   reaction	   mixture	   and	   vortexed	   thoroughly	   for	   3	  minutes.	   The	  mixture	  was	   centrifuged	   at	   14000	   rpm	   for	   7	  minutes	   and	   the	   top	  layer	  added	  to	  a	  new	  tube.	  An	  equal	  volume	  of	  chloroform	  was	  added	  to	  this	  layer	  which	   was	   then	   vortexed	   thoroughly.	   This	   was	   centrifuged	   at	   14000	   rpm	   for	   5	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minutes	  and	   the	   top	   layer	  again	   removed.	  This	  was	  mixed	  10:1	  with	  3M	  sodium	  acetate	  then	  1:1	  with	  isopropanol.	  The	  mixture	  was	  kept	  at	  -­‐20	  °C	  for	  1	  hour	  then	  pelleted	  by	  centrifuging	  at	  4	   °C	  and	  14000	  rpm	   for	  20	  minutes.	  The	  supernatant	  was	  removed	  and	  the	  pellet	  was	  washed	  gently	  with	  200	  µl	  of	  70%	  ethanol,	  which	  was	  then	  removed	  after	  a	  further	  5	  minute,	  14000	  rpm	  centrifugation	  at	  4	  °C.	  After	  removal	  of	  the	  ethanol,	  the	  pellet	  was	  air-­‐dried	  for	  10	  minutes	  and	  resuspended	  in	  20µl	   of	   sterile	   water.	   The	   DNA	   was	   quantified	   on	   a	   Nanodrop™	   1000	  spectrophotometer	  (Thermo	  Scientific).	  	   A	  DNA	  probe	  was	  transcribed	  using	  a	  T7	  RNA	  digoxygenin	  (DIG)	   labelling	  kit	   (Roche).	   2µg	   of	   linearised	   DNA	   was	   mixed	   with	   4µl	   DIG	   labelling	   mix,	   2µl	  RNAse	   inhibitor,	   2µl	   T7	   polymerase	   in	   a	   total	   volume	  of	   40µl	   sterile	  water	   then	  incubated	  for	  2	  hours	  at	  37	  °C.	  The	  DNA	  template	  was	  removed	  with	  a	  30	  minute	  digestion	  with	  an	  additional	  4µl	  of	  DNAse	  then	  precipitated	  with	  lithium	  chloride:	  the	  reaction	  was	  mixed	  with	  1µl	  pH8	  0.5M	  EDTA,	  2.5µl	  4M	  LiCl	  and	  75µl	  ethanol	  and	  kept	  at	  -­‐80°C	  for	  1	  hour,	  then	  pelleted	  by	  centrifugation	  at	  4	  °C,	  14000rpm	  for	  30	  minutes.	  The	  supernatant	  was	  removed	  and	  the	  pellet	  was	  gently	  washed	  with	  100µl	  ethanol,	  which	  was	  also	  removed	  following	  a	  10	  minute	  centrifugation	  at	  4	  °C,	   14000	   rpm.	   After	   removal	   of	   the	   supernatant,	   the	   pellet	   was	   air-­‐dried	   for	   5	  minutes	  and	  resuspended	  in	  sterile	  water.	  Presence	  of	  RNA	  was	  confirmed	  by	  gel	  electrophoresis	  of	  1µl	  of	  resuspension	  on	  a	  1%	  agarose	  gel.	  80µl	  of	  formamide	  was	  added	  to	  resuspension	  which	  was	  then	  stored	  at	  -­‐80	  °C.	  	  	   An	  antisense	  probe	  was	  synthesised	  by	  linearising	  with	  an	  Apa1	  digest,	  and	  Sp6	  polymerase.	  
2.3.2	  WISH	  protocol	  	   Embryos	  were	   fixed	  overnight	   in	  phosphate	  buffered	   saline	   (PBS)	   (Fisher	  Scientific)	  with	   4%	   paraformaldehyde	   (PFA)	   at	   4°C,	   then	   transferred	   into	   100%	  methanol	  and	  stored	  at	  -­‐20	  °C	  at	  no	  more	  than	  20	  embryos	  per	  eppendorf.	  	   The	  embryos	  were	  rehydrated	  by	  washing	  in	  500ml	  of	  a	  methanol	  series	  of	  3:1,	   1:1,	   and	   1:3	   methanol:PBS	   for	   5	   minutes	   in	   each	   wash.	   The	   embryos	   were	  washed	  4	   times	  with	  PBT	   (0.1%	   tween	  20	   in	  PBS)	   for	  5	  minutes	   each.	  This	  was	  followed	   by	   a	   treatment	   in	   10mg/ml	   of	   proteinase	   K	   for	   15	   minutes	   for	   24hpf	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embryos,	   30	   minutes	   for	   48	   hpf	   embryos	   and	   60	   minutes	   for	   72	   hpf	   embryos,	  followed	  by	  fixing	  for	  a	  second	  time	  in	  4%PFA-­‐PBS	  for	  20	  minutes.	  	   The	  embryos	  were	  incubated	  in	  a	  pre-­‐hybridisation	  buffer	  for	  5	  hours	  at	  70	  °C	  then	  incubated	  with	  probe-­‐hybidisation	  buffer	  for	  18	  hours	  at	  70	  °C.	  the	  probe	  was	   removed	   by	   successively	   washing	   with	   3:1,	   1:1	   and	   1:3	   washes	   of	   the	  hybridisation	  buffer	  and	  2x	  SSC	  for	  15	  minutes	  each	  wash.	  A	  final	  wash	  2x	  SSC	  was	  then	   followed	   by	   2	   30	   minute	   washes	   with	   0.2x	   SSC	   at	   70	   °C,	   which	   was	   then	  diluted	  with	  3:1,	   1:1	   and	  1:3	  washes	  of	   0.2x	   SSC	   and	  PBT	  buffer	   at	   20	   °C	   for	  10	  minutes	  each	  with	  a	  final	  wash	  of	  PBT	  for	  10	  minutes.	  	   The	   embryos	   were	   incubated	   in	   blocking	   buffer	   (PBT,	   2%	   sheep	   serum	  (Stratech)	  and	  2mg/ml	  BSA)	  for	  3	  hours	  on	  a	  rocking	  platform.	  The	  embryos	  were	  then	   incubated	   with	   an	   anti-­‐DIG-­‐AP	   (Roche)	   antibody	   in	   blocking	   buffer	   at	   a	  1:5000	  dilution	  for	  18	  hours	  at	  4	  °C	  with	  gentle	  rocking.	  This	  was	  washed	  off	  with	  6	  ×	  15	  minute	  washes	  in	  PBT.	  The	  embryos	  were	  washed	  3	  times	  in	  staining	  wash	  (100mM	  pH	  9.5	  tris	  HCL,	  50mM	  magnesium	  chloride,	  100	  mM	  sodium	  chloride	  and	  0.1%	  tween	  20).	  Embryos	  were	  then	  stained	  with	  staining	  solution	  (staining	  wash	  with	   100mg/ml	   NBT	   (Roche)	   and	   50	   mg/ml	   BCPIP	   (Roche))	   until	   staining	  developed.	  The	   reaction	  was	   stopped	  by	   replacing	   this	  wash	  with	  1mM	  EDTA	   in	  PBS	  with	  pH	  adjusted	  to	  5.5.	  The	  embryos	  were	  refixed	  in	  PBS	  with	  4%	  PFA,	  then	  stored	  at	  -­‐20	  °C	  in	  methanol.	  
2.4	  Tol2	  mRNA	  synthesis	  Tol2	   mRNA	   was	   generated	   using	   the	   pCS2FA-­‐transposase	   construct	   from	   the	  Tol2Kit	   (plasmid	   396).	   The	   pCS2FA-­‐transposase	   plasmid	   was	   linearised	   with	   a	  Not1	   digestion	   (NEB)	   as	   described	   previously	   and	   transcribed	   using	   an	   Sp6	  mMESSAGE	  mMACHINE®	  kit	  (Ambion).	  1	  µg	  of	  template	  DNA	  was	  mixed	  with	  2	  µl	  enzyme	  mix,	  2	  µl	  reaction	  buffer,	  10	  µl	  NTP/CAP	  mixture	  in	  a	  total	  volume	  of	  10	  µl	  nuclease-­‐free	  water.	  The	  reaction	  was	  mixed	  gently	   then	  briefly	  centrifuged	  then	  incubated	  for	  2	  hours	  at	  37	  °C.	  the	  template	  DNA	  was	  degraded	  with	  a	  15	  minute	  digestion	   at	   37	   °C	   with	   Turbo	   DNAse.	   The	   RNA	   was	   recovered	   using	   phenol:	  chloroform	  extraction	  as	  described	  previously	  and	  resuspended	  in	  20	  µl	  nuclease	  free	  water.	  The	  yield	  of	  mRNA	  was	  estimated	  on	  an	  agarose	  gel.	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2.5	  PCR	  amplification	  PCR	  reactions	  were	  set	  up	  with	  1µl	  of	  10µM	  dNTPs	  (a	  mix	  of	  dATP,	  dTTP,	  dCTP,	  dGTP	  at	  2.5µM	  each)	   (Promega)	  with	  0.25	  µl	  Phusion	  polymerase	  (NEB),	  1.25	  µl	  each	  of	  10	  µM	  forward	  and	  reverse	  primers,	  100	  ng	  of	  template	  DNA	  and	  4	  µl	  of	  Phusion	  GC	  buffer	   (NEB)	   in	   total	   volume	  of	  20	  µl	   nuclease	   free	  water.	  The	  basic	  PCR	  conditions	  were:	  	  98	  °C	  for	  30	  seconds	  	  then	  30	  cycles	  of	  	  98	  °C	  for	  30	  seconds	  for	  denaturation,	  60°C	  50	  seconds	  for	  annealing,	  72°C	  30	  seconds	  for	  extension,	  	  with	  a	  final	  extension	  of	  	  72	  °C	  for	  10	  minutes	  	  The	   annealing	   temperature	  was	   optimised	   for	   each	  primer	  pair	   by	  performing	   a	  gradient	  PCR	  between	  55	  and	  65	  °C	  and	  extension	  time	  was	  increased	  to	  3	  minutes	  for	  the	  FRET	  mutagenesis.	  	  PCR	  primers	  are	  described	  in	  Table	  1.	  
2.6	  Embryo	  Treatment	  All	  zebrafish	  experiments	  and	  transgenic	  line	  maintenance	  were	  performed	  under	  a	   Home	   Office	   animal-­‐handling	   license	   to	   conform	   to	   Animals	   (Scientific	  Procedures)	  Act	  1986.	  
2.6.1	  Tail	  transection	  
2.6.1.1	  Tail	  transection	  of	  pigmented	  WT	  embryos	  post	  72	  hpf	  Pigmented	   day	   72	   hpf	   embyos	  were	   anaesthetised	   in	  MS-­‐222	   and	   placed	  onto	  reversed	  scotch	  tape	  to	  help	  remove	  excess	  liquid.	  The	  tail	  was	  amputated	  at	  the	  most	   distal	   point	   of	   the	   pigment	   gap	   perpendicular	   to	   the	   circulation	   of	   the	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aorta	   using	   a	   microscalpel	   (World	   precision	   instruments)	   under	   a	   dissecting	  microscope.	   Embryos	   were	   placed	   into	   fresh	   E3	   immediately	   post	   injury	   and	  allowed	  to	  recover	  at	  28.5	  °C	  
2.6.1.2	  tail	  transection	  of	  non-­‐pigmented	  (nacre)	  and	  less	  than	  72hpf	  embryos	  	   Embryos	  were	   transferred	   to	   fresh	  E3	  at	  a	  density	  of	  20-­‐25	  per	  plate	  and	  anaesthetised	  with	  MS-­‐222.	  Tail	  transection	  was	  performed	  midway	  between	  the	  terminal	  point	  of	  the	  aortic	  venous	  loop	  and	  the	  distal	  most	  part	  of	  the	  tail	  using	  a	  number	  15	  scalpel	  blade	  under	  a	  dissecting	  scope.	  Embryos	  were	  placed	  in	  E3	  to	  allow	  recovery	  as	  above.	  
2.6.2	  Zebrafish	  egg	  microinjection	  Tanks	   of	   paired	   fish,	   10	   of	   each	   sex,	   were	   marbled	   overnight.	   Embryos	   were	  collected	  and	   injected	  no	  more	   than	  20	  minutes	  post	   fertilization	  during	   the	  one	  cell	   stage.	   Embryos	   were	   collected	   and	   ~50	  were	   aligned	   onto	   a	  microinjection	  plate.	   Injections	   were	   performed	   using	   a	   palled	   Kwik-­‐FilTM	   borosilicate	   glass	  capillary	   (World	  Precision	   Instruments)	   loaded	  with	   the	  DNA	  sample	  using	  a	  gel	  loading	  pipette	  tip,	  the	  end	  of	  the	  needle	  was	  then	  broken	  off	  using	  fine	  forceps	  to	  create	   the	   injection	   aperture	   (~50	   μm	   -­‐150μm	   in	   diameter).	   DNA	   injection	  concentration	  was	   optimized	   to	   50ng/μl	   at~1nl	   DNA	   solution	   per	   embryo,	   Tol2	  RNA	  was	  optimized	  to	  30ng/μl.	  V	  anguillarum	  DNA	  was	  injected	  at	  one	  tenth	  the	  stock	  concentration	  of	  65ng/µl	   (a	  kind	  gift	  of	  Victor	  Mulero,	  Murcia).	  Phenol	  red	  was	  added	  as	  at	  a	  concentration	  of	  1µl	  in	  10µl	  to	  enable	  clearer	  visualisation	  of	  the	  injection.	   Consistency	   of	   injection	   volume	   was	   ensured	   using	   a	   pneumatic	  picopump	   (PV830,	   World	   Precision	   Instruments)	   and	   air	   compressor,	   using	   a	  micromanipulator	   to	   manoeuvre	   the	   needle	   into	   place	   and	   a	   microscope	   to	  visualize	   the	   injections.	   Post	   injection,	   the	   fish	  were	   placed	   in	   E3	  medium	   at	   50	  embryos	   per	   plate	   and	   incubated	   at	   28.5	   oC	   for	   6	   hours,	   after	   which	   dead	   and	  unviable	  embryos	  were	  removed	  from	  the	  medium.	  The	  fish	  were	  kept	  at	  28.5	  oC.	  Transgenic	   embryos	   were	   selected	   using	   relevant	   markers/reporters	   by	  fluorescence	  microscopy	  and	  maintained	  at	  no	  more	   than	  80	  embryos	  per	  plate.	  These	  embryos	  were	  then	  manually	  dechorionated	  48-­‐72	  hpf.	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2.6.3	  Chemical	  treatment	  For	  chemical	   treatment,	  embryos	  were	  split	   into	  a	  24	  well	  plate	  at	  a	  density	  of	  5	  per	   well,	   in	   0.5ml	   of	   fresh	   E3.	   Compounds	   were	   made	   up	   to	   double	   strength	  concentration	  at	  0.5ml	  per	  each	  well	  being	   treated	  and	  mixed	   thoroughly	  before	  experimental	  blinding	  and	  addition	  to	  each	  well.	  The	  plates	  were	  swirled	  gently	  to	  evenly	   mix	   each	   compound.	   Final	   treatment	   concentrations	   were	   50µm	   for	   AC-­‐YVAD-­‐CMK	  (Calbiochem)	  and	  Q-­‐VD.Oph	  (R&D	  systems),	  1µM	  for	  Brilliant	  Blue	  G,	  10	   µM	   for	   KN62	   (Calbiochem)	   and	   1µg/ml	   LPS	   (E.	   coli	   serotype	   R515,	   Alexis	  Biochemicals).	  Embryos	  were	  kept	  at	  28oC	  for	  the	  course	  of	  the	  treatment.	  	   Tg(BACmpo:FRET	   DEVD)sh237	   embryos	   were	   subjected	   to	   isopimpinellin	  treatment	  by	  addition	  of	  25µM	  isopimpinellin	   (R&D	  systems)	   to	   the	   low	  melting	  point	   agar	   used	   for	  mounting	   and	   the	  maintenance	   of	   an	  E3	   layer	   over	   the	   agar	  with	  a	  concentration	  of	  25 µM	  isopimpinellin.	  	   For	   treatment	   of	   Tg(lyz:nsfB.mCherry)sh260	   embryos,	   metronidazole	   was	  added	  at	  a	  concentration	  of	  5 µM	  to	  a	  30	  ml	  plate	  of	  embryos	   for	  4	  hours	  before	  imaging.	  
2.7	  Construct	  generation	  
2.7.1	  Transformation	  25µl	   of	   competent	   Top10	   cells	   (Invitrogen) were	   thawed	   on	   ice.	   1µl	   of	   prepped	  plasmid	  or	  2.5µl	  of	  reaction	  were	  added	  to	  the	  cells,	  which	  were	  then	  gently	  mixed.	  The	  cells	  were	  incubated	  on	  ice	  for	  30	  minutes	  then	  heat	  shocked	  for	  45	  seconds	  at	  42oC.	   The	   cells	   were	   left	   on	   ice	   for	   a	   further	   10	   minutes	   then	   150µl	   of	   room	  temperature	   SOC	   medium	   (Invitrogen)	   was	   added	   and	   the	   cells	   were	   mixed	  vigorously	  for	  1	  hour	  at	  37	  oC	  on	  a	  shaker	  at	  200rpm.	  The	  cells	  were	  then	  plated	  out	   onto	   warmed	   selection	   plates	   with	   the	   relevant	   antibiotic	   and	   left	   to	   grow	  overnight	  at	  37oC.	  Selection	  plates	  were	  made	  with	  autoclaved	  LB	  agar	  and	  either	  kanamycin	  or	  carbenicillin	  antibiotic	  at	  50µg/ml	  	  
2.7.2	  DNA	  purification	  Post	   transformation,	   bacterial	   colonies	   were	   selected	   and	   inoculated	   into	   either	  3ml	   or	   50ml	   of	   autoclaved	   LB	   broth	   with	   added	   kanamycin	   or	   carbenicillin	   (as	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above)	  and	  shaken	  vigorously	  at	  200rpm	  overnight	  at	  37oC.	  Plasmid	  cultures	  were	  purified	   using	   the	   alkaline	   lysis	   method	   and	   a	   commercial	   kit	   (QIAgen).	   For	  sequencing,	  diagnostic	  digests	  and	  subcloning	  applications,	  the	  miniprep	  protocol	  and	   a	   3ml	   culture	   volume	   was	   used;	   for	   larger	   volumes	   of	   DNA	   necessary	   for	  vector	   construction,	   transfection	   and	   microinjection,	   the	   high	   speed	   midiprep	  protocol	  and	  a	  50ml	  culture	  volume	  was	  used.	  Column	  purification	  was	  also	  used	  in	   gel	   extraction	   following	   restriction	   digests	   (QIAgen).	   DNA	   concentration	   was	  measured	  using	  a	  Nanodrop™	  1000	  spectrophotometer	  (Thermo	  Scientific).	  	  
2.7.3	  Vector	  construction	  The	  Gateway	  recombination	  reaction	  is	  described	  in	  detail	  in	  Chapter	  6.	  (Figure	  6.2)	  
2.7.3.1	  Conversion	  of	  DNA	  concentration	  DNA	   concentration	   as	   ng/µl	   was	   converted	   to	   femtomoles	   using	   the	   following	  equation:	  𝑛𝑔  𝑜𝑓  𝐷𝑁𝐴  𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑 = (𝑓𝑒𝑚𝑡𝑜𝑚𝑜𝑙𝑒𝑠  𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑  ×  𝑠𝑖𝑧𝑒 𝑏𝑝 )× 66010! 	  
2.7.3.2	  Vector	  maps	  and	  sequence	  construction.	  Vector	   maps	   and	   sequences	   were	   assembled	   using	   ApE	   software	  (http://biologylabs.utah.edu/jorgensen/wayned/ape/).	  ApE	  was	  used	  to	  generate	  restriction	   maps	   for	   diagnostic	   digests	   and	   the	   recombination	   tool	   was	   used	   to	  generate	   entry	   clone	   and	   expression	   vector	   sequences	   for	   BP	   and	   LR	  recombination.	  
2.7.3.3	  BP	  cloning	  The	  gene	  of	  interest	  was	  amplified	  using	  attB	  site	  containing	  primers	  (Table	  1)	  and	  gel	  purified	  as	  described.	  15	   femtomoles	  of	   the	  PCR	  product	  was	  combined	  with	  100ng	  of	  donor	  plasmid	  in	  TE	  buffer	  in	  a	  total	  volume	  of	  4µl.	  1µl	  of	  BP	  clonase	  II	  enzyme	  mix	  (Invitrogen)	  and	  vortexed	  briefly.	  The	  resulting	  reaction	  was	  left	  at	  18	  °C	   for	   20	   hours	   then	   transformed	   into	   Top10	   cells	   and	   plated	   onto	   kanamycin	  selection	  medium.	  Entry	  clone	  recombination	  was	  confirmed	  by	  sequencing	  with	  M13	  forward	  and	  reverse	  primers.	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2.7.3.4	  LR	  cloning	  5	   femtomoles	   of	   each	   entry	   clone	  were	   combined	  with	   10	   femtomoles	   of	  destination	  vector	   in	  a	   final	  volume	  of	  4µl.	  1µl	   of	  LR	  clonase	   II	  plus	   (Invitrogen)	  was	  added	  to	  the	  mixture	  and	  vortexed	  briefly.	  The	  reaction	  mix	  was	  kept	  at	  18	  °C	  for	   20	   hours	   then	   transformed	   into	   Top10	   cells	   and	   plated	   onto	   carbenicillin	  selection	  medium.	  Correct	  integration	  was	  performed	  using	  a	  diagnostic	  digest:	  3-­‐6	   colonies	   were	   miniprepped	   and	   subjected	   to	   restriction	   digest	   at	   37	   °C	   for	   3	  hours,	  the	  resulting	  products	  were	  resolved	  using	  gel	  electrophoresis.	  Restriction	  enzymes	   were	   selected	   to	   yield	   4-­‐5	   restriction	   fragments	   of	   differing	   sizes,	  preferably	  with	  restriction	  sites	  present	  in	  each	  entry	  clone.	  
2.7.3.5	  pDEST(MPEG1:Gal4.VP16:polyA)	  	  The	  MPEG1	  5’	  entry	  clone	  (Ellett	  et	  al.	  2010)	  was	  eluted	  from	  the	  delivered	  filter	  with	  5µl	  of	  TE	  buffer	  and	  retransformed	   into	  Top10	  cells	   then	  midiprepped.	  The	  entry	   clone	  was	   recombined	  using	  LR	  cloning	  with	   the	  pME-­‐Gal4.VP16	  and	  p3E-­‐PolyA	   (387	   and	   302	   from	   the	   Tol2kit	   respectively)	   in	   the	   pDESTTol2pA2	   (394)	  backbone.	  pDEST(MPEG1:Gal4.VP16:polyA)	  diagnostic	  digest	  was	  performed	  with	  Kpn1	  (NEB),	  and	  a	  correct	  plasmid	  was	  selected	  and	  midiprepped.	  
2.7.3.6	  pDEST(lyz:nsfB.mCherry)	  The	  p5E-­‐lyz	   entry	   clone	   (a	  kind	  gift	   of	  Xingang	  Wang,	   Institute	  of	  Molecular	   and	  Cell	  Biology,	  Singapore)	  and	  pME-­‐nsfB	  (a	  kind	  gift	  of	  Mike	  Parsons,	  Johns	  Hopkins)	  were	  eluted	  and	  retransformed	  as	  described	  above.	  These	  clones	  were	  combined	  with	  p3E-­‐mCherrypA	  (388)	  and	  pDESTTol2pA2	  in	  an	  LR	  recombination	  reaction.	  Correct	  recombination	  was	  confirmed	  using	  an	  AlwN1	  (NEB)	  restriction	  digest.	  
2.7.3.7	  pME-­‐MCS-­‐zfIL-­‐1β	  The	   IL-­‐1β	   middle	   entry	   vector	   was	   constructed	   using	   the	   middle	   entry	  multiple	  cloning	  site	  entry	  vector	  pME-­‐MCS.	  Primers	  designed	  from	  the	  deposited	  zebrafish	   IL-­‐1β	   sequence	   (accession:	   AAQ16563.1)	   including	   a	   5’	   HindIII	  restriction	  site	  and	  a	  3’	  BamHI	  site	  were	  used	  to	  amplify	  the	  IL-­‐1β	  coding	  sequence	  from	  48hpf	  zebrafish	  DNA.	  The	  purified	  PCR	  product	  was	  ligated	  into	  an	  Invitrogen	  TOPO	   blunt	   vector	   (Invitrogen).	   The	   ligated	   vector	  was	   transformed	   into	   Top10	  cells	   and	   grown	  up	  on	  kanamycin	   selection	  medium.	  Colonies	  were	   analysed	   for	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correct	   ligation	   using	   an	   EcoRI	   restriction	   digest.	   The	   purified	   plasmid	   and	   the	  pME-­‐MCS	   entry	   vector	  were	   subjected	   to	   a	  HindIII	   and	  BamHI	   restriction	   digest	  and	   resolved	   using	   gel	   electrophoresis.	   The	   bands	   representing	   the	   empty	   pME-­‐MCS	   vector	   and	   the	   IL-­‐1β	   insert	   were	   gel	   extracted	   into	   a	   final	   volume	   of	   10µl	  elution	  buffer	  each.	  The	   IL-­‐1β	   fragment	  was	   ligated	   into	   the	   linearised	  pME-­‐MCS	  entry	   clone	   vector	   in	   a	   ratio	   of	   3ml	   IL-­‐1β	   fragment	   to	   1ml	   entry	   clone	   in	   a	   final	  volume	  of	  10ml	  using	  T4	  ligase	  (NEB).	  The	  ligation	  mix	  was	  kept	  overnight	  at	  18	  °C	  and	   transformed	   into	   Top10	   cells,	   which	   were	   grown	   on	   kanamycin	   selection	  plates,	   selected	   and	   miniprepped.	   The	   purified	   plasmids	   were	   subjected	   to	   a	  HindIII,	   BamHI	   restriction	   digest	   to	   check	   for	   correct	   insertion	   of	   the	   IL-­‐1β	  sequence.	  	  
2.7.3.8	  pDEST(UAS:MCS-­‐zfIL-­‐1β.EGFP),	  pDEST(UAS:MCS-­‐zfIL-­‐1β.mCherry)	  pME	  MCS	   IL-­‐1β	  was	   combined	  with	   p5E	  UAS,	   pDESTTol2pCG2	   (395)	   and	   either	  p3E-­‐EGFPpA	   (366)	   or	   p3E-­‐mCherrypA	   in	   an	   LR	   recombination	   reaction	   to	  generate	  an	  EGFP	  or	  mCherry	   fusion	  protein	  respectively.	  Correct	  recombination	  was	  confirmed	  using	  a	  Kpn1	  restriction	  digest.	  
2.7.3.9	  pDEST(4xUAS:zfIL-­‐1β.EGFP),	  pDEST(4x	  UAS:zfIL-­‐1β.	  mCherry)	  pME-­‐zfIL-­‐1β	   was	   generated	   using	   BP	   cloning	   as	   described	   previously	   using	  accession	  sequence	  AAQ16563.1	  for	  primer	  design.	  p5E	  4xUAS	  was	  amplified	  from	  a	  4xUAS:nsfB.mCherry	   expression	  plasmid	   (a	   kind	   gift	   from	  Mike	  Parsons,	   Johns	  Hopkins)	   using	   the	   provided	   sequence	   data	   and	   as	   described	   previously	   for	   BP	  cloning.	  pME-­‐zfIL-­‐1β	   and	   p5E	   4xUAS	   were	   combined	   with	   pDESTTol2pCG2	   (395)	   and	  either	   p3E-­‐EGFPpA	   or	   p3E-­‐mCherrypA	   in	   an	   LR	   recombination	   reaction	   to	  generate	  an	  EGFP	  or	  mCherry	   fusion	  protein	  respectively.	  Correct	  recombination	  was	  confirmed	  using	  an	  Xba1	  (NEB)	  restriction	  digest.	  
2.7.3.10	  pDEST(MPEG1:IL-­‐1β.EGFP),	  pDEST(MPEG1:IL-­‐1β.	  mCherry)	  pME-­‐zfIL-­‐1β	  was	  combined	  with	  the	  Mpeg1	  5’	  entry	  clone,	  pDESTTol2pCG2	  (395)	  and	   either	   p3E-­‐EGFPpA	   or	   p3E-­‐mCherrypA	   in	   an	   LR	   recombination	   reaction	   to	  generate	  an	  EGFP	  or	  mCherry	   fusion	  protein	  respectively.	  Correct	  recombination	  was	  confirmed	  using	  an	  AlwN1	  restriction	  digest.	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2.7.4	  FRET	  YVHD	  mutagenesis	  The	  FRET	  DEVD	  plasmid	  (Rehm	  et	  al.	  2002)	  consisting	  of	  a	  FRET	  construct	  of	  CFP	  and	  YFP	   separated	   by	   nucleotides	   encoding	   the	   optimal	   Caspase	   3	   cleavage	   site,	  DEVD,	  on	  a	  PcDNA3	  vector	  was	  mutagenized	  to	  the	  Caspase	  1	  cleavage	  site	  present	  on	   IL-­‐1β, YVHD	   (Rano	   et	   al.	   1997;	   Thornberry	   et	   al.	   1997).	   The	   primers	   were	  designed	   according	   to	   the	   parameters	   provided	   in	   the	   Stratagene	   Quikchange	  mutagenesis	  protocol;	  as	   the	  primers	  were	   intended	  to	  replace	  5	  nucleotides	   the	  primer	   length	   was	   kept	   at	   the	   maximum	   recommended	   45	   base	   pairs	   and	   the	  highest	  possible	  GC	  content	  to	  ensure	  robust	  binding	  of	  the	  elongated	  primer	  arms.	  The	   Primers	   were	   extended	   by	   PCR	   to	   create	   a	   new	   plasmid	   followed	   by	   the	  degradation	  of	  the	  existing	  plasmid	  with	  a	  1	  hour	  digestion	  with	  Dpn1	  (NEB)	  at	  37	  oC.	  The	  plasmids	  were	  transformed	  into	  Top10	  cells	  and	  grown	  up	  overnight	  at	  37	  oC	   on	   ampicillin	   selection	   plates.	   Colonies	   were	   miniprepped	   and	   confirmed	   by	  sequencing.	  
2.8	  Zebrafish	  Line	  generation	  
2.8.1	  Zebrafish	  embryo	  generation	  For	  injection,	  and	  single	  transgenic	  line	  experiments,	  embryos	  were	  generated	  by	  marbling.	  Wire	  mesh	  tanks	  suspended	  over	  a	  solid	  container	  were	  covered	  with	  a	  layer	  of	  marbles	  and	  gently	  placed	  into	  the	  bottom	  of	  the	  aquarium	  tank	  at	  4-­‐8	  pm	  the	  day	  before	  embryos	  were	  needed.	  For	  injection,	  embryos	  were	  collected	  every	  15	  minutes	   after	   aquarium	   lighting	  was	   turned	  on.	   Embryos	  were	   strained	   from	  the	  marble	  tans	  and	  placed	  into	  fresh	  E3	  and	  marble	  tanks	  were	  placed	  back	  into	  the	  aquarium	  tanks.	  For	  non-­‐injection	  uses,	  embryos	  were	  collected	  4	  hours	  after	  aquarium	  lights	  were	  turned	  on.	  	   For	   line	   crosses,	   embryos	  were	   generated	   by	   pair	  mating.	   Single	  male	   or	  female	  fish	  from	  each	  line	  were	  placed	  into	  a	  single	  pair	  mating	  tank	  with	  a	  plastic	  divider	   which	  was	   removed	   an	   hour	   after	   aquarium	   lighting	  was	   activated.	   The	  adults	   were	   separated	   after	   4	   hours	   and	   embryos	   strained	   from	   these	   tanks.	  Embryos	  were	  selected	  as	  described.	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2.8.2	  Line	  generation	  and	  maintenance	  For	   line	  generation,	   injected	  embryos	  were	   selected	  by	   transgenic	  markers	  were	  possible;	   Tg(pNF-­‐κB:EGFP)	  positive	   embryos	   were	   selected	   by	   EGFP	   expression,	  
Tg(lyz:nsfB.mCherry)	   embryos	   selected	   by	   mCherry	   expression	   in	   myeloid	   cells,	  
Tg(mpeg1:Gal4.VP16)	   embryos	   were	   grown	   unselected.	   Injected	   embryos	   were	  grown	   at	   a	   density	   of	   20	   per	   tank	   (Techniplast)	   and	   screened	   after	   2	   months.	  
Tg(pNF-­‐κB:EGFP)	  and	  Tg(lyz:nsfB.mCherry)	  embryos	  were	  screened	  by	  crossing	  to	  Nacre	  wild	  types.	  The	  offspring	  were	  screened	  for	  transgene	  expression.	  Multiple	  founders	  were	  identified	  for	  the	  Tg(pNF-­‐κB:EGFP)	  line,	  and	  one	  was	  selected	  as	  a	  line	   founder	  and	  designated	  with	   the	  Allele	  number	   sh235.	  A	   single	   founder	  was	  identified	   for	   Tg(lyz:nsfB.mCherry)	   and	   the	   resulting	   progeny	   raised	   under	   the	  allele	  number	  sh260.	  
Tg(mpeg1:Gal4.VP16)	  adults	  were	   crossed	   to	  Tg(UAS:Kaede)	   and	   screened	  for	  GFP	  expression	  in	  myeloid	  cells.	  A	  number	  of	  founders	  were	  identified	  and	  the	  progeny	  from	  one	  of	  these	  was	  raised	  under	  the	  allele	  designation	  sh256.	  The	   Tg(BACmpo:FRET	   DEVD)	   founder	   showed	   very	   low	   rates	   of	   allele	  transmission	   to	   its	   progeny.	   And	   only	   3	   of	   the	   embryos	   raised	   survived	   to	  adulthood.	   These	   were	   outcrossed	   to	   WIK	   wildtypes	   and	   the	   resulting	   progeny	  grown	  to	  generate	  the	  line,	  under	  the	  allele	  number	  sh237.	  For	   routine	   line	   maintenance,	   embryos	   were	   grown	   at	   30	   per	   tank	   to	  encourage	   even	   sex	   ratios.	   A	   Tg(BACmpo:FRET	   DEVD)sh237;	  
Tg(lyz:nsfB.mCherry)260	  compound	  transgenic	  line	  was	  made	  by	  pair	  mating	  these	  two	  lines	  into	  a	  compound	  transgenic.	  
2.9	  Cell	  culture	  
2.9.1	  HEK293T	  
2.9.1.1	  Maintenance	  HEK293T	   cells	   were	   maintained	   in	   Dulbecco	   Modified	   Eagle	   Medium	   (DMEM)	  (Invitrogen)	   supplemented	   with	   10%	   heat	   inactivated	   low	   endotoxin	   FCS	  (SourceBioScience),	   0.1	  mg/ml	   penicillin	   (Invitrogen),	   0.1	  mg/ml	   streptomycin	  (Invitrogen)	   and	  0.1	  mg/ml	  L-­‐glutamate	   in	   a	  water	   saturated	   incubator	  with	  5%	  CO2.	   Cells	  were	   passaged	   every	   2-­‐3	   days	  when	   reaching	   80%	   confluence	  with	   2	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quick	  washes	  with	  warmed	  PBS	  and	  5	  minute	  treatment	  with	  1	  ml	  0.05	  %	  Trypsin	  (Invitrogen).	  Cell	  density	  was	  determined	  using	  a	  haemocytometer	  and	  cells	  were	  split	  1:10	  into	  10ml	  of	  warm	  media.	  
2.9.1.2	  Transfection	  A	  single	  20mm	  circular	  coverslip	  was	  placed	  into	  each	  well	  of	  a	  24	  well	  plate	  and	  HEK293T	  cells	  were	  seeded	  into	  these	  wells	  at	  a	  density	  of	  2.5	  ×	  104	  cells	  per	  well	  in	   a	   volume	   of	   0.5ml	   of	   warm	  media.	   Cells	   were	  maintained	   in	   an	   incubator	   as	  described	   above.	   The	   following	   day,	   the	   cells	   were	   washed	   twice	   with	   PBS	   and	  provided	   with	   0.5ml	   warm	  media.	   The	   cells	   were	   transfected	   by	   adding	   1µg	   of	  DNA,	  1µl	  of	  Turbofect	  (Fermentas)	  in	  a	  total	  volume	  of	  100µl	  of	  serum	  free	  DMEM	  and	  swirled	  gently.	  4	  hours	  post	  transfection,	  caspase	  inhibitors	  were	  added	  for	  20	  hour	  overnight	  treatment.	  	   Cells	   were	   fixed	   by	   first	   briefly	   washing	   twice	   with	   PBS,	   then	   20	  minute	  treatment	  with	  4%	  PFA/PBS.	  This	  was	  followed	  by	  a	  further	  3	  washes	  in	  distilled	  water,	  after	  which	  the	  coverslips	  were	  removed	  and	  overturned	  onto	  microscope	  slides	  with	  a	  drop	  of	  VECTASHIELD®	  (Vector	  Labs)	  and	  sealed	  with	  nail	  varnish.	  
2.9.2	  THP-­‐1	  
2.9.2.1	  Maintenance	  THP-­‐1	   cells	   (ATCC)	   were	   maintained	   in	   RPMI-­‐1640	   (Invitrogen)	   supplemented	  with	   10%	   heat	   inactivated	   low	   endotoxin	   FCS	   (SourceBioScience),	   0.1	  mg/ml	  penicillin	   (Invitrogen),	   0.1	  mg/ml	   streptomycin	   (Invitrogen)	   and	   0.1	  mg/ml	   L-­‐glutamate	  with	  50	  μM	  2-­‐mercaptoethanol.	  In	  a	  water	  saturated	  incubator	  with	  5%	  CO2.	  Cells	  were	  passaged	  every	  3	  days	  by	  splitting	  1:5	  into	  a	  T75	  flask.	  	  
2.9.2.2	  Transfection	  Cell	  density	  was	  measured	  using	  a	  haemocytometer	  allowing	  106	  THP-­‐1	  cells	  per	  transfection	   to	   be	   centrifuged	   and	   pelleted	   at	   200g	   and	   22	   oC.	   Cells	   were	  resuspended	   in	   a	   mixture	   of	   82	   µl	   Nucleofection	   buffer	   and	   18	   µl	   buffer	  supplement	  (Nucleofector®	  Kit	  V)	  with	  1µg	  of	  plasmid	  DNA	  per	  reaction.	  The	  cells	  were	   electroporated	   using	   a	   Nucelofector™	   (Lonza)	   and	   the	   inbuilt	   THP-­‐1	   high	  viability	   protocol.	   Cells	   were	   quickly	   returned	   to	   2ml	   of	   warmed	   RPMI	   media	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containing	  20nM	  PMA	  to	  differentiate	  them.	  Transfected	  THP-­‐1	  cells	  were	  washed	  daily	  with	   PBS	   and	   supplied	  with	   fresh	  media	   containing	   the	   inhibitor	   or	   PAMP	  treatment	  described.	  
2.10	  Imaging	  
2.10.1	  WISH	  mounting	  and	  imaging	  WISH	  embryos	   in	  methanol	  were	  rehydrated	  with	  brief	  washes	   in	  3:1,	  1:1	  and	  1:3	  methanol:PBS,	  which	  was	  then	  replaced	  with	  80%	  glycerol.	  The	  embryos	  were	   rocked	  gently	  until	   they	   sank	   into	   the	  glycerol.	  They	  were	   stored	  at	   -­‐20	   °C	  until	   imaging.	   Whole	   fish	   were	   imaged	   on	   a	   Nikon	   SMZ1500	   stereomicroscope	  with	   a	   DS-­‐Fi1	   camera	   using	   NIS	   elements	   software	   to	   generate	   focused	   images	  from	   multiple	   z	   plane	   acquisitions	   (Nikon).	   For	   higher	   resolution	   images,	   the	  embryo	   tails	  were	   removed	  and	  mounted	   in	  glycerol	  with	  no.	  0	   coverglass	   (SLS)	  and	  imaged	  on	  a	  Bx51	  compound,	  with	  a	  Camedia	  C-­‐3030ZOOM	  camera	  and	  a	  40x	  NA	  1.15	  water	  immersion	  objective	  using	  Cell	  B	  software.	  	  
2.10.2	  Mounting	  live	  embryos	  for	  imaging.	  Embryos	  were	  anaesthetised	  by	  transferring	  them	  to	  clean	  E3	  medium	  and	  adding	  MS-­‐222	  dropwise	  until	  cessation	  of	  movement.	  Embryos	  were	  mounted	  in	  a	  40mm	  dish	  with	  a	  section	  of	  the	  base	  replaced	  by	  a	  No.0	  microscopy	  glass	  coverslip	  (SLS).	  They	  were	  arranged	  and	   immobilised	   in	  molten	  0.75	  %	   low	  melting	  point	   (LMP)	  agarose	   at	   ~32	   oC	   containing	   0.017%	   MS-­‐222.	   The	   embryos	   and	   agarose	   were	  prevented	  from	  drying	  out	  by	  the	  addition	  of	  a	  2ml	  MS-­‐222	  containing	  layer	  of	  E3	  placed	  on	  top	  of	  the	  agarose	  during	  imaging.	  
2.10.3	  Tg(pNF-­‐κB:EGFP)sh235	  mounting	  and	  imaging	  (long	  term	  and	  8h).	  
Tg(pNF-­‐κB:EGFP)sh235	   embryos	   were	   injured	   72	   hpf	   and	   kept	   at	   28	   oC	   for	   30	  minutes.	  Embryos	  were	  then	  mounted	   in	  LMP	  agarose	  and	   imaging	  was	   initiated	  an	  hour	  after	  injury	  using	  a	  TE-­‐2000U	  microscope	  (Nikon)	  with	  a	  Orca-­‐AG	  Camera	  (Hamamatsu)	   running	   Volocity™	   imaging	   software	   (Perkin	   Elmer).	   Images	   were	  acquired	   using	   a	   10x	   NA	   0.3	   PlanFluor	   objective,	   at	   2.5	  minute	   intervals	   over	   a	  focal	  depth	  of	  100µM	  with	  10	  z	  planes.	  Volocity™	  was	  used	  to	  generate	  a	  calculated	  point	   spread	   function	   (PSF)	   based	   on	   the	   objective	   used	   and	   EGFP	   emission	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frequency	  and	   the	   images	  were	  deconvolved	  using	  Volocity™	   for	  30	   iterations	   to	  generate	  the	  final	  images.	  For	  compound	  treatment,	  embryos	  were	   injured	  and	  treated	  as	  described.	  After	  an	  8	  hour	   incubation	  at	  28	   oC,	   the	  embryos	  were	  mounted	   in	  LMP	  agarose	  and	  imaged.	  A	  100µM	  focal	  depth	  was	  used,	  divided	  into	  10	  focal	  planes	  centred	  on	  the	  circulation	  in	  the	  dorsal	  aorta-­‐venous	  loop.	  The	  images	  were	  compressed	  into	  a	   single	   plane	   and	   a	   region	   of	   interest	   was	   drawn	   around	   the	   site	   of	   injury,	  delimited	  by	   the	  extent	  of	   the	  pigment	   line	  gap,	  but	   ignoring	  neuromast	   support	  cells.	  The	  average	  intensity	  across	  this	  ROI	  was	  recorded.	  
2.10.4	  Leukocyte	  recruitment	  count	  Post	  injury	  and	  treatment	  with	  selected	  compounds,	  the	  embryos	  were	  kept	  at	  28	  oC	  for	  6	  hours.	  After	  this	  time,	  any	  dead	  embryos	  were	  removed	  and	  the	  rest	  of	  the	  embryos	   manually	   counted	   for	   leukocyte	   recruitment.	   Embryos	   were	  anaesthetised	   with	   0.017%	  MS-­‐222	   as	   described	   previously	   and	   the	   number	   of	  neutrophils	  at	  the	  site	  of	  injury	  were	  counted	  from	  the	  proximal	  most	  point	  of	  the	  pigment	  line	  parallel	  to	  the	  injury	  to	  the	  line	  of	  the	  injury	  itself	  using	  an	  M165FC	  stereomicroscope	  (Leica)	  
2.10.4	  HEK293T	  FRET	  image	  acquisition	  Fixed	   cells	   as	   described	   previously	   were	   imaged	   on	   a	   TE-­‐2000U	   microscope	  (Nikon)	  with	   a	  Orca-­‐AG	  Camera	   (Hamamatsu)	   using	  Volocity™	   imaging	   software	  (Perkin	  Elmer)	  under	  the	  following	  exposure	  and	  emission	  settings.	  For	  each	  FRET	  acquisition,	   3	   images	   were	   taken.	   The	   cells	   were	   imaged	   with	   a	   D436/20x	   CFP	  excitation	   filter	   and	   a	   D480/40m	   CFP	   emission	   filter	   to	   aquire	   an	   image	   of	   the	  donor	   fluorescence,	   then	   with	   a	   HQ500/20x	   YFP	   excitation	   filter	   and	   a	  HQ535/30m	  emission	  to	  aquire	  an	  image	  of	  the	  YFP	  fluorophore	  with	  a	  CFP	  to	  YFP	  image	   taken	   with	   the	   CFP	   excitation	   and	   the	   YFP	   emission	   filter.	   A	   455DCLP	  dichroic	   mirror	   was	   used	   for	   these	   images	   (filters	   and	   dichroic	   from	   Chroma).	  Exposure	  settings	  were	  determined	  by	  autoexposure	  to	  the	  YFP	  emission	  channel	  and	  maintaining	  the	  same	  exposure	  setting	  in	  all	  3	  channels.	  3-­‐4	  random	  fields	  of	  view	   were	   imaged	   for	   each	   repeat	   yielding	   a	   total	   of	   10	   images	   per	   treatment	  group	   from	   3	   repeats.	   Images	   to	   calculate	   CFP	   and	   YFP	   spectral	   bleedthrough	  constants	  were	  acquired	  with	  these	  settings	  on	  cells	  expressing	  either	  CFP	  or	  YFP	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separately.	   Images	  were	   acquired	   at	   10x	  magnification	   using	   a	   0.3NA	   PlanFluor	  objective	  (Nikon).	  
2.10.5	  HEK293T	  FRET	  processing/analysis	  Spectral	  bleedthrough	  constants	  were	  calculated	  using	  Volocity™	  software:	  regions	  of	  interest	  (ROI)	  were	  drawn	  around	  10-­‐12	  cells	  of	  varying	  intensity	  and	  Volocity™	  was	   used	   to	   calculate	   the	   bleedthrough	   constant.	   FRET	   was	   calculated	   by	  Volocity™	   using	   these	   constants.	   Background	   corrections	   were	   determined	   by	  Volocity™	   from	   a	   cell-­‐free	   region	   of	   interest.	   Threshold	   corrections	   were	  performed	   by	   carrying	   over	   these	   background	   constants	   into	   the	   “threshold”	  dialogue	   box.	   Cell	   measurements	   were	   performed	   by	   Volocity™,	   objects	   were	  defined	   in	   the	  6th	  percentile	  of	  CFP	   intensity	  with	  a	   size-­‐guide	  of	  250µm2.	  These	  data	  were	  exported	  to	  excel	  where	  the	  average	  intensity	  for	  each	  FRET	  calculation	  method	  used	  was	  calculated	  across	  each	  field	  of	  view.	  Figures	  were	  generated	  and	  statistical	  analysis	  performed	  using	  Prism®	  (Graphpad).	  
2.10.6	  Tg(BACmpo:FRET	  DEVD)sh237	  isopimpinellin	  acquisition	  and	  processing	  Six	  embryos	  at	  a	  72	  hpf	  developmental	  stage	  were	  injured	  as	  described	  above	  and	  kept	  at	  28	  oC	  for	  30	  minutes.	  They	  were	  mounted	  as	  described	  with	  the	  addition	  of	  Isopimpinellin	  to	  the	  LMP	  agarose,	  and	  E3	  layer.	  Embryos	  treated	  with	  1%	  DMSO	  were	   injured	   and	   mounted	   at	   the	   same	   time	   as	   a	   control.	   The	   embryos	   were	  imaged	   for	  8	  hours	  with	   acquisition	   initiated	  1	  hour	  post	   injury	  under	   the	   same	  acquisition	  settings	  described	  above	  with	  images	  taken	  every	  180	  second,	  with	  the	  observer	  blinded	  to	  the	  experimental	  condition.	  Volocity™	  was	  used	  to	  generate	  an	  nF	  channel	  with	  threshold	  set	  at	  150%	  of	  the	  mean	  intensity	  of	  the	  signal	  from	  a	  cell	   free	   ROI.	   Spectral	   bleedthrough	   was	   determined	   from	   previously	   fixed	  HEK293T	  samples.	  The	  image	  sequences	  were	  compressed	  to	  a	  single	  z-­‐plane.	  The	  images	  were	  investigated	  for	  instances	  of	  neutrophil	  apoptosis	  by	  the	  loss	  of	  FRET	  but	  retention	  of	  YFP	  signal	  and	  these	  data	  were	  recorded	  and	  quantified.	  
2.10.7	  Tg(BACmpo:FRET	  DEVD)sh237;Tg(lyz:nsfB.mCherry)sh260	  acquisition	  The	  Tg(BACmpo:FRET	  DEVD)sh237	  was	   crossed	   to	  Tg(lyz:nsfB.mCherry)sh260.	   At	  72	  hpf,	  embryos	  were	  treated	  with	  metronidazole	  then	  mounted	  for	  imaging	  after	  4	   hours.	   The	   embryos	  were	   imaged	   on	   a	   UltraVIEW	   VoX	   spinning	   disk	   confocal	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microscope	  (Perkin	  Elmer)	  mounted	  on	  a	  Axiovert	  200M	  (Zeiss)	  running	  Volocity™	  software	  for	  image	  acquisition	  (Perkin	  Elmer).	  Images	  were	  captured	  at	  the	  Caudal	  Haematopoetic	  Tissue	  (CHT)	  of	  the	  embryos.	  4	  fluorescent	  settings	  were	  captured	  for	   each	   image.	   CFP	   was	   imaged	   with	   a	   440	   nm	   laser	   line	   for	   excitation	   and	   a	  485/705nm	  dual	  band-­‐pass	   filter	   for	  emission,	  YFP	  was	   imaged	  with	  a	  514	   laser	  line	  for	  excitation	  and	  a	  587	  filter	  for	  emission,	  and	  the	  FRET	  channel	  was	  imaged	  with	   the	   CFP	   excitation	   and	   YFP	   emission	   settings.	   The	   mCherry	   channel	   was	  acquired	   with	   a	   561	   nm	   laserline	   for	   excitation	   and	   a	   525/640	   dual	   band-­‐pass	  filter	   for	   emission.	   The	   images	   were	   acquired	   using	   a	   40x	   PlanFLN	   NA	   1.3	   oil	  immersion	  objective.	  This	  yielded	   images	  of	   the	  mpx	   FRET	  reporter	  and	  allowed	  colocalisation	  with	  cells	  expressing	  nsfB.mCherry.	  The	   images	  were	  processed	  as	  described	  above	  and	  visualised	  for	  apoptotic	  events.	  
2.10.8	  THP-­‐1	  FRET	  YVHD	  acquisition	  THP-­‐1	   cells	   transfected	   with	   FRET	   YVHD,	   or	   with	   FRET	   DEVD	   being	   used	   as	   a	  control,	   were	   differentiated	   with	   20nm	   PMA	   as	   described	   previously	   onto	  LabTek™	  8	  chambered	  coverglass	  (Thermo	  Scientific).	  Controls	  were	  as	  follows:	  2	  well	   YVHD,	   2	   wells	   YVHD	   with	   Caspase	   1	   inhibitor	   treatment,	   2	   wells	   DEVD,	   2	  wells	   DEVD	  with	   Caspase	   1	   inhibitor	   treatment.	   24	   hours	   post	   transfection,	   the	  media	  was	   replaced	   and	   control	   chambers	   of	   cells	  were	   treated	  with	   50nm	  AC-­‐YVAD-­‐CMK	  Caspase	   1	   inhibitor	   for	   18	   hours.	   After	   AC-­‐YVAD-­‐CMK	   treatment	   the	  cells	  were	  primed	  with	  1µg/ml	  LPS	   for	  3	  hours.	   Cells	  were	   imaged	   as	  described	  with	   HEK293T	   cells	   above	   at	   the	   timepoints	   indicated.	   3	   ROIs	   were	   designated	  randomly	  within	   each	   chamber.	   Immediately	   before	   initiation	   of	   acquisition,	   the	  cells	  were	  stimulated	  with	  500nm	  3’-­‐O-­‐(4-­‐benzoyl)benzyl-­‐ATP	  (BzATP).	  
2.10.9	  THP-­‐1	  FRET	  YVHD	  analysis	  Spectral	  bleedthrough	  was	  determined	  from	  previously	  fixed	  HEK293T	  samples.	  nF/Donor	  was	  determined	  as	  described	  previously	  and	  exported	  to	  Excel	  (Microsoft).	  The	  nF/Donor	  intensity	  for	  each	  object	  was	  averaged	  across	  each	  field	  of	  view	  and	  figures	  were	  generated	  in	  Prism®	  (Graphpad).	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2.10.10	  THP-­‐1	  IL-­‐1β.EGFP	  THP-­‐1	  cells	  transfected	  with	  the	  IL-­‐1β.EGFP	  expression	  plasmid	  and	  seeded	  onto	  6	  well	   plates.	   Cells	   were	   then	   differentiated	   with	   20nm	   PMA.	   48	   hours	   post	  transfection	   cells	   were	   stimulated	   with	   500nm	   BzATP	   and	   imaged	   at	   5	   minute	  intervals	   using	   a	   10x	   0.3NA	   PlanFLuor	   objective	   on	   a	   TE-­‐2000U	   microscope	  (Nikon)	  with	  a	  Orca-­‐AG	  Camera	  (Hamamatsu).	  
2.10.11	   Tg(fms:Gal4.VP16)i186;Tg(UAS:nsfB.mCherry)i149	   pDEST(UAS:MCS-­‐zfIL-­‐
1β.EGFP)	  image	  acquisition	  FMS	  UNM	  embryos	  were	  injected	  with	  pDEST(UAS:MCS-­‐zfIL-­‐1β.EGFP)	  and	  selected	  for	  Cmlc2EGFP	  and	  mCherry	  expression	  at	  48	  hpf.	  Embryos	  were	   injured	  72	  hpf	  and	  mounted	  in	  LMP	  agarose	  after	  10	  minutes.	  The	  site	  of	  injury	  was	  imaged	  every	  2	   minutes	   using	   a	   10x	   0.3NA	   PlanFLuor	   objective	   on	   a	   TE-­‐2000U	   microscope	  (Nikon)	  with	  an	  Orca-­‐AG	  Camera	  (Hamamatsu).	  
2.10.12	  pDEST(MPEG1:IL-­‐1β.EGFP)	  image	  acquisition.	  AB	  wildtype	  embryos	  were	   injected	  with	  pDEST(mpeg1:IL-­‐1β.EGFP)	   as	  described	  and	  selected	  for	  cmlc2EGFP	  expression	  after	  48h.	  At	  72	  hpf	  embryos	  were	  injured	  and	  incubated	  for	  30	  minutes	  at	  28	  oC.	  after	  30	  minutes,	  embryos	  were	  mounted	  in	  LMP	   agarose	   and	   imaged	   using	   a	   UltraVIEW	   VoX	   spinning	   disk	   confocal	  microscope	  (Perkin	  Elmer)	  mounted	  on	  a	  Axiovert	  200M	  (Zeiss)	  running	  Volocity™	  software	   for	   image	   acquisition	   (Perkin	   Elmer).	   A	   40x	   PlanFLN	   NA	   1.3	   oil	  immersion	   objective	   was	   used.	   Images	   of	   single	   cells	   were	   acquired,	   upper	   and	  lower	  limits	  of	  the	  focal	  depth	  defined	  by	  the	  limits	  of	  the	  cell,	  and	  6	  focal	  planes	  were	   used.	   Gain	   was	   set	   at	   125	   to	   keep	   exposure	   to	   a	   minimum.	   Images	   were	  acquired	  every	  15	  seconds.	  
2.11	  Data	  collection	  and	  statistical	  analysis	  Data	  was	   collected	   either	   from	  Volocity™	   or	   visual	   counting	   and	   input	  manually	  into	   Prism®	   (Graphpad),	   which	   was	   used	   to	   generate	   figures	   and	   statistical	  analyses.	   The	   observer	   was	   blinded	   to	   experimental	   treatments	   throughout	   to	  avoid	  experimental	  bias.	  Throughout	  the	  study,	  “*”	  refers	  to	  a	  p	  value	  of	  ≤0.05,	  “**”	  to	  ≤0.01	  and	  “***”	  to	  ≤0.001	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Table	  2.1	  PCR	  primers	  
Gateway	  sequencing	  primers	  
5'	  forward	  sequencing	   CTATGACCATGATTACGCCAAGCTA 







3'	  forward	  sequencing	   CAGCTTTCTTGTACAAAGTGG 
3'	  reverse	  sequencing	   CAGTGAATTATCAACTATGTA 







FRET	  mutagenesis	  sequencing	  primer	  









Forward	   GATTAAAGCTTATGGCATGCGGGCAATATGAAGTC 







GGAATTC 	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Chapter	  3:	  Bioinformatic	   Investigation	  of	  Zebrafish	  as	  a	  model	  
of	  Interleukin-­‐1β 	  Biology	  	  Zebrafish	   and	   humans	   share	   significant	   conservation	   in	   elements	   of	   their	  immune	  system.	  Zebrafish	  orthologues	  exist	  of	  TLRs	  and	  other	  pattern	  recognition	  receptors,	  NF-­‐κB,	  and	  more.	  To	  use	   zebrafish	  as	  a	  viable	  model	  of	   IL-­‐1β	  biology,	  this	  pathway	  in	  zebrafish	  must	  share	  enough	  conservation	  with	  the	  human	  IL-­‐1β	  pathway	   that	   any	   discoveries	   made	   in	   zebrafish	   on	   IL-­‐1β	   modulation	   could	   be	  transferred	  to	  human	  medicine	  with	  a	  chance	  of	  success.	  To	  this	  end	  I	  undertook	  a	  bioinformatics	   study	   of	   the	   immune	   components	   in	   the	   zebrafish	   IL-­‐1β	   pathway	  that	  have	  not	  already	  been	  studied	  starting	  with	  zebrafish	  IL-­‐1β	  itself.	  	  
3.1	  Zebrafish	  IL-­‐1β	  function	  and	  processing	  	   The	   fish	   immune	   system	   encodes	   orthologues	   of	   IL-­‐1β,	   however,	   these	  sequences	  lack	  a	  consensus	  caspase-­‐1	  cleavage	  site	  like	  that	  found	  in	  mammalian	  IL-­‐1β	  orthologues	  (Zou	  et	  al.	  1999;	  Bird,	  Zou,	  et	  al.	  2002;	  Bird,	  T.	  Wang,	  et	  al.	  2002;	  Hong	   et	   al.	   2004;	   Angosto	   et	   al.	   2012).	   It	   is	   unclear	   whether	   IL-­‐1β	   therefore	  functions	   in	   a	   similar	   way	   in	   the	   zebrafish	   as	   it	   does	   in	   mammalian	   cells.	   The	  induction	  of	   the	   IL-­‐1β	  message	  has	  been	  described	   in	   response	   to	  peptidoglycan	  injection	  in	  carp	  (T.	  Kono	  et	  al.	  2002);	  Francisella	  in	  zebrafish	  (Vojtech	  et	  al.	  2009);	  
V.	  anguillarum	  DNA,	  flagellin	  and	  LPS	  in	  pufferfish	  (MP	  Sepulcre	  et	  al.	  2009);	  LPS	  in	  catshark	  (Bird,	  T.	  Wang,	  et	  al.	  2002)	  and	  LPS	   in	   trout	  (Zou	  et	  al.	  1999);	  which	  indicate	  that	  the	  role	  of	  IL-­‐1β	  as	  a	  proinflammatory	  cytokine	  is	  conserved	  between	  mammalian	  and	  fish	  lineages.	  Processing	  of	  IL-­‐1β	  into	  a	  mature	  cytokine	  has	  been	  demonstrated	   in	   trout	   (Hong	   et	   al.	   2004)	   and	   seabream	   (López-­‐Castejón,	   M	  Sepulcre,	   et	   al.	   2007),	   however	   the	   caspase-­‐1	   dependence	   of	   these	   processing	  mechanisms	  has	  been	  questioned.	  	  The	   caspase-­‐1	   cleavage	   site	   is	   poorly	   conserved	   outside	   the	   mammalian	  clade	   (Figure	   3.1),	   however	   these	   orthologues	   contain	   an	   IL-­‐1β	   family	   signature	  (Bird,	  Zou,	  et	  al.	  2002).	  The	  human	  IL-­‐1β	  gene	  is	  present	  in	  a	  cluster	  of	  Interleukin	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1	  like	  genes,	  but	  this	  cluster	  is	  highly	  polymorphic	  and	  the	  presence	  of	  so	  many	  IL-­‐1	   gene	   family	   members	   around	   the	   same	   chromosomal	   region	   suggests	   their	  evolutionary	  origin	  from	  a	  single	  gene	  (Dunn	  et	  al.	  2001;	  Brocker	  et	  al.	  2010).	  This	  appears	   to	   have	   occurred	   at	   some	   point	   in	   mammalian	   evolution,	   as	   there	   are	  fewer	   interleukins	   present	   on	   the	   same	   linkage	   group	   in	   mice	   than	   in	   human	  genome	  (Figure	  3.2).	  In	  zebrafish,	   the	  IL-­‐1β	  gene	  clusters	  separately	   from	  other	   interleukins	  on	  chromosome	  10,	  with	  no	  other	  nearby	  interleukins.	  For	  human	  IL-­‐1β,	  both	  pro	  and	  mature	   sequences	   (accession	   AAA59135.1	   and	   AAC03536.1	   respectively)	   align	  most	   closely	   to	   the	   annotated	   zebrafish	   IL-­‐1β	   protein	   (accession	   NP_998009.1)	  which	  also	  has	  human	  pro	  IL-­‐1β	  as	   its	  best	  reciprocal	  BLAST	  hit.	  However,	   there	  were	   no	   hits	   for	   human	   IL-­‐1α	   and	   IL-­‐1RA	   alignment,	   which	   matches	   previous	  studies	  which	  failed	  to	  find	  zebrafish	  homologues	  (Huising	  et	  al.	  2004).	  Huising	  et	  
al	  also	  found	  IL-­‐18	  homologues	  in	  Medaka	  and	  Fugu,	  but	  I	   failed	  to	  find	  a	  similar	  IL-­‐18	  homologue	  in	  the	  zebrafish	  genome.	  An	   alignment	   of	   these	   two	   proteins	   shows	   that	   the	   proteins	   have	   overall	  high	  homology	  (Figure	  3.3	  A).	  An	  alignment	  of	  the	  IL-­‐1β	  cytokine	  post	  processing	  with	  the	  putative	  active	  IL-­‐1β	  region,	  defined	  by	  BLAST	  as	  starting	  at	  residue	  106,	  shows	  an	  even	  higher	  homology,	  which	  would	  be	  expected	   if	   this	  was	   the	  active	  region	  of	  the	  molecule.	  The	  zebrafish	  IL-­‐1β	  sequence	  was	  analysed	  using	  RaptorX	  (Källberg	  et	  al.	  2012)	  and	  Phyre	  (Kelley	  &	  Sternberg	  2009).	  Phyre	  predicted	  a	  β-­‐sheet	  rich	  structure	  very	  similar	   to	   that	  of	  human	  IL-­‐1β	  (Priestle	  et	  al.	  1988)	   for	  the	  c	   terminal	  domain	  of	   the	  protein	  (Figure	  3.4).	  However,	   the	  structural	  model	  produced	   by	   RaptorX	   disagreed	   on	   where	   this	   IL-­‐1β	   like	   domain	   began	   and	  generated	  an	  α-­‐helix	  prediction	  for	  what	  would	  be	  the	  equivalent	  of	  the	  receptor	  activation	   residues	   on	   the	   cytokine.	   This	   split	   also	   differs	   from	   that	   assigned	   by	  BLAST	   and	   other	   alignment	   tools.	   To	   test	   whether	   other	   tools	   detected	   this	  segment	   as	   an	   α-­‐helix	   or	   β-­‐strand,	   the	   protein	   sequence	   was	   submitted	   into	   I-­‐TASSER	   (Y.	   Zhang	   2008;	   A.	   Roy	   et	   al.	   2010)	   and	   PsiPred	   (Buchan	   et	   al.	   2010).	  PsiPred	   yielded	   very	   similar	   results	   to	   Phyre	   using	   a	   different	  methodology	   not	  based	  on	  the	  template	  method	  that	  Phyre	  or	  RaptorX	  uses	  and	  I-­‐TASSER	  confirmed	  the	   results	   of	   Phyre,	   whilst	   also	   predicting	   structures	   where	   the	   Pro-­‐domain	  blocked	   access	   to	   the	   first	  β−strand.	  These	   results	   also	  both	   show	   that	   the	  most	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conserved	  residues	  map	  to	  the	  predicted	  beta	  sheet	  regions	  on	  the	  protein	  (Figure	  3.5).	  I-­‐TASSER	  also	  predicted	  that	  this	  structure	  most	  likely	  interacted	  with	  IL-­‐1R	  and	   that	   by	   GO	   terms,	   the	   protein	   was	   most	   likely	   to	   bind	   to	   IL-­‐1R	   have	   an	  extracellular	  function	  involved	  in	  inflammation	  and	  immunity.	  Overall,	   zebrafish	   IL-­‐1β	   has	   high	   degree	   of	   sequence	   homology	   and	   a	  conserved	  structure	  based	  on	  structural	  prediction	  tools.	  	  
3.2	  Zebrafish	  IL-­‐1	  receptors.	  IL-­‐1	   receptors	   in	   zebrafish	   have	   proved	   much	   more	   difficult	   to	   explore	  bioinformatically.	   Human	   IL-­‐1RI	  maps	  most	   closely	   to	   the	   RAcP	   like	   1	   sequence	  and	  the	  hypothetical	  proteins	  IL-­‐1R	  like	  2	  and	  IL-­‐1R	  like	  2,	  predicted	  by	  automated	  sequence	   analysis	   (accession	   NP_001136054.1,	   XP_001339654.4	   and	  XP_002663470.2	  respectively.)	  Zebrafish	   IL-­‐1RI	   has	   been	   annotated	   by	   Huising	   et	   al	   (2004)	   (accession	  ENSDARP00000012342)	   and	   maps	   to	   chromosome	   3,	   where	   it	   encodes	   a	  peptidase	   like	  protein.	  López-­‐Castejón	  et	  al.	   (2007),	  however,	  define	  IL-­‐1RI	  using	  the	   accession	   ENSDARP00000055956	   and	   IL-­‐1RII	   using	   the	   accession	  ENSDARP00000064952,	  which	  have	  not	  been	  available	  since	  the	  Zv8	  release	  of	  the	  zebrafish	   genome.	   Meijer	   et	   al.	   (2004)	   have	   cloned	   a	   partial	   message	   of	   the	  zebrafish	   IL-­‐1R	  mRNA	   (deposited	   as	  AAQ91322.1),	  which	   still	  maps	   to	   the	   same	  message	   fragment	  on	   the	  Zv9	  assembly,	  however,	   remains	  poorly	  annotated	  and	  only	  codes	  for	  the	  TIR	  domain.	  Alignments	  were	  not	  made	  to	  IL-­‐1R	  due	  to	  this	  lack	  of	  clarity.	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Figure	   3.1.	   Zebrafish	   IL-­‐1β	   does	   not	   align	   to	   give	   a	   direct	   match	   for	   the	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Figure	  3.3.	  The	  mature	  IL-­‐1β	  cytokine	  has	  higher	  homology	  between	  humans	  
and	   zebrafish	   than	   an	   overall	   alignment	   of	   the	   entire	   pro-­‐protein	   would	  







Figure	   3.4.	   Human	   and	   zebrafish	   mIL-­‐1β	   is	   a	   trefoil	   structure	   composed	  
primarily	  of	  β-­‐sheets.	  JMOL	  image	  of	  mIL-­‐1β	  (accession	  AAA59135.1)	  (Ai	  and	  Aii)	  and	  of	  zfIL-­‐1β	  (Bi	  and	  Bii)	  predicted	  using	  Phyre	  from	  two	  different	  angles	  shows	  a	  highly	  similar	  trefoil	  structural	  arrangement	  composed	  of	  β-­‐sheets.	  
A.i B.i 
A.ii B.ii 
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3.3	  IL-­‐1β	  processing	  by	  caspase-­‐1	  orthologues	  	   Although	   IL-­‐1β	   structure	   remains	   relatively	   homologous,	   it	   is	   unclear	  whether	  IL-­‐1β	  is	  cleaved	  and	  processed	  in	  zebrafish.	  There	  are	  numerous	  pieces	  of	  evidence	  that	  suggest	  that	  this	  may	  not	  be	  the	  case.	  The	  human	  cleavage	  site	  is	  not	  conserved	   outside	   of	   mammalian	   caspase-­‐1	   orthologues	   (Figure	   3.1),	   and	   a	  number	  of	  studies	  have	  failed	  to	  identify	  cleavage	  sites	  in	  the	  IL-­‐1β	  orthologues	  of	  other	  fish	  species,	  such	  as	  trout	  (Zou	  et	  al.	  1999)	  and	  gilthead	  seabream	  (Angosto	  et	   al.	   2012).	   In	   trout,	   the	   cleavage	   of	   IL-­‐1β	   by	   caspase	   equivalents	   was	   not	  investigated	   and	   the	   study	   lacked	   a	   secondary	   stimulus	   for	   inflammasome	  activation.	  However,	  in	  seabream,	  Angosto	  et	  al	  showed	  that	  despite	  IL-­‐1	  release	  as	  a	  smaller	   isoform,	  corresponding	   to	   the	  mature	  cytokine,	   the	  processing	  was	  not	  dependent	  on	  caspase-­‐1.	  	   Whether	  this	  applies	  to	  zebrafish	  would	  be	  dependent	  on	  the	  evolutionary	  relationships	  between	   these	   caspase	  and	   IL-­‐1β	  orthologues.	  Huising	  et	   al	   (2004)	  show	   that	   zebrafish	   caspase-­‐A	   and	   -­‐B	   are	   phylogenetically	   most	   similar	   to	  mammalian	  caspase-­‐1	  orthologues,	  however	  functional	  activity	  was	  not	  assessed.	  Caspase	   A	   and	   B,	   the	   closest	   orthologues	   to	   mammalian	   caspase-­‐1	   and	   5	  (Masumoto	   et	   al.	   2003)	   have	   highly	   conserved	   catalytic	   domains,	   but	   less	  conserved	  N-­‐terminal	  domains	  (Figure	  3.6).	  Whereas	  the	  N-­‐terminus	  of	  caspase-­‐1	  is	   a	   caspase	   recruitment	   or	   CARD	   domain,	   caspase-­‐A	   and	   -­‐B	   instead	   have	   pyrin	  domains,	  a	  related	  death-­‐fold	  domain	  (Martinon	  et	  al.	  2001)	  with	  less	  conservation	  to	  the	  N	  terminus	  of	  Capase	  1.	  	   Overall,	   the	   phylogenetic	   alignment	   of	   the	   human	   caspase-­‐1	   protein	  with	  mouse,	   chicken	   and	   seabream	   caspase-­‐1	   and	   zebrafish	   caspase-­‐A	   show	   that	  zebrafish	   caspase-­‐A	   is	   evolutionarily	   further	   from	   human	   caspase-­‐1	   than	   its	  seabream	   orthologues	   (Figure	   3.7	   A),	   however	   when	   considering	   just	   the	  	  functional	  caspase	  domain,	  this	  effect	  is	  reversed	  (Figure	  3.7	  B).	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Figure	   3.6.	   Alignment	   of	   Human	   caspase-­‐1	   and	   zebrafish	   caspase-­‐A	   shows	  




Figure	  3.7.	  Caspase-­‐1	  phylogenetic	  tree.	  Caspase-­‐1	  alignments	  show	  phylogenetic	  difference	  between	  zebrafish	  and	  human	  caspase-­‐1	  orthologues	  as	  further	  than	  Seabream	  caspase-­‐1	  (A),	  unless	  only	  caspase	  functional	  domains	  are	  considered	  (B).	  Functional	  domain	  based	  on	  López-­‐Castejón	  et	  al.,	  (2008)(Accession	  numbers	  Sparus:	  CAM32183.1,	  Danio:	  NP_571580.1,	  Homo:	  NP_150634.1,	  Mus:	  NP_033937.2,	  Gallus:	  AAC69917.1).	  Generated	  using	  Clustal	  Omega.	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3.4	  Discussion.	  	  	   In	  order	  to	  develop	   in	  vivo	  reporters	  of	   IL-­‐1β,	   it	   is	  essential	  to	  ensure	  that	  the	   model	   organism	   used	   is	   appropriate.	   The	   advantages	   of	   the	   zebrafish	   as	   a	  model	   for	   inflammation	   were	   laid	   out	   in	   chapter	   1,	   where	   the	   current	  understanding	  of	  the	  conservation	  of	  immune	  genes	  and	  functions	  in	  vertebrates	  is	  summarised.	   Numerous	   components	   in	   innate	   immune	   pathways	   are	   conserved	  however,	  it	  is	  still	  uncertain	  how	  the	  divergence	  between	  fish	  and	  mammals	  affects	  the	  IL-­‐1β	  pathway.	  	   In	  mammals,	  the	  IL-­‐1β	  locus	  is	  highly	  polymorphic,	  with	  the	  suggestion	  that	  a	  number	  of	  the	  Il-­‐1	  family	  members	  evolved	  from	  a	  single	  locus.	  This	  appears	  to	  have	  happened	   in	   the	  mammalian	   lineage	  as	  so	  many	  related	   IL-­‐1	  proteins	  were	  not	  found	  in	  fish.	  The	  syntenic	  difference	  between	  mice	  and	  humans	  demonstrates	  the	  magnitude	  of	   the	  divergence	  of	   this	   locus	   in	   the	  mammalian	   clade,	   however,	  the	   expansion	   of	   the	   IL-­‐1	   family	   into	   so	   many	   paralogues	   highlights	   the	  evolutionary	  importance	  of	  IL-­‐1	  itself.	  From	   a	   protein	   sequence	   perspective,	   the	   C-­‐terminal	   region	   of	   zfIL-­‐1β,	  corresponding	   to	   the	   protein	   sequence	   of	   the	   mature	   human	   IL-­‐1β	   cytokine	   is	  highly	   conserved	   between	   humans	   and	   zebrafish.	   As	   no	   role	   has	   yet	   been	  confirmed	   for	   the	   pro	  domain	   of	   IL-­‐1β,	   residing	   in	   the	  N-­‐terminus	   of	   the	   coding	  sequence,	   it	   is	   highly	   likely	   that	   its	   role	   is	   mostly	   inhibitory.	   This	   could	   occur	  through	   allosteric	   blocking	   of	   important	   residues	   on	   mature	   IL-­‐1β	   or	   through	  increasing	   the	   size	   of	   the	   cytokine	   for	   export,	   although	   as	   IL-­‐1β	   secretion	   is	  coupled	   to	   its	   processing,	   the	   latter	   is	   unlikely.	   Nevertheless,	   if	   its	   function	   is	  purely	   inhibitory,	   there	   would	   be	   weak	   evolutionary	   selection	   pressure	   against	  any	  mutants	  unless	  they	  affected	  its	  function.	  In	  contrast,	  the	  C-­‐terminal	  region	  of	  the	  protein	  corresponding	  to	  the	  mature	  cytokine	  would	  be	  under	  much	  stronger	  selection	  pressure	   to	  retain	   its	  sequence	  and	   its	   function,	  as	  changes	  here	  would	  likely	  affect	  the	  ability	  to	  bind	  to	  its	  receptor	  and	  transduce	  a	  signal.	  It	  is	  therefore	  expected	   that	   this	   region	   of	   the	   protein	   would	   retain	   much	   more	   similarity	  between	  species	  than	  the	  N-­‐terminal	  propeptide.	  Analysis	  of	  these	  protein	  regions	  demonstrated	  that	   this	  was	   indeed	  the	  case;	   the	  prodomain	  equivalent	  region	  on	  zebrafish	  IL-­‐1β	  has	  far	  fewer	  identical	  residues,	  but	  has	  large	  regions	  of	  similarity,	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whereas	   the	   C-­‐terminal	   domain,	   corresponding	   to	   the	   human	   mature	   IL-­‐1β	  sequence	   has	   significantly	   more	   identical	   residues	   (Figure	   3.3).	   Furthermore,	  structural	   prediction	   of	   the	   protein	   sequence	   using	   Phyre	   and	   RaptorX	   support	  these	  hypotheses	  and	  suggest	  a	  β-­‐trefoil	  shape	  for	  IL-­‐1β	  composed	  primarily	  of	  β-­‐sheets.	  However,	   these	  approaches	  may	   introduce	  a	  certain	  bias.	  Both	  Phyre	  and	  RaptorX	  base	  their	  prediction	  on	  homology	  to	  existing	  models,	  which	  they	  use	  as	  templates	   and	   may	   introduce	   error	   if	   a	   template	   for	   a	   closer	   homologue	   is	   not	  available.	  In	  this	  study,	  the	  closest	  structural	  match	  in	  Phyre	  was	  the	  chicken	  IL-­‐1β	  protein,	   whereas	   RaptorX	   used	   a	   series	   of	   human	   IL-­‐1β	  mutants	   as	   a	   structural	  template.	  The	  difference	  between	  these	  approaches	  was	  addressed	  by	  combining	  further	  methods	   such	  as	   the	  UCL	  Psipred	   server	   to	   investigate	   these	  differences.	  Psipred	  attempts	  to	  predict	  secondary	  structure	  rather	  than	  to	  generate	  a	  tertiary	  structure	   for	   the	   entire	   protein,	   and	   was	   used	   here	   to	   look	   at	   the	   difference	   in	  secondary	  structure	  predicted	  by	  the	  two	  newer	  methods.	  Overall,	  whilst	  the	  use	  of	   structure	   prediction	   does	   not	   provide	   as	   robust	   a	   method	   for	   generating	   a	  structure	   as	   a	   solved	   crystal	   structure	   for	   zebrafish	   IL-­‐1β,	   it	   does	   provide	  supporting	  evidence	  for	  the	  similarity	  in	  structure	  between	  IL-­‐1β	  orthologues.	  	  Although	   the	   evolutionary	   importance	   and	   conservation	   of	   IL-­‐1β	   as	   a	  cytokine	   has	   been	   suggested	   via	   its	   sequence	   and	   structural	   homology,	   the	  zebrafish	  IL-­‐1β	  receptor	  is	  poorly	  characterized.	  There	  is	  disagreement	  about	  the	  coding	   sequence	   for	   the	   receptor,	   and	   presently	   there	   are	   no	   orthologues	  annotated	  as	  either	  IL-­‐1RI	  or	  IL-­‐1RII	  on	  the	  latest	  genome	  assembly	  (Zv9)	  except	  for	   the	  automated	  hypothetical	  entries	   IL-­‐1RI-­‐like-­‐1	  and	  -­‐2.	  From	  these	  data	   it	   is	  very	  difficult	  to	  determine	  the	  comparability	  between	  the	  zebrafish	  IL-­‐1	  receptors	  and	   their	   human	   orthologues.	   Further	   detail	   would	   be	   gained	   from	   molecular	  cloning	   of	   these	   receptors	   and	   investigating	   their	   exon	   structure,	   domain	  organization	  and	  expression,	  however	  currently	  this	  information	  is	  not	  available.	  	  One	  major	  potential	  problem	  with	  using	   zebrafish	   as	   a	  model	   for	   IL-­‐1β	   is	  the	   lack	   of	   an	   obvious	   conserved	   caspase	   cleavage	   site	   on	   zfIL-­‐1β	   that	  maps	   to	  mammalian	  orthologues.	  Another	  is	  the	  lack	  of	  in	  vitro	  data	  to	  support	  a	  lack	  of	  IL-­‐1β	   cleavage	   in	   fish	   (Angosto	   et	   al.	   2012).	   However,	   existing	   data	   may	   be	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incomplete	   and	   these	   caveats	  may	  not	   apply	   to	   the	   current	   study.	  Angosto	  et	  al.	  (2012)	  show	  that	  mIL-­‐1β	  is	  released	  from	  seabream	  leukocytes,	  and	  is	  unaffected	  by	   inhibition	   with	   AC-­‐YVAD-­‐CMK	   and	   AC-­‐ZVAD-­‐FMK.	   However,	   previous	  publications	   show	   that	   seabream	   P2X7	   receptors	   respond	   differently	   to	   ATP	  stimulation	   than	   their	   human	   and	   rat	   counterparts,	   and	   were	   not	   capable	   of	  inducing	   caspase-­‐1	   mediated	   cleavage	   of	   human	   IL-­‐1β,	   with	   this	   incapability	  localized	   to	   the	   intracellular	   domain	   of	   seabream	   P2X7;	   demonstrated	   by	   the	  ability	   of	   a	   seabream	   extracellular	   domain-­‐rat	   intracellular	   domain	   chimaeric	  protein	  to	  activate	  caspase-­‐1	  in	  response	  to	  ATP.	  Conversely,	  zebrafish	  P2X7	  was	  able	   to	   trigger	   IL-­‐1β	   processing	   and	   functioned	   in	   a	   similar	   way	   to	   rat	   P2X7	   in	  response	   to	   inhibition,	   although	   the	   inhibitors	   used;	   Brilliant	   Blue	   G,	   PPADS,	  suramin	   and	   magnesium;	   were	   less	   effective	   than	   for	   Human	   P2X7	   (López-­‐Castejón,	  M.	  Young,	  et	  al.	  2007).	  Human	  and	  zebrafish	  caspase-­‐1	  orthologues	  were	  also	   shown	   to	   only	   share	   36.4	   and	   35.9	  %	   amino	   acid	   similarity	  with	   seabream	  caspase-­‐1	   (López-­‐Castejón	   et	   al.	   2008)	   and	   it	   is	   known	   that	   the	   seabream	   and	  zebrafish	  show	  great	  phylogenetic	  divergence	  (Sarropoulou	  et	  al.	  2007).	  	  	   From	   these	   sources,	   it	   is	   uncertain	  whether	   studies	   of	   seabream	   caspase	  processing	   of	   IL-­‐1β	   are	   directly	   applicable	   to	   studies	   of	   zebrafish	   IL-­‐1β	   biology,	  and	  recent	  publications	   in	  the	   field	  show	  that	   this	  may	  not	  be	  the	  case.	  Recently,	  Vojtech	   et	   al	   (2012)	   have	   demonstrated	   that	   Zebrafish	   caspases	   -­‐A	   and	   -­‐B	  mediated	  IL-­‐1β	  cleavage	  of	  zebrafish	  IL-­‐1β	  and	  that	   this	  processing	   is	  at	  aspartic	  acid	  residues	  104	  and	  122	  for	  caspase-­‐A	  and	  -­‐B	  respectively.	  These	  residues	  are	  in	  the	   putative	   caspase	   recognition	   sites	   NVVD	   and	   TICD	   on	   zf	   IL-­‐1β	   (Figure	   3.7),	  which	  are	  located	  close	  to	  the	  equivalent	  human	  cleavage	  site	  YVHD.	  Furthermore,	  zebrafish	  leukocytes	  are	  also	  capable	  of	  secreting	  mature	  IL-­‐1β	  and	  that	  zebrafish	  caspases	  were	  sensitive	  to	  inhibition	  by	  AC-­‐YVAD-­‐CMK	  (Vojtech	  et	  al.	  2012).	  	  	   Overall,	   these	   bioinformatic	   data	   suggest	   that	   IL-­‐1β	   is	   structurally	   highly	  conserved,	  between	  zebrafish	  and	  humans,	  and	  that	  the	  components	  required	  for	  processing	   IL-­‐1β	   and	   signaling	   also	   share	   a	   significant	   degree	   of	   homology.	   In	  
silico,	   the	   zebrafish	   appears	   to	   be	   a	   viable	   model	   of	   IL-­‐1β	   biology	   but	   further	  experimental	  confirmation	  is	  required,	  as	  undertaken	  in	  chapter	  4.	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Figure	   3.8.	   Proposed	   caspase-­‐A	   and	   -­‐B	   cleavage	   sites	   on	   zebfafish	   IL-­‐1β.	  Human	   IL-­‐1β,	   accession	   AAA59135.1,	   with	   caspase-­‐1	   cleavage	   site	   (blue	   box)	  aligned	  to	  zebrafish,	  NP_998009.1,	  with	  caspase-­‐A	  cleavage	  sites	  EVLD	  and	  NVVD	  (black	   boxes)	   and	   caspase-­‐B	   cleavage	   sites	   NVVD	   and	   TICD	   (red	   boxes)	   as	  described	  by	  Vojtech	  et	  al.	  (Vojtech	  et	  al.	  2012)	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Chapter	   4:	   Functional	   Validation	   of	   Zebrafish	   as	   a	   model	   of	  
Interleukin-­‐1β 	  Biology	  	  	   I	   have	   previously	   shown	   that	   zebrafish	   and	   human	   IL-­‐1β	   protein	  orthologues	   share	   both	   sequence	   and	   structural	   similarity,	   and	   alongside	   other	  published	  results	  these	  data	  suggest	  that	  proinflammatory	  cytokine	  IL-­‐1β	  function	  is	   conserved	   between	   zebrafish	   and	   mammals.	   In	   order	   to	   further	   characterise	  zebrafish	  IL-­‐1β	  function	  to	  support	  this	  hypothesis,	  I	  investigated	  IL-­‐1β	  expression	  in	   response	   to	   inflammatory	   and	   infectious	   stimuli,	   and	   observed	   the	   effect	   of	  mammalian	  IL-­‐1β	  pathway	  inhibitors	  on	  measures	  of	  inflammation	  in	  zebrafish.	  	  
4.1	  IL-­‐1β	  message	  expression	  
4.1.1	   IL-­‐1β	   is	   expressed	   at	   low	   levels	   in	   zebrafish	   embryos	   in	   the	   absence	   of	  
inflammatory	  stimuli.	  Whole	   mount	   in	   situ	   hybridization	   (WISH)	   was	   used	   to	   determine	   the	  spatial	   expression	   of	   IL-­‐1β	   in	   zebrafishand	   its	   response	   to	   inflammatory	   stimuli.	  Using	  an	  in	  situ	  RNA	  probe	  generated	  from	  a	  zebrafish	  IL-­‐1β	  cDNA	  construct	  kindly	  provided	  by	  Sara	  Kohal,	  the	  expression	  of	  IL-­‐1β	  mRNA	  was	  studied	  in	  embryos	  24,	  48	  and	  72	  hours	  post	  fertilisation	  (hpf)	  embryos.	  	   In	  24	  hpf	  embryos	  IL-­‐1β	  expression	  was	  found	  to	  be	  localised	  to	  the	  site	  of	  early	   leukocyte	   haematopoiesis	   above	   the	   yolk	   sac,	   the	   first	   site	   of	   primitive	  macrophage	   development	   (Herbomel	   et	   al.	   1999),	   and	   is	   localized	   in	   a	   punctate	  manner	   similar	   to	   the	   distribution	   of	   leukocytes	   during	   this	   development	   phase	  (Figure	  4.1	  A).	  Expression	  in	  48hpf	  embryos	  is	  localized	  to	  these	  areas,	  but	  appears	  less	   intense.	   (Figure	   4.1	   B).	   This	   effect	  was	   not	   seen	   in	   the	   sense	   control	   probe	  (Figure	  4.1	  C)	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4.1.2	  Injury	  is	  a	  powerful	   inducer	  of	  IL-­‐1β 	  mRNA	  in	  zebrafish	  embryos	  compared	  to	  
LPS	  and	  Vibrio	  anguillarum	  DNA	  Published	   data	   has	   previously	   demonstrated	   the	   responsiveness	   of	   the	  zebrafish	  immune	  system	  to	  inflammatory	  and	  infectious	  stimuli	  such	  as	  LPS	  (MP	  Sepulcre	   et	   al.	   2009).	   Furthermore	   DNA	   isolated	   from	   the	   fish	   pathogen	   Vibrio	  
anguillarum	   (MP	   Sepulcre	   et	   al.	   2009)	   was	   shown	   to	   induce	   an	   inflammatory	  response.	   These	   stimuli	   were	   investigated	   for	   IL-­‐1β	   induction	   using	   WISH,	  However,	   neither	   LPS	   treatment	   nor	   injection	   of	   V.	   anguillarum	   DNA	   showed	   a	  significant	  increase	  in	  staining	  for	  IL-­‐1β	  mRNA	  in	  LPS	  treated	  fish	  [Figure	  4.2	  B,C].	  Furthermore	  any	  apparent	  increase	  in	  staining	  in	  V.	  anguillarum	  injected	  fish	  may	  also	  be	  attributable	  to	  the	  non	  sterile	  injection	  technique	  used	  in	  administering	  the	  treatment.	  The	  lack	  of	  IL-­‐1β	  staining	  following	  these	  treatments	  is	  recapitulated	  in	  48hpf	   fish	  where	   the	  same	   lack	  of	   response	   to	  LPS	  and	  V.	  anguillarum	   treatment	  can	  be	  seen	  (Figure	  4.3	  B,	  C).	  Following	  these	  results	   I	  decided	  to	  move	  on	  to	  an	  injury	  based	  inflammatory	  stimulus.	  	   Injury	   has	   long	   been	   a	   mainstay	   of	   inflammatory	   assays	   in	   zebrafish	  embryos	  (Renshaw	  et	  al.	  2006)	  and	  as	  a	  powerful	  inflammatory	  stimulus	  might	  be	  expected	  to	  induce	  IL-­‐1β	  signalling.	  When	  tested,	  injury	  by	  tail	  transection	  induced	  the	  transcription	  of	  the	  IL-­‐1β	  mRNA	  message.	  In	  24hpf	  embryos	  injury	  stimulated	  the	  expression	  of	  IL-­‐1β	  when	  probed	  2	  hours	  post	  injury	  (Figure	  4.4).	  This	  staining	  persisted	  at	  8	  hours	  post	  injury,	  although	  to	  an	  apparently	  lower	  level	  than	  at	  the	  initial	   2-­‐hour	   timepoint.	   The	   staining	   is	   localised	   at	   the	   site	   of	   injury	   and	   to	  punctate	  bodies	  around	  the	  injury	  site	  and	  the	  caudal	  hematopoietic	  tissue	  (CHT)	  Injured	   fish	   also	   show	   more	   staining	   away	   from	   the	   site	   of	   injury	   around	   the	  aforementioned	   early	   hematopoietic	   regions	   2	   hours	   post	   injury.	   Close	  examination	   of	   these	   staining	   patterns	   shows	   them	   to	   be	   localized	   within	   what	  appear	   to	  be	   leukocytes	  based	  on	   their	   irregular	  morphology	   and	   localization	   to	  the	  CHT	  (Figure	  4.5).	  At	  26	  hpf,	  these	  cells	  are	  most	  likely	  early	  macrophages,	  but	  could	   also	   be	   early	   neutrophil	   progenitor	   cells.	   A	   number	   of	   cells	   display	   a	  mononuclear	  morphology	  and	  are	  likely	  to	  be	  monocytic	  in	  origin	  (Figure	  4.5).	  Injuring	   48hpf	   embryos	   demonstrates	   a	   very	   similar	   staining	   pattern	  (Figure	  4.6),	  with	  peak	  staining	  seen	  at	  2	  and	  4	  hours	  post	  injury,	  and	  less	  at	  6	  and	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Figure	   4.1.	   IL-­‐1β	   expression	   in	   response	   to	   injury	   using	   WISH	   with	   sense	  
controls.	  24	  and	  48	  hpf	  embryos	  (A	  and	  B	  respectively)	  stain	  for	  IL-­‐1β	  mRNA	  in	  punctate	   cells	   around	   the	   yolk	   and	   sites	   of	   injury,	   72	   hpf	   embryos	   have	  symmetrical	   staining	   localized	   in	   the	   head	   and	   brain	   region.	  WISH	  with	   a	   sense	  probe	  (C)	  show	  no	  staining	  except	  for	  a	  delocalised	  faint	  staining	  in	  the	  hindbrain	  indicative	  of	  non-­‐specific	  probe	  trapping.	  Scale	  bar	  =	  500	  µm	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Figure	   4.4.	   Injury	   is	   a	   potent	   inducer	   of	   IL-­‐1β	   mRNA	   expression	   in	   early	  
embryos.	   2	   hours	   post	   injury,	   24	   hpf	   embryos	   show	   significant	   IL-­‐1β	   mRNA	  upregulation	  at	  the	  site	  of	  injury	  and	  over	  the	  yolk	  sac	  (arrows)	  to	  a	  greater	  extent	  than	   those	   shown	   in	  untreated	  embryos	   (Figure	  4.1A).	  8	  hours	  post	   injury	   there	  are	   less	  stained	  cells	   in	   the	  rest	  of	   the	  embryos,	  but	   IL-­‐1β	  expression	  remains	  at	  the	  site	  of	  injury.	  Scale	  bar	  =	  500µm	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Figure.	  4.5.	  IL-­‐1β	  is	  expressed	  in	  macrophage	  like	  cells	  in	  response	  to	  injury	  
in	   24hpf	   embryos.	   High-­‐resolution	   compound	   light	   microscopy,	   using	   a	   40x	  objective,	   of	  multiple	   representative	   embryos	   reveals	   that	   cells	   stained	   for	   IL-­‐1β	  mRNA	  via	  WISH	  have	  a	  very	  leukocyte-­‐like	  morphology	  and	  appear	  to	  have	  moved	  from	  the	  CHT	  towards	  the	  site	  of	  injury.	  These	  cells	  have	  an	  irregular	  morphology	  and	  stain	  strongly	  for	  IL-­‐1β	  mRNA.	  Scale	  bar=	  50	  µm	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8-­‐hour	  timepoints,	  though	  it	  should	  be	  stressed	  that	  many	  other	  factors	  can	  affect	  the	   strength	   of	   staining	   of	   a	   WISH	   and	   that	   this	   should	   not	   be	   considered	   a	  quantitative	  assay.	  Very	  intense	  staining	  can	  be	  seen	  in	  a	  few	  embryos	  at	  the	  site	  of	  injury,	  yet	  its	  absence	  in	  other	  embryos	  and	  injured	  embryos	  stained	  with	  a	  sense	  probe	   (Figure	   4.1)	   implies	   that	   this	   effect	   is	   unlikely	   to	   be	   due	   to	   non	   specific	  staining	  of	  damaged	  or	  necrotic	  tissue	  at	  the	  site	  of	  injury.	  The	  exact	  cellular	  localisation	  of	  the	  staining	  at	  these	  sites	  remains	  unclear	  and	  is	  difficult	  to	  determine	  due	  to	  the	  intensity	  of	  the	  signal.	  A	  closer	  look	  at	  the	  stained	   cells	   under	   higher	   power	  microscopy	   again	   reveals	   them	   as	   having	   very	  leukocyte	   like	  morphology,	  with	   single	   nuclei	   (Figures	   4.5,	   4.8).	   These	   cells	   also	  appear	  to	  cluster	  around	  the	  endothelium	  of	  the	  aorta	  and	  intersegmental	  vessels,	  which	   has	   previously	   been	   shown	   to	   act	   as	   a	   conduit	   for	  macrophage	  migration	  towards	  sites	  of	  injury	  (Figure	  4.7)	  (Gray	  et	  al.	  2011).	  Together	  these	  observations	  imply	  that	  the	  stained	  cells	  are	  likely	  to	  be	  a	  monocyte/macrophage	  lineage.	  Whole	  embryo	   imaging	   shows	   that	   staining	   away	   from	   the	   site	   of	   injury	   is	   strongest	   at	  2hpi	  (Figure	  4.5),	  where	  more	  cells	  can	  be	  seen	  in	  the	  rest	  of	  the	  fish	  and	  over	  the	  yolk	   sac;	   the	   presence	   of	   cells	   elsewhere	   in	   the	   fish	   is	   reduced	   progressively	  throughout	  the	  response	  and	  in	  most	  embryos	  is	  gone	  by	  later	  timepoints,	  leaving	  staining	  localized	  mostly	  to	  the	  site	  of	  injury.	  In	  the	  characterisation	  of	  embryonic	  zebrafish	   macrophages,	   Herbomel	   et	   al.	   (1999)	   also	   note	   that	   macrophages	  throughout	  the	  embryo	  adopt	  an	  activated	  phenotype	  in	  response	  to	  inflammatory	  insults.	  	   These	  data	  show	  that	  IL-­‐1β	  is	  more	  strongly	  induced	  by	  injury	  than	  by	  the	  other	   methods	   of	   inflammatory	   insult	   tested.	   In	   response	   to	   injury,	   IL-­‐1β	   is	  expressed	   in	   cells	   exhibiting	  morphology,	  developmental	   timescale	  and	  apparent	  behaviour	  of	  macrophages.	  The	  strongest	  time	  for	  IL-­‐1β	  induction	  is	  at	  2-­‐4	  hours	  post	  injury,	  with	  a	  reduction	  in	  signalling	  after	  6	  hours.	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Figure	   4.8.	   IL-­‐1β	   expression	   is	   upregulated	   in	   macrophage	   like	   cells	   in	  
response	   to	   injury.	  High-­‐resolution	  microscopy	  of	   injured	  48hpf	  embryos	  show	  WISH	   staining	   is	   localized	   to	   large	   mononuclear,	   morphologically	   irregular	   and	  non-­‐localised	  cells.	  scale	  bar=	  20	  µm	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4.2	  Caspase	  and	  P2X7	  inhibition	  on	  markers	  of	  inflammation	  
4.2	  1	  NF-­‐κB	  signaling	  reporters	  NF-­‐κB	   is	   a	   critical	   component	   of	   the	   IL-­‐1β	   signaling	   pathway	   and,	   as	  described	  previously,	  is	  responsible	  for	  inducing	  its	  transcription.	  NF-­‐κB	  plays	  an	  important	   role	   in	   a	   number	   of	   further	   inflammatory	   processes	   as	   well	   as	   in	  development	  and	  regeneration	  in	  the	  zebrafish	  (Kanther	  et	  al.	  2011).	  Kanther	  et	  al	  (2011)	   have	   previously	   described	   the	   construction	   of	   an	   NF-­‐κB	   reporter	  transgenic	  zebrafish	  in	  which	  EGFP	  is	  induced	  in	  cells	  in	  response	  to	  the	  activation	  of	  NF-­‐κB.	  This	  group	  kindly	  provided	  the	  construct	  used	  to	  generate	  this	  reporter	  line	   enabling	   me	   to	   generate	   a	   new	   allele	   of	   this	   reporter	   line	   by	   injecting	   this	  reporter	   into	  WIK	  wild-­‐type	   embryos.	   Once	   grown,	   screening	   by	   pair	  mating	   to	  wild	   types	   showed	   that	   approximately	   15%	   of	   the	   adults	   were	   capable	   of	  transmitting	   the	   transgene	   to	   their	  progeny.	  Of	   these	  adults,	   approximately	  10%	  had	  progeny	  of	  mixed	  intensities.	  During	  development,	  Tg(pNF-­‐κB:EGFP)sh235	  expresses	  EGFP	  in	  neuromast	  support	  cells,	  muscle,	  epithelium,	  immune	  cells,	  and	  endothelial	  cells	  (Figure	  4.9);	  indicating	  active	  NF-­‐κB	  in	  these	  tissues	  during	  growth	  and	  development.	  The	  line	  founder	   transmitted	   the	   allele	   to	  more	   than	   the	   50%	   of	   progeny	   expected	   for	   a	  single	  allele	  of	  the	  transgene,	  and	  embryos	  derived	  from	  this	  founder	  had	  a	  mix	  of	  fluorescent	  intensities	  (Figure	  4.10);	  indicating	  the	  presence	  of	  more	  than	  a	  single	  allele	  and	  therefore	  multiple	  insertions	  of	  the	  transgene.	  Based	   on	   their	   fluorescent	   intensity	   it	   was	   decided	   that	   embryos	   with	  multiple	  insertions	  would	  make	  a	  more	  effective	  reporter	  with	  regards	  to	  reducing	  exposure	  and	  decreasing	  acquisition	  time	  during	   imaging,	  however,	   the	  presence	  of	   larvae	   with	   various	   levels	   of	   EGFP	   expression	   is	   a	   potential	   source	   of	  experimental	  error	  and	  therefore	  necessitated	  the	  development	  of	  an	  experimental	  strategy	  to	  reduce	  this	  error.	  Larvae	   derived	   from	   the	   F1	   generation	   showed	   a	   mix	   of	   fluorescent	  intensities	  corresponding	  to	  a	  mixture	  of	  copy	  numbers	  carried	  by	  each	  offspring.	  Quantitative	   assays	   using	   this	   line	   require	   an	   unbiased	   and	   fluorescently	  homogenous	   baseline	   intensity	   to	   reduce	   error;	   therefore,	   sufficient	   embryos	   of	  approximately	  the	  same	  fluorescent	  intensity	  were	  selected	  from	  each	  embryo	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Figure	   4.9.	   Tg(NF-­‐κB:EGFP)sh235,	   a	   reporter	   of	   NF-­‐κB	   activation,	   shows	  
significant	   activity	   of	   NF-­‐κB	   during	   development.	   Tg(pNF-­‐κB:EGFP)sh235	  demonstrates	   the	   temporal	   and	   spatial	   pattern	   of	   NF-­‐κB	   activation	   during	  development.	   (A)	   At	   24hpf,	   NF-­‐κB	   is	   active	   in	   the	   musculature,	   with	   further	  expression	   in	  neuromast	  support	  cells	  and	  endothelium	  at	   later	   timepoints	  of	  48	  	  (B)	  and	  72	  hpf	  (C).	  Scale	  bar	  =320	  µm	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Figure	  4.10.	  Tg(pNF-­‐κB:EGFP)sh235	  siblings	  show	  a	  varying	  intensity	  of	  EGFP	  
indicating	  multiple	  insertions	  of	  the	  expression	  vector.	  72hpf	  sh235	  embryos	  from	   the	   same	   clutch	   show	   at	   least	   3	   different	   brightnesses	   (A,	   B	   and	   C).	  Homozygous	   and	  heterozygous	   embryos	  would	  only	   account	   for	   two	  phenotypic	  variants,	  therefore	  more	  than	  1	  allele	  of	  the	  gene	  must	  be	  present.	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clutch	   collected	   for	   each	   experiment.	   Consequently,	   results	   from	   these	   embryos	  must	   also	   be	  normalized	   to	   the	  particular	   intensity	   of	   the	   control	   embryos	   from	  each	  experiment	   in	  order	   for	   results	  between	  experiments	   to	  be	   compared.	  This	  will	   also	   correct	   for	   any	   differences	   in	   hardware	   functioning	   with	   regards	   to	  fluorescent	  transmission	  efficiency	  between	  experiments.	  For	   quantitative	   assays	   with	   this	   line,	   the	   control	   sample	   numbers	   were	  increased	  to	  30	  to	  provide	  increased	  statistical	  power	  to	  account	  for	  the	  variation	  in	  embryo	  intensity	  and	  microscope	  function	  between	  experiments.	  The	   large	  numbers	  of	   controls	  were	   averaged	   for	   each	   repeat	   experiment	  and	   these	   averages	   compared	   between	   experimental	   repeats	   to	   determine	   the	  proportional	  change	   in	   intensity	  due	  to	   the	  embryo	  selection	  and	  any	  alterations	  made	   to	  microscopy	  hardware	  between	  experiments.	  The	  difference	  was	  used	   to	  generate	  a	  multiplication	  factor	  for	  the	  change,	  which	  was	  used	  to	  normalise	  every	  data	   point	   in	   each	   experiment	   by	   the	   average	   intensity	   difference	   between	   each	  experiment	  denoted	  by	  this	  factor.	  This	  enabled	  the	  normalised	  data	  to	  be	  pooled	  between	  experimental	  repeats	  for	  statistical	  analysis.	  	  
4.2.2	  Tg(pNF-­‐κB:EGFP)sh235	  as	  a	  reporter	  of	  inflammation	  I	   hypothesised	   that	   inhibition	   of	   IL-­‐1β	   pathway	   components	   will	   reduce	   IL-­‐1β	  release	  and	  consequently	   inflammation	  at	   the	  site	  of	   injury	   in	  zebrafish.	   In	  WISH	  assays	   (Figures	  4.3-­‐4.8),	   injury	  was	   the	  most	   powerful	   stimulant	   of	   IL-­‐1β	  mRNA	  production.	   Here,	   I	   used	   an	   injury	   assay	   to	   investigate	   the	   effects	   of	   P2X7	   and	  caspase-­‐1	  inhibitors	  on	  assays	  of	  inflammation.	  In	   mammals,	   the	   P2X7	   receptor	   is	   responsible	   for	   the	   activation	   of	   the	  NLRP3	  inflammasome	  via	  reception	  of	  the	  DAMP	  stimulus	  extracellular	  ATP.	  Due	  to	   the	   high	   levels	   of	   conservation	   between	   mammalian	   and	   zebrafish	   P2X7	  receptors	   (López-­‐Castejón,	   M.	   Young,	   et	   al.	   2007),	   I	   hypothesised	   that	   P2X7	  inhibition	   would	   have	   a	   similar	   effect	   on	   IL-­‐1β	   production	   (Figure	   4.11).	   This	  response	   was	   not	   directly	   observable	   due	   to	   the	   lack	   of	   a	   characterised	   IL-­‐1β	  specific	   reporter	   and	   was	   measured	   indirectly	   using	   the	   Tg(pNF-­‐κB:EGFP)sh235	  line	  as	  a	  readout	  of	  inflammatory	  signalling	  at	  the	  site	  of	  injury.	  I	  initially	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Figure	  4.11	  Inhibition	  of	  P2X7	  (Sanz	  &	  Di	  Virgilio	  2000)	  and	  caspase-­‐1	  (B.	  Miller	  et	  al.	  1995)	  function	  leads	  to	  a	  reduction	  in	  mature	  Il-­‐1β 	  production.	  Reduction	  of	  IL-­‐1β	  signalling	  via	  P2X7	  and	  caspase-­‐1	  inhibition	  reduces	  inflammatory	  signalling,	  and	  I	  hypothesise	  that	  inhibiting	  this	  pathway	  in	  zebrafish	  would	  result	  in	  a	  reduction	  of	  inflammatory	  signalling	  in	  inflammatory	  assays.	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characterised	   the	   injury	   response	   in	   these	   fish;	   embryos	   mounted	   and	   imaged	  from	   an	   hour	   post	   injury	   revealed	   that	   NF-­‐κB	   activation	   measured	   by	   EGFP	  intensity	   increases	  at	  the	  site	  of	   injury	  over	  the	  8-­‐hour	  experimental	  time	  course	  (Figure	   4.12	  A).	   Concurrent	  with	   the	   increase	   in	   fluorescence	   induced	  by	   injury,	  leukocytes,	   distinguished	   by	   their	   irregular	   morphology	   and	   rapid	   movement	  (Figure	  4.12	  B)	  (visible	  in	  a	  time	  lapse	  movie),	  can	  be	  seen	  migrating	  towards	  the	  site	  of	  injury;	  however,	  most	  of	  the	  EGFP	  signal	  at	  the	  site	  of	  the	  injury	  originates	  from	  the	  damaged	  tissues	  themselves.	  The	   increase	   in	   EGFP	   fluorescence	  was	   used	   as	   a	   readout	   of	   fluorescence	  and	  an	  assay	  around	  the	  modulation	  of	  this	  signal	  was	  developed.	  72hpf	  Tg(pNF-­‐
κB:EGFP)sh235	  embryos	  were	   injured	   and	   treated	  with	   P2X7	   inhibitors	   Brilliant	  Blue	  G	  and	  KN62	  and	  imaged	  8	  hours	  post	  injury	  (hpi).	  The	  fluorescence	  at	  the	  site	  of	  injury	  was	  compared	  with	  untreated	  embryos	  (Figure	  4.13)	  and	  showed	  a	  trend	  towards	   decrease	   that	   did	   not	   reach	   statistical	   significance.	   A	   power	   calculation	  performed	  on	  the	  mean	  of	   this	  data	  revealed	  that	  sample	  sizes	  would	  have	  to	  be	  increased	  to	  30	  for	  Brilliant	  blue	  and	  70	  for	  KN62	  to	  have	  90%	  confidence	  in	  the	  statistical	  difference.	  To	  more	  directly	  measure	  the	  effect	  of	  caspase	  A	  activation,	  the	  experiment	  was	  repeated	  with	  caspase-­‐1	  inhibitor	  AC-­‐YVAD-­‐CMK.	  The	  caspase-­‐1	  and	  caspase-­‐A	   proteins	   share	   similar	   sequence	   specificities	   (Masumoto	   et	   al.	   2003)	   and	   I	  hypothesised	   that	   AC-­‐YVAD-­‐CMK	   would	   therefore	   inhibit	   caspase-­‐A.	   Tg(pNF-­‐
κB:EGFP)sh235	  embryos	  treated	  with	  AC-­‐YVAD-­‐CMK	  showed	  a	  significant	  decrease	  in	   NF-­‐κB	   activation	   at	   the	   site	   of	   injury	   compared	   to	   DMSO	   control	   treated	  embryos	  (Figure	  4.14).	  This	  effect	  was	  not	  repeated	  with	  the	  pan-­‐caspase	  inhibitor	  Q-­‐VD.OPh.	  These	  data	  indicate	  that	  the	  NF-­‐κB	  pathway	  is	  susceptible	  to	  inhibition	  with	   the	   caspase-­‐1	   specific	   inhibitor	   AC-­‐YVAD-­‐CMK,	   and	   potentially	   sensitive	   to	  P2X7	   inhibition,	   supporting	   the	   hypothesis	   that	   inhibiting	   proteins	   in	   the	   IL-­‐1β	  processing	  and	  release	  pathway	  negatively	  regulates	  the	  inflammatory	  response.	  
4.2.3	  Caspase	  A	  inhibitor	  AC-­‐YVAD-­‐CMK	  and	  P2X7	  inhibitors	  KN62	  and	  Brilliant	  blue	  
G	  reduce	  neutrophil	  recruitment	  to	  sites	  of	  injury	  
Tg(pNF-­‐κB:EGFP)sh235	   acts	   as	   a	   reporter	   based	   on	   NF-­‐κB	   activation,	   a	  pathway	  relevant	  in	  significantly	  more	  than	  the	  inflammatory	  signalling	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Figure	   4.12.	   NF-­‐κB	   is	   activated	   in	   response	   to	   injury.	   72hpf	   Tg(pNF-­‐
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Figure	   4.13.	   P2X7	   inhibitors	   Brilliant	   Blue	   G	   and	  KN62	   have	   no	   significant	  
effect	  on	  NF-­‐κB	  activation	  in	  response	  to	  injury.	  NF-­‐κB	  activation	  at	  the	  site	  of	  injury	  assayed	  using	  Tg(pNF-­‐κB:EGFP)sh235	  as	  an	  NF-­‐κB	  activation	  reporter,	  is	  not	  significantly	   affected	   by	   mammalian	   P2X7	   inhibitors	   Brilliant	   Blue	   G	   and	   KN62	  (one	  way	  ANOVA	  with	  Dunnet's	  post	  test,	  n=3,	  20	  fish	  per	  treatment	  group)	  
	  
Figure	  4.14	  Caspase-­‐1	  inhibitor	  AC-­‐YVAD-­‐CMK	  downregulated	  the	  activation	  
of	  NF-­‐κB	  at	  the	  site	  of	  injury.	  NF-­‐κB	  activation	  at	  the	  site	  of	  injury	  assayed	  using	  























































investigated	   here,	   and	   a	   proportion	   of	   the	   signal	   detected	   here	   in	   response	   to	  injury	  is	  also	  likely	  to	  be	  linked	  to	  wound	  healing	  and	  regeneration	  of	  the	  injured	  tissue.	   In	   order	   to	   look	   at	   the	   inflammatory	   pathways	   in	   more	   detail,	   a	   more	  specific	   assay	   of	   inflammation	   was	   required.	   Tg(mpx:EGFP)i114	   (Renshaw	   et	   al.	  2006)	  specifically	  labels	  neutrophils	  and	  allows	  the	  monitoring	  of	  their	  behaviour	  in	   response	   to	   inflammatory	   stimuli.	   This	   line	   has	   been	   used	   in	   the	   study	   of	  recruitment	   and	   resolution	  of	   inflammation	   at	   sites	   of	   injury	   (Ellett	   et	   al.	   2010),	  also	  investigated	  using	  other	  leukocyte	  markers	  (L.	  Li	  et	  al.	  2012).	  I	  used	  this	  as	  a	  more	  specific	  assay	  of	  inflammation	  to	  investigate	  P2X7	  and	  caspase-­‐A	  inhibition.	  Injured	  3dpf	  Tg(mpx:EGFP)i114	  were	  treated	  with	  P2X7	  inhibitors	  Brilliant	  blue	  G	  and	   KN62	   and	   neutrophils	   recruited	   to	   the	   site	   of	   injury	   were	   counted	   after	   6	  hours.	  Both	   inhibitors	  significantly	  reduced	  the	  recruitment	  of	  neutrophils	   to	   the	  injury	   (Figure	   4.15),	   indicating	   a	   negative	   effect	   on	   the	   overall	   inflammatory	  response.	   Treatment	   with	   caspase	   inhibitors	   AC-­‐YVAD-­‐CMK	   and	   Q-­‐VD.OPh,	  resulted	   in	   a	   decrease	   in	   neutrophil	   recruitment	   after	   AC-­‐YVAD-­‐CMK	   treatment,	  but	   not	   treatment	   with	   pan-­‐caspase	   inhibitor	   Q-­‐VD.OPh	   (Figure	   4.16).	  Inflammatory	  signalling	  at	  the	  sites	  of	  injury	  was	  reduced	  by	  the	  inhibition	  of	  P2X7	  and	  caspase-­‐A	  in	  zebrafish	  on	  the	  basis	  of	  neutrophil	  recruitment	  to	  sites	  of	  injury.	  
	  
4.3	  Macrophage	  recruitment	  as	  a	  reporter	  of	  inflammation	  
4.3.1	  Macrophage	  recruitment	  to	  sites	  of	  injury.	  The	   inflammatory	   response	   involves	   a	   number	   other	   cells	   as	   well	   as	  neutrophils	  and	  as	  discussed	  in	  chapter	  1,	  studies	  of	  mammalian	  models	  of	  IL-­‐1β	  biology	   have	   revealed	   the	   importance	   of	   macrophages	   in	   the	   production	   and	  signaling	   pathways	   of	   IL-­‐1β.	   IL-­‐1β	   is	   also	   detected	   by	  mammalian	  macrophages,	  inducing	  the	  expression	  of	  other	  inflammatory	  signals	  and	  responses.	  In	  situ	  data	  presented	   in	   this	   study	   (Figures	   4.3-­‐4.8)	   suggest	   that	   IL-­‐1β	   is	   expressed	   in	  macrophages	   in	   response	   to	   injury,	   but	   were	   unclear	   whether	   zebrafish	  macrophages	  also	  respond	  to	  this	  cytokine.	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  Figure	   4.15.	   Neutrophil	   recruitment	   in	   Tg(mpx:EGFP)i114	   is	   reduced	   by	  
treatment	  with	  P2X7	  inhibitors	  Brillaint	  Blue	  G	  and	  KN62	  Tg(mpx:EGFP)i114	  show	  a	  reduction	  in	  neutrophil	  recruitment	  6	  hpi	  when	  treated	  with	  Brilliant	  Blue	  G	  and	  KN62	  (one	  way	  ANOVA,	  Dunnett's	  post	  test.	  n=3,	  8	  fish	  per	  treatment	  group)	  
	  
Figure	  4.16.	  Mammalian	  caspase	  inhibitor	  AC-­‐YVAD-­‐CMK	  reduces	  neutrophil	  
















































4.3.2	  Macrophage	  specific	  transgenic	  lines	  Tools	   to	   study	   macrophage	   behaviour	   were	   limited	   to	   the	  
Tg(fms:Gal4.VP16)i186;Tg(UAS:nsfB.mCherry)i149	   compound	   line.	   The	   fms	  promoter	   drives	   Gal4-­‐VP16	   in	   macrophages,	   xanthophores,	   neuromasts	   and	  hindbrain;	   and	   is	   therefore	   not	   macrophage	   specific.	   Macrophages	   can	   be	  identified	  from	  other	  labelled	  cells	  only	  by	  their	  motility,	  morphology	  and	  size.	  The	  driver	   line	   is	  crossed	  to	  a	  UAS	  driven	  mCherry	  tag,	  however,	  a	  significant	  part	  of	  the	  mCherry	   signal	   has	   been	   lost	   over	   successive	   generations	   (Figure	   4.17).	   The	  occurrence	  of	  UAS	  promoter	  silencing	  has	  been	  previously	  reported	  (Akitake	  et	  al.	  2011),	   however	   in	   the	   majority	   of	   these	   fish	   the	   silencing	   is	   severe	   enough	   to	  prevent	   the	   identification	   of	   more	   than	   a	   minority	   of	   macrophages.	   The	   use	   of	  these	   fish	   for	   the	  previously	  described	  recruitment	  assays	   is	   further	  complicated	  by	   the	   presence	   of	   a	   large	   number	   of	   xanthophores	   in	   the	   tissue	   of	   the	   tail	   fin,	  making	  macrophage	  counting	  at	   the	   site	  of	   injury	  more	  difficult.	  Macrophages	   in	  the	  Tg(fms:Gal4.VP16)i186;Tg(UAS:nsfB.mCherry)i149	  can	   still	   be	   identified	   using	  confocal	  microscopy	   to	   select	   a	   focal	   plane	   excluding	   the	   epithelial	   layers	  where	  xanthophores	  are	   localized,	  however,	   the	   limited	  thickness	  of	  the	  fish	  around	  the	  tail	  where	   injury	  assays	  are	  performed	   limits	   this	   approach.	  For	   these	   reasons,	   I	  looked	  for	  alternatives	  for	  investigating	  macrophage	  recruitment	  and	  macrophage	  behaviour.	  	  Recently,	  Ellet	  et	  al	   (2010)	  have	  published	   the	  discovery	  of	  a	   significantly	  improved	  macrophage	  specific	  reporter.	  The	  mpeg1	  promoter	  line	  is	  macrophage	  specific	  during	  the	  larval	  stage,	  making	  it	  far	  more	  effective	  as	  a	  macrophage	  label	  than	  the	   fms	  promoter	   line	   in	  zebrafish	  embryos	  due	  to	   the	   lack	  of	  expression	   in	  other	  cell	  types.	  	  I	  used	  the	  mpeg1	  promoter	  entry	  clone	  described	  in	  the	  Ellet	  et	  al.	  (2010)	  paper	  to	  generate	  a	  Gal4	  expression	  vector	  using	  gateway	  cloning.	  The	  5’	  mpeg1	  entry	  clone	  was	   combined	  with	   the	  middle	   entry	   Gal4	   entry	   clone,	   the	   3’	   entry	   polyA	   entry	  clone	  and	  the	  PA2	  destination	  vector	  from	  the	  Tol2Kit	  (Kwan	  et	  al.	  2007)	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Figure	  4.17.	  Tg(fms:Gal4.VP16)i186;Tg(UAS:nsfB.mCherry)i149	  is	  a	  transgenic	  
marker	   of	   macrophages.	   Tg(fms:Gal4.VP16)i186;Tg(UAS:nsfB.mCherry)i149	  expresses	   the	   nitroreductase	   mCherry	   fusion	   protein	   in	   a	   number	   of	   tissues,	  including	  macrophages,	  xanthophores,	  hindbrain	  and	  neuronal	  cells.	  Xanthophores	  in	   the	   tissue	  of	   the	   tail	   (arrows	   show	  xanthophores	  at	   the	   tail,	   expression	   in	   the	  hindbrain	  and	  neuronal	  cells	  and	  macrophages	  over	  the	  yolk)	  make	  distinguishing	  macrophage	   recruitment	   and	   resolution	   in	   response	   to	   injury	   particularly	  problematic.	   Siblings	   from	   the	   same	   clutch,	   (A)	   and	   (B),	   imaged	   at	   differing	  exposure	   settings	   to	   demonstrate	   markedly	   different	   levels	   of	   expression	   and	  fluorophore	   intensity,	   probably	   releated	   to	   significant	   methylation	   of	   the	   UAS	  promoter	  (Akitake	  et	  al.	  2011).	  Scale	  bar	  =	  320	  µm	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  to	   yield	   a	   tol2	   equipped	  mpeg1:gal4	   construct.	   I	   injected	   this	   construct	   into	   AB	  wild	   types	   alongside	   tol2	   mRNA.	   Once	   grown,	   the	   fish	   were	   crossed	   to	   a	  
Tg(UAS:Kaede)	   fish	   line	   and	   screened	   for	   fluorophore	   expression.	  A	   founder	  was	  identified	   by	   the	   expression	   of	   Kaede	   in	   macrophages.	   The	   Tg(UAS:Kaede)	   line	  used	   has	   been	   generated	   relatively	   recently	   and	   so	   shows	   a	   low	   level	   of	   UAS	  silencing	  remaining	  useable	   for	  quantitative	  assays,	  however,	  care	  must	  be	  taken	  when	   selecting	   a	   group	   of	   embryos	   for	   the	   assay	   to	   ensure	   all	   embryos	   have	  approximately	  the	  same	  number	  of	  labelled	  macrophages.	  As	  shown	  in	  Figure	  4.18,	  our	  Tg(mpeg1:Gal4.VP16)sh256,	  Tg(UAS:Kaede)	  has	  significantly	  more	  macrophage	  specificity	  than	  Tg(fms:Gal4.VP16)i186;Tg(UAS:nsfB.mCherry)i149,	  with	  far	  less	  off	  target	  expression.	  Labelled	  macrophages	  can	  be	  seen	  in	  both	  fish	  lines	  (Figure	  4.18	  B	   and	   C)	   however	   the	   fms	   promoter	   makes	   it	   very	   difficult	   to	   distinguish	  macrophages	  from	  other	  cell	  types,	  which	  interfere	  with	  visualizing	  macrophages	  directly	  when	  using	  non-­‐confocal	  microscopy.	  	  
4.3.3	  Macrophage	  rectruitment	  to	  sites	  of	  injury	  is	  inhibited	  by	  caspase-­‐1	  Inhibitor	  
AC-­‐YVAD-­‐CMK	  and	  P2X7	  inhibitors	  Brilliant	  Blue	  G	  and	  Kn62	  With	  a	  reliable	  macrophage	  mpeg1	  marker	  it	  was	  possible	  to	  investigate	  the	  effects	  of	  AC-­‐YVAD-­‐CMK	  on	  macrophage	  recruitment.	  Published	  data	  describes	  the	  role	  of	  macrophages	  in	  wound	  healing	  and	  inflammation	  resolution,	  as	  well	  as	  the	  development	   of	   endothelial	   tissue	   in	   angiogenesis;	   however,	   the	   recruitment	   of	  macrophages	  at	  an	  early	  stage	  of	  inflammation,	  the	  upregulation	  of	  IL-­‐1β	  mRNA	  in	  response	  to	  injury	  and	  the	  role	  of	  macrophages	  in	  mammalian	  inflammation	  imply	  that	   macrophages	   are	   important	   in	   the	   initial	   stages	   of	   inflammation.	  
Tg(mpeg1:Gal4.VP16)sh256:Tg(UAS:Kaede)	   embryos	   were	   injured	   as	   described	  previously	  and	  treated	  for	  6	  hours	  with	  AC-­‐YVAD-­‐CMK	  and	  Q-­‐VD.OPh.	  The	  number	  of	   macrophages	   at	   the	   site	   of	   injury	   was	   counted	   after	   6	   hours.	   AC-­‐YVAD-­‐CMK	  significantly	  decreased	  the	  recruitment	  of	  macrophages	  to	  the	  wound	  whereas	  Q-­‐VD.OPh	  had	  no	  effect	  (Figure	  4.19).	  P2X7	  inhibitors	  Brilliant	  Blue	  G	  and	  KN62	  also	  significantly	  reduced	  macrophage	  recruitment	  to	  the	  site	  of	  injury	  (Figure	  4.20).	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4.4	  Effects	  of	  caspase-­‐1	  and	  P2X7	  inhibitors	  on	  inflammatory	  markers	  In	  summary,	  these	  data	  show	  that	  the	  IL-­‐1β	  mRNA	  message	  is	  induced	  in	  response	  to	   injury	  and	  to	  a	   lesser	  extent	   in	  response	   to	   the	   injection	  of	  Vibrio	  anguillarum	  DNA,	   though	   it	   is	   unclear	   whether	   this	   response	   is	   due	   to	   the	   presence	   of	   the	  pathogen	  DNA,	   or	  due	   to	   the	  non	   sterile	  nature	  of	   the	   injection.	  This	  message	   is	  stained	   in	  mononuclear	  cells	  with	  an	   irregular	  morphology	  which	  cluster	  around	  the	  yolk	  sac,	  CHT	  and	  expected	  sites	  of	  intersegmental	  vessels	  and	  appear	  to	  have	  been	   fixed	   in	   the	   process	   of	  migrating	   towards	   the	   site	   of	   injury,	   all	   behaviours	  characteristic	   of	   macrophages.	   Futhermore,	   using	   NF-­‐κB	   activation,	   neutrophil	  recruitment	  and	  macrophage	  recruitment	  as	  markers	  of	   inflammation,	  these	  data	  show	   that	   mammalian	   caspase-­‐1	   inhibitor	   AC-­‐YVAD-­‐CMK	   decreases	   the	  inflammatory	   response,	   as	   do	   mammalian	   P2X7	   inhibitors	   Brilliant	   Blue	   G	   and	  KN62.	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Figure	   4.18.	   Tg(mpeg1:Gal4.VP16)sh256	   is	   a	   more	   reliable	   macrophage	  
marker	   than	   Tg(fms:Gal4.VP16)i186	   in	   embryonic	   zebrafish.	   A.	   the	   fms	  promoter	  and	  mpeg1	   promoter	  driving	  Tg(UAS:Kaede).	   The	  mpeg1	   promoter	  has	  significantly	   improved	   macrophage	   specificity	   than	   fms,	   with	   fewer	   non-­‐macrophage	   tissues	   labelled.	   Macrophages	   can	   be	   seen	   throughout	   the	   fish	   and	  within	  the	  tissue	  of	  the	  CHT	  (arrows).	  Scale	  =	  500	  µm	  (A),	  200µm	  (B,	  C)	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Figure	   4.19.	   Macrophage	   recruitment	   to	   the	   site	   of	   injury	   is	   inhibited	   by	  
mammalian	   caspase-­‐1	   inhibitor	  AC-­‐YVAD-­‐CMK.	  Caspase-­‐1	   inhibitor	  AC-­‐YVAD-­‐CMK	   reduces	   recruitment	   of	   macrophages	   to	   the	   site	   of	   injury	   in	  
Tg(mpeg1:Gal4.VP16)sh256,	  Tg(UAS:Kaede)	   embryos	  when	   assayed	   at	   6hpi.	   (one	  way	  ANOVA,	  Dunnett's	  post	  test.	  n=3,	  8	  fish	  per	  treatment	  group)	  
	  
Figure	   4.20.	   Macrophage	   recruitment	   to	   the	   site	   of	   injury	   is	   inhibited	   by	  
mammalian	   P2X7	   inhibitors	   KN62	   and	   Brilliant	   Blue	   G.	   P2X7	   inhibitors	  Brilliant	   Blue	   G	   and	  KN62	   reduce	   the	   recruitment	   of	  macrophages	   to	   the	   site	   of	  injury	   in	   Tg(mpeg	   1:Gal4.VP16)sh256,	   Tg(UAS:Kaede)	   embryos	   when	   assayed	   at	  6hpi.	  (One	  way	  ANOVA,	  Dunnett's	  post	  test.	  n=3,	  8	  fish	  per	  treatment	  group)	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4.5	  Discussion	  
4.5.1	  V.	  anguillarum	  DNA	  as	  an	  inducer	  of	  inflammation	  IL-­‐1β	  signaling	  did	  not	  appear	  to	  be	   induced	  by	  infectious	  stimuli.	  Neither	  LPS	   nor	   V.	   anguillarum	   DNA	   increased	   the	   staining	   for	   IL-­‐1β	   mRNA	   via	   WISH,	  which	   is	   particularly	   puzzling	   due	   to	   the	   way	   the	   V.	   anguillarum	   DNA	   was	  prepared.	  The	  V.	  anguillarum	  DNA	  sample	  was	  a	  kind	  gift	  of	  Victor	  Mulero	  (Murcia	  Spain).	  It	  is	  a	  miniprep	  of	  a	  liquid	  culture	  of	  VA,	  and	  as	  such	  it	  is	  expected	  that	  the	  miniprep	   protocol	   will	   not	   have	   removed	   many	   pathogen	   associated	   molecular	  patterns	  present	   in	  such	  a	  culture.	  The	   failure	  of	   this	   to	  elicit	  a	   response	   implies	  that,	   as	   a	   pathogen,	   VA	   DNA	   doesn’t	   stimulate	   the	   IL-­‐1β	   pathway	   in	   zebrafish.	  Alternatively,	  if	  the	  miniprep	  was	  too	  efficient	  at	  removing	  genomic	  bacterial	  DNA	  leaving	   just	   inserted	   plasmids,	   it	   wouldn’t	   have	   contained	   any	   of	   the	   molecular	  patterns	   necessary	   to	   induce	   IL-­‐1β;	   in	   which	   eventuality	   an	   induction	   of	   pro	  inflammatory	  pathways	  downstream	  of	   IL-­‐1β	  wouldn’t	  be	   expected	  at	   all,	   unless	  this	   DNA	   was	   capable	   of	   inducing	   TLR	   signalling.	   When	   injected	   into	   Tg(pNF-­‐
κB:EGFP)sh235	   embryos,	   VA	   DNA	   greatly	   increases	   the	   fluorescent	   intensity	   of	  EGFP	  throughout	  the	  fish,	  indicating	  that	  the	  pathway	  is	  activated	  by	  the	  injection,	  however,	   with	   the	   presence	   of	   multiple	   NF-­‐κB:EGFP	   alleles	   in	   the	   line,	   it	   is	  impossible	  to	  quantitively	  assay	  this	  response	  and	  perform	  further	  experiments	  on	  whether	  this	   is	  due	  to	  the	  presence	  of	   the	  VA	  DNA	  sample,	  or	  the	   injection	   itself.	  This	  could	  be	  investigated	  with	  the	  preparation	  of	  a	  new	  sample	  of	  V.	  anguillarum	  DNA	   using	   a	   more	   stringent	   purification	   method,	   such	   as	   a	   phenol	   chloroform	  extraction	  or	  with	  injection	  in	  sterile	  conditions.	  The	  latter	  would	  indicate	  whether	  the	  injection	  itself	  was	  promoting	  an	  inflammatory	  response,	  whereas	  the	  former	  would	  inform	  on	  whether	  the	  response	  was	  due	  to	  sample	  preparation.	  I	  think	  its	  unlikely	  that	  the	  response	  is	  due	  to	  the	  presence	  of	  the	  pathogenic	  DNA,	  and	  that	  it	  is	  more	   likely	  due	  to	  other	   factors	   in	  the	  sample	  or	   injection.	  Pattern	  recognition	  receptors	  would	   be	  more	   likely	   to	   be	   activated	   by	   PAMPs	   than	   by	   the	   bacterial	  DNA	  and	  it	  is	  more	  likely	  that	  this	  is	  what	  causes	  the	  response	  seen	  in	  the	  Tg(pNF-­‐
κB:EGFP)sh235	   line	  however,	   the	   injection	  protocol	   is	  not	  sterile,	  so	  could	  induce	  NF-­‐κB	  signalling	  on	  its	  own.	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Induction	  of	  IL-­‐1β	  message	  by	  pro-­‐inflammatory	  stimuli	  The	  in	  situ	  data	  using	  an	  IL-­‐1β	  hybridization	  probe	  supports	  the	  hypothesis	  that	  the	  increase	  in	  NF-­‐κB	  activity	  is	  due	  to	  injection.	  As	  Figures	  4.2	  and	  4.3	  show,	  the	   injected	   embryos	   show	   a	   slight	   increase	   in	   IL-­‐1β	  mRNA	   expression	   but	   also	  show	   some	   abnormal	   development	   (second	   and	   fourth	   fish	   in	   Figure	   4.2	   and	  second	   fish	   in	   Figure	   4.3),	   but	   as	   a	  WISH,	   this	   is	   difficult	   to	   quantify.	   Abnormal	  development	   is	   a	   typical	   response	  when	   >1nl	   is	   injected	   into	   zebrafish	   embryos	  from	   an	   early	   stage	   and	   can	   be	   seen	   in	   RNA,	   DNA	   and	  morpholino	   injections	   to	  varying	   degrees.	   An	   effect	   on	   the	   gross	   morphology	   on	   the	   fish	   would	   also	   be	  expected	  to	  result	  in	  aberrant	  transcription	  factor	  signalling,	  such	  as	  increased	  NF-­‐κB	   activation.	   For	   these	   reasons,	   It	   is	   more	   likely	   that	   any	   effects	   seen	   from	  injecting	  the	  DNA	  are	  more	  likely	  due	  to	  injection	  trauma.	  This	  leaves	  the	  injury	  as	  the	  most	  viable	  technique	  to	  investigate	  inflammatory	  responses.	  It	  is	  important	  to	  note	   that	   WISH	   reports	   the	   presence	   of	   mRNA,	   and	   does	   not	   report	   signal	  induction.	   It	   is	   possible	   that	   injury	   is	   stimulating	   mRNA	   stability	   (Bufler	   et	   al.	  2004),	  and	   the	  resulting	  signal	  could	  be	  a	   result	  of	  both	   induction	  and	   increased	  mRNA	  stability.	  The	   induction	   of	   IL-­‐1β	  mRNA	  was	   very	   strong	   in	   response	   to	   injury	   and	  demonstrates	   the	   importance	  of	   this	   cytokine	   in	   the	   inflammatory	  response.	  The	  pattern	   of	   induction	   suggests	   that	   IL-­‐1β	   is	   more	   important	   at	   earlier	   stages	   of	  injury	   where	   IL-­‐1β	   is	   induced	   in	   immune	   cells	   throughout	   the	   embryo	   2	   hours	  after	   injury	  and	   the	   strongest	   response	  appears	   to	  be	  after	  around	  4	  hours.	  This	  suggests	   that	   IL-­‐1β	   is	   important	   in	   inducing	   parts	   of	   the	   inflammatory	   response	  rather	  than	  in	  its	  resolution,	  which	  matches	  data	  in	  mammalian	  cells	  where	  IL-­‐1β	  is	  described	  as	  a	  pro	  inflammatory	  cytokine.	  Interestingly,	  there	  is	  also	  less	  probe	  trapping	  at	  the	  site	  of	  injury	  at	  2	  hpi,	  than	  in	  4-­‐8	  hpi	  embryos	  (Figure	  4.6)	  and	  from	  these	   data	   it	   is	   difficult	   to	   determine	   whether	   this	   indeed	   is	   a	   result	   of	   probe	  trapping,	   or	   a	   physiological	   response	   to	   injury.	   This	   could	   be	   investigated	   by	  determining	   the	   cellular	   localisation	   of	   the	   IL-­‐1β	   staining	   through	   double	  WISH	  staining.	   In	   Tg(pNF-­‐κB:EGFP)sh235	   embryos,	   NF-­‐κB	   signalling	   is	   active	   in	   other,	  non	   leukocyte	   tissues	   (Figure	   4.11)	   implying	   the	   activation	   of	   inflammatory	  pathways	  in	  these	  tissues.	  It	  may	  be	  possible	  to	  use	  a	  similar	  system	  to	  investigate	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IL-­‐1β	   specific	   gene	   activation	   by	   using	   the	   IL-­‐1β	   promoter	   to	   drive	   EGFP	   rather	  than	  NF-­‐κB	  response	  elements.	  The	   data	   suggest	   that	   due	   to	   expression	   at	   such	   an	   early	   developmental	  stage,	   before	   the	   appearance	   of	   neutrophils,	   staining	   in	   cells	   with	   leukocytic	  morphology	   and	   large,	   single	   nuclei	   and	   localization	   to	   sites	   of	   haematopoiesis	  over	   the	   yolk	   and	   in	   the	   CHT,	   that	   these	   stained	   cells	   are	  macrophages.	   In	   later	  developmental	  stages	  there	  appears	  to	  be	  an	   induction	  of	   the	  IL-­‐1β	  message	   in	  a	  greater	   number	   of	   cells,	   which	   could	   correspond	   to	   either	   the	   increase	   in	  macrophages	  at	  later	  developmental	  stages,	  as	  these	  cells	  develop	  or	  the	  induction	  of	   IL-­‐1β	   in	   other	   immune	   cells	   such	   as	   neutrophils.	   In	   future	   work,	   I	   would	  investigate	   IL-­‐1β	   localisation	   using	   a	   double	   in	   situ	   for	   IL-­‐1β	   and	   a	  macrophage	  marker	   to	   determine	   whether	   the	   IL-­‐1β	   signal	   is	   in	   fact	   in	   macrophages,	   and	  whether	  other	  cell	  types	  are	  also	  responsible	  for	  this	  response.	  Nevertheless,	  these	  data	  suggest	  that	  the	  evolutionary	  importance	  of	  IL-­‐1β	  in	  response	  to	  injury	  in	  the	  inflammatory	  response	  is	  conserved	  between	  humans	  and	  zebrafish.	  	  
4.5.2	  Tg(pNF-­‐κB:EGFP)sh235	  as	  a	  tool	  to	  study	  inflammation	  	   Though	  the	  Tg(pNF-­‐κB:EGFP)sh235	   line	  proved	  useful	  for	  this	  study,	  it	  has	  significant	   limitations	   when	   performing	   quantitative	   assays.	   Crosses	   to	   yield	  transgenic	  embryos	  must	  be	  carefully	  performed	  to	  control	  the	  number	  of	  alleles	  each	   embryo	   has	   as	   this	   has	   a	   direct	   effect	   on	   the	   intensity	   of	   the	   zebrafish.	  However,	  the	  line	  has	  limited	  fluorescent	  intensity	  with	  just	  a	  single	  insertion,	  so	  a	  mechanism	   to	   increase	   the	  brightness	  of	   the	   transgene,	   such	  as	   increase	   in	   copy	  number,	  is	  necessary.	  The	  fish	  is	  most	  reliable	  as	  a	  homozygote	  with	  a	  single	  allele	  insertion,	  but	  best	  imaged	  and	  measured	  with	  multiple	  insertions	  or	  alleles.	  In	  this	  study	  I	  approached	  the	  issue	  by	  first	  sorting	  the	  embryos	  at	  4	  hpf	  to	  remove	  any	  embryos	  born	  earlier	  or	  later	  than	  this	  timepoint	  so	  all	  embryos	  were	  at	  the	  same	  developmental	   stage	   to	   reduce	   any	   difference	   in	   protein	   expression	   due	   to	  development	  for	  each	  experiment,	  at	  72hpf,	  the	  embryos	  were	  again	  sorted	  by	  eye	  under	  a	  fluorescence	  dissecting	  scope	  to	  select	  embryos	  of	  approximately	  the	  same	  brightness,	  these	  were	  randomly	  allocated	  to	  treatment	  groups	  without	  the	  use	  of	  a	  fluorescence	  microscope	  to	  avoid	  experimental	  bias.	  This	  approach	  avoids	  errors	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introduced	  through	  changes	  in	  transgene	  intensity	  brought	  about	  by	  copy	  number	  or	  developmental	  level,	  but	  uses	  embryos	  of	  a	  sufficient	  fluorescent	  intensity	  to	  be	  easily	  imaged	  and	  quantified.	  The	  importance	  of	  compensating	  for	  copy	  number	  or	  fluctuations	  in	  intensity	  due	  to	  developmental	  status	  cannot	  be	  overstated,	  and	  an	  approach	   that	   limits	   the	   errors	   due	   to	   these	   factors	   yet	   maintains	   a	   strong	  fluorescent	  intensity	  for	  quantitation,	  like	  the	  approach	  described	  in	  this	  study,	  is	  recommended.	  	   The	  change	   in	   the	  NF-­‐κB	  signal	  upon	   treatment	  with	   the	   inhibitors	   tested	  appeared	  to	  be	  very	  small,	  leading	  to	  a	  large	  number	  of	  embryos	  needed	  in	  order	  to	   increase	   statistical	   power.	   NF-­‐κB	   is	   important	   in	   zebrafish	   development	   as	  evidenced	  by	   its	   expression	   in	   a	   large	  number	  of	   cell	   types	  at	  72hpf	  when	   these	  assays	  were	  performed	  (Figure	  4.9),	  and	  the	  role	  of	  NF-­‐κB	  in	  wound	  healing	  and	  regeneration	  has	  already	  been	  reported.	  A	  tail	  fin	  injury	  assay	  of	  NF-­‐κB	  activation	  in	  response	  to	  injury	  would	  be	  expected	  to	  initiate	  both	  inflammatory	  and	  wound	  healing	  responses,	  and	  it	  is	  only	  the	  inflammatory	  responses	  that	  are	  expected	  to	  be	   susceptible	   to	   modulation	   by	   caspase-­‐1	   and	   P2X7	   inhibitors;	   therefore,	   the	  change	  in	  signal	  from	  NF-­‐κB	  activation	  is	  expected	  to	  be	  very	  small.	  To	  achieve	  the	  statistical	  power	  necessary	  for	  quantifying	  this	  response,	  it	  is	  necessary	  to	  remove	  as	  much	  experimental	  error	  and	  noise	  from	  this	  system	  as	  possible.	  In	  this	  study,	  this	   approach	   necessitated	   the	   use	   of	   larger	   numbers	   of	   embryos	   than	   for	   the	  leukocyte	  recruitment	  assays.	  	  	   In	  this	  study	  I	  used	  NF-­‐kB	  activation	  as	  a	  marker	  of	  inflammatory	  signalling,	  however,	   NF-­‐kB	   is	   important	   in	   significantly	   more	   than	   inflammatory	   function	  (Baeuerle	   &	   Baltimore	   1996),	   further	   evidenced	   by	   the	   activation	   of	   NF-­‐kB	   not	  only	  in	  injury	  but	  also	  in	  developmental	  processes	  (Figure	  4.9).	  the	  roles	  of	  NF-­‐κB	  in	   these	   functions	   questions	   its	   reliability	   as	   an	   inflammatory	   reporter.	   A	   more	  specific	   reporter	   would	   require	   EGFP	   induction	   under	   a	   gene	   induced	   by	  inflammatory	   stimuli,	   such	  as	   IL-­‐1β	   itself,	   also	   capable	  of	  being	   induced	  by	   itself	  (Dinarello	  et	  al.	  1987),	  and	  it	  would	  be	  interesting	  to	  repeat	  these	  assays	  in	  such	  a	  reporter.	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4.5.3	  Effects	  of	  caspase-­‐A	  and	  P2X7	  inhibition	  on	  inflammatory	  signalling	  Experimentally,	   mammalian	   caspase-­‐1	   inhibitor	   AC-­‐YVAD-­‐CMK	   decreased	  both	  NF-­‐κB	  activation	  at	  the	  site	  of	  injury,	  as	  well	  as	  decreasing	  the	  recruitment	  of	  macrophages	   and	   neutrophils	   to	   the	  wound.	   Although	   it	   is	   unclear	  whether	   AC-­‐YVAD-­‐CMK	   inhibits	   the	   zebrafish	   caspase-­‐1	  equivalent	   caspase-­‐A,	  published	  data	  (Masumoto	  et	  al.	  2003;	  Vojtech	  et	  al.	  2012)	  suggest	  that	  this	  is	  likely	  to	  be	  the	  case	  based	  on	   the	   target	   sequence	  specificity	  of	   caspase-­‐A.	  This	   study	  shows	   that	  AC-­‐YVAD-­‐CMK	   affects	   inflammatory	   initiation	   and	   therefore	   suggests	   a	   homologous	  role	   for	   caspase-­‐A	   in	   zebrafish	   inflammatory	   signalling.	  NF-­‐κB	   is	   downstream	  of	  IL-­‐1β	   signalling	   in	   IL-­‐1	   sensitive	   cells	   and	   an	   inhibition	   of	   IL-­‐1β	   release	   would	  effect	   this	   downstream	   signalling	   and	   reduce	   the	   fluorescent	   signal	   from	   NF-­‐κB	  activation.	  A	  resulting	  reduction	  in	  the	  activation	  of	  downstream	  cells	  would	  also	  inhibit	  the	  release	  of	  further	  inflammatory	  factors	  and	  result	  in	  a	  reduction	  in	  the	  inflammatory	  response	  and	  the	  recruitment	  of	  further	  immune	  cells	  to	  the	  site	  of	  injury.	   The	   reduction	   of	   neutrophil	   and	   macrophage	   recruitment	   to	   the	   site	   of	  injury	   could	   also	   be	   due	   to	   a	  more	   direct	   effect	   of	   caspase	   A	   inhibition	   and	   the	  reduction	  in	  direct	  IL-­‐1β	  exposure	  of	  these	  cells.	  A	   pan-­‐caspase	   inhibitor,	   Q-­‐VD.OPh	   had	   no	   effect	   on	   the	   recruitment	   of	  leukocytes	  and	  NF-­‐κB	  activation	  at	  the	  site	  of	  injury,	  however	  it	  would	  be	  expected	  to	   at	   least	   match	   the	   effect	   of	   AC-­‐YVAD-­‐CMK	   on	   caspase	   A.	   As	   a	   pan	   caspase	  inhibitor,	  Q-­‐VD.OPh	  would	  also	  be	  expected	  to	  affect	  pro	  apoptotic	  caspases.	  Three	  possible	   explanations	   for	   the	   lack	   of	   response	   to	   Q-­‐VD.OPh	   treatment	   on	   NF-­‐κB	  activation	   and	   leukocyte	   recruitment	   are	   that	  perhaps	  Q-­‐VD.OPh	  either	  does	  not	  penetrate	  the	  fish	  to	  sites	  of	  activity	  as	  well	  as	  AC-­‐YVAD-­‐CMK	  does;	  that	  Q-­‐VD.OPh	  is	  not	  compatible	  with	  zebrafish	  caspases,	  or	  that	  any	  decrease	  in	  caspase-­‐A	  based	  inhibition	  is	  offset	  by	  an	  increase	  in	  cells	  being	  targeted	  towards	  a	  necrotic	  rather	  than	   apoptotic	   cell	   death	   pathway,	   a	   subsequent	   increase	   in	   necrotic	   cell	   debris	  and	   the	   consequent	   increase	   in	   additional	   inflammatory	   signalling.	  This	   increase	  could	  mask	  a	  reduction	  in	  caspase-­‐1	  mediated	  signalling	  and	  I	  would	  expect	  would	  also	  result	  in	  a	  larger	  increase	  in	  the	  inflammatory	  markers	  investigated	  than	  was	  shown.	   It	   is	   therefore	  more	   likely	   that	   zebrafish	   are	   insensitive	   to	  Q-­‐VD.OPh	   via	  either	   its	   incompatibility	  with	  zebrafish	  caspases,	  or	   its	   inability	   to	  reach	  sites	  of	  
	   99	  
caspase	  activation.	  Other	  studies	  in	  the	  Renshaw	  lab	  have	  failed	  to	  show	  an	  effect	  of	  this	  inhibitor	  in	  inflammation	  resolution	  assays.	  	   The	  similarities	   in	  zebrafish	  and	  mammalian	  P2X7	  receptors	  have	  already	  been	  studied,	  however,	  the	  data	  in	  this	  study	  imply	  that	  P2X7	  is	  also	  functionally	  conserved	   in	   zebrafish.	   Treatment	   with	   P2X7	   inhibitors	   negatively	   affected	  leukocyte	   recruitment	   at	   the	   site	   of	   the	   injury	   demonstrating	   its	   role	   in	  inflammatory	   signalling.	   However,	   the	   same	   inhibitors	   failed	   to	   affect	   NF-­‐κB	  activation	   at	   the	   site	   of	   injury.	   This	   could	   be	   a	   statistical	   effect	   due	   to	   a	   lack	   of	  power	   in	   the	   experiment	   or	   that	   these	   inhibitors	   may	   not	   be	   very	   effective	   in	  zebrafish,	   although	   the	   latter	   conclusion	   is	   unsupported	   by	   the	   decrease	   in	  leukocyte	  recruitment.	  It	  is	  more	  likely	  that	  these	  inhibitors	  had	  an	  effect	  that	  fell	  below	   the	   threshold	   for	   statistical	   significance,	   a	   conclusion	  supported	  by	  Figure	  4.11,	  which	  shows	  a	  trend	  towards	  a	  decrease.	  	  Although	  we	  cannot	  be	  certain	  that	  AC-­‐YVAD-­‐CMK,	  brilliant	  blue	  and	  KN62	  are	  inhibiting	  caspase-­‐A	  or	  zebrafish	  P2X7	  respectively,	  these	  data	  in	  combination,	  along	   with	   the	   similarities	   in	   IL-­‐1β	   sequence,	   alongside	   the	   similarities	   in	   the	  components	  of	  the	  IL-­‐1β	  processing	  and	  release	  components	  imply	  the	  role	  of	  IL-­‐1β	  is	  conserved	  between	  mammals	  and	  zebrafish.	  A	  more	  definite	  conclusion	  could	  be	   reached	   by	   investigating	   the	   cleavage	   of	   caspase-­‐A	   substrates,	   such	   as	   IL-­‐1β,	  and	   would	   be	   possible	   with	   an	   anti	   zebrafish	   IL-­‐1β	   specific	   antibody	   used	   in	  western	   blot	   assays	   to	   determine	   whether	   caspase-­‐A	   is	   active	   with	   treatment.	  However,	   western	   blots	   are	   difficult	   to	   quantify	   and	   this	   may	   result	   in	   a	   false	  conclusion	  if	  there	  are	  other	  pathways	  active	  other	  than	  P2X7	  that	  can	  activate	  IL-­‐1β,	   or	   if	   AC-­‐YVAD-­‐CMK	   has	   less	   efficacy	   in	   some	   of	   the	   cell	   types	   being	  investigated.	  Further	  assays	  on	  caspase-­‐A	  activity	  in	  vivo	  could	  provide	  a	  wealth	  of	  data	   on	   IL-­‐1β	   signalling	   in	   zebrafish,	   but	   for	   the	   purpose	   of	   this	   study,	   I	   have	  shown	  that	  mammalian	  caspase-­‐A	  and	  P2X7	  inhibitors	  reduce	  inflammation	  at	  the	  site	  of	  injury	  and	  likely	  do	  this	  through	  inhibition	  of	  IL-­‐1β	  signalling.	  	   Alongside	   these	   data,	   is	   the	   generation	   and	   further	   characterization	   of	  
Tg(pNF-­‐κB:EGFP)s235	   and	   Tg(mpeg1:gal4.VP.16)sh256	   as	   described,	   which	   will	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undoubtedly	   be	   useful	   tools	   for	   the	   study	   of	   innate	   immune	   function.	   The	  mpeg	  promoter	   is	   a	   valuable	   tool	   for	   the	   study	   of	   macrophage	   function	   in	   vivo	   in	  zebrafish	   as	   described	   by	   Ellet	   et	   al.	   (2010)	   and	   allows	   the	   behaviour	   of	  macrophages	   to	   be	   visualized,	  which	   has	   not	   been	  possible	   before.	   This	   is	  made	  easier	  by	  its	  format	  as	  an	  entry	  clone	  compatible	  with	  the	  gateway	  system,	  which	  makes	  it	  possible	  to	  use	  it	  as	  a	  direct	  driver	  for	  a	  macrophage	  label,	  bypassing	  the	  need	   for	   a	   Gal4-­‐UAS	   system	   and	   allowing	   more	   reliable	   data	   collection.	   In	   this	  study	  we	  have	  taken	  advantage	  of	  the	  entry	  clone	  to	  generate	  a	  number	  of	  useful	  tools,	  which	  will	  be	  described	  later.	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Chapter	  5,	  Development	  of	  a	  FRET	  based	  caspase-­‐1	  activation	  reporter.	  
	  
5.1	  Introduction.	  
5.1.1	  Inflammasome	  function	  in	  IL-­‐1β	  processing	  	   The	  inflammasome	  complex	  is	  assembled	  in	  response	  to	  pro	  inflammatory	  stimuli	   such	   as	   PAMPs	   detected	   by	   the	   cell.	   In	   mammalian	   models,	   the	  inflammasome	   mediates	   the	   cleavage	   and	   activation	   of	   pro-­‐caspase-­‐1,	   which	   in	  turn	  is	  responsible	  for	  the	  cleavage	  of	  pro-­‐IL-­‐1β	  into	  a	  bioactive	  cytokine.	  Current	  methods	   of	   studying	   inflammasome	   function	   have	   utilized	   antibody	   techniques	  such	   as	   immunoprecipitation	   and	   fluorescent	   staining,	   on	   fixed	   cells.	   These	  mechanisms	  provide	   insight	   into	   inflammasome	  function,	  but	  operate	  on	  a	  single	  timepoint,	   so	   may	   miss	   important	   insights	   into	   inflammasome	   mechanisms.	  Mechanisms	  of	   inflammasome	  function,	  activation	  and	  localization	  have	  yet	  to	  be	  fully	   identified,	   and	   the	   pathway,	   as	   well	   as	   its	   relation	   to	   IL-­‐1β	   release	   and	  processing	  remains	  poorly	  understood.	  The	  IL-­‐1β	  processing	  stage	  mediated	  by	  inflammasome	  activation	  precedes	  IL-­‐1β	   signalling	   and	   provides	   an	   ideal	   step	   for	   therapeutic	   intervention,	   so	  understanding	   this	   pathway	   is	   essential	   to	   controlling	   IL-­‐1β	   signalling	   and	  downstream	   inflammatory	   processes.	   I	   hypothesise	   that	   an	   in	   vivo	   live	   imaging	  reporter	   of	   inflammasome	   activation	   would	   provide	   valuable	   insights	   on	   the	  temporal	  and	  spatial	  aspects	  of	  inflammasome	  function,	  and	  allow	  these	  aspects	  to	  be	   further	   characterised.	   Such	   a	   reporter	   would	   act	   to	   bridge	   any	   gaps	   in	  understanding	   between	   inflammasome	   action	   and	   the	   release	   of	   IL-­‐1β	   in	   living	  systems.	  	  
5.1.2	  Förster	  Resonance	  Energy	  Transfer	  (FRET)	  as	  an	  active	  caspase	  reporter.	  	   Förster	   Resonance	   Energy	   Transfer	   (FRET)	   is	   a	   technique	   based	   on	  resonant	   energy	   transfer	   between	   two	   fluorophores	   of	   similar	   excitation	   and	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Figure	   5.1.	   Förster	   Resonance	   Energy	   Transfer	   (FRET)	   in	   a	   CFP/YFP	  
fluorophore	   pair.	   FRET	   is	   a	   non-­‐radiative	   transfer	  mechanism	   that	   occurs	   over	  distances	  of	  approximately	  5nm.	  At	  these	  distances,	  energy	  is	  transferred	  from	  the	  donor	   fluorophore	   (CFP)	   to	   the	   acceptor	   fluorophore	   (YFP).	   The	   FRET	   signal	   is	  therefore	   the	   emission	   of	   CFP	   excitation	   energy	   at	   the	   YFP	   emission	   peak.	  Separation	  of	  the	  fluorophores	  results	  in	  the	  loss	  of	  this	  signal.	  	  emission	   spectra.	   In	   FRET,	   two	   spectrally	   similar	   fluorophores,	   commonly	   BFP-­‐GFP	  or	  CFP-­‐YFP	  are	  imaged	  under	  excitation	  and	  emission	  frequencies	  that	  excite	  both	   fluorophores	   individually.	   In	   any	   FRET	   pair,	   one	   fluorophore	   has	   a	   smaller	  wavelength	   and	   a	   higher	   excitation	   energy	   and	   is	   called	   the	   Donor	   fluorophore	  (BFP	  or	  CFP	  in	  previous	  examples),	  whereas	  the	  other	  has	  a	  longer	  wavelength	  and	  correspondingly	  lower	  excitation	  energy	  and	  is	  referred	  to	  as	  the	  Acceptor	  (GFP	  or	  YFP).	  If	  there	  is	  enough	  spectral	  overlap	  between	  the	  emission	  wavelength	  of	  the	  donor	  and	  the	  excitation	  wavelength	  of	  the	  acceptor	  then	  it	  is	  possible	  that	  when	  excited,	   the	   emission	   energy	   of	   the	   donor	   fluorophore	   can	   excite	   the	   acceptor	  fluorophore,	   resulting	   in	   a	   signal	   corresponding	   to	   acceptor	   emission	   in	   the	  absence	  of	   input	  energy	  of	  the	  right	  frequency	  to	  excite	  the	  acceptor	  fluorophore	  directly.	  	   FRET	   is	   a	   non-­‐radiative	   transfer	   mechanism,	   and	   as	   such	   behaves	  differently	  from	  a	  radiative	  energy	  transfer	  mediated	  by	  photons.	  Detectable	  FRET	  can	  only	  occur	  over	  small	  distances	  of	  5-­‐10nm,	  distances	  significantly	  smaller	  than	  the	   emission	   wavelengths	   of	   the	   fluorophores	   involved	   at	   470-­‐550nm	   and	   is	  mediated	   by	   virtual	   photons	   (Andrews	   1989).	   The	   efficiency	   of	   this	   transfer	  mechanism	  relies	  on	  the	  distance	  between	  the	  two	  fluorophores	  and	  is	  governed	  by	  the	  following	  equation:	  	  
	   103	  
1                     𝐸 = 11+ 𝑟𝑅! !	  	  Where	  r	  is	  the	  distance	  between	  the	  fluorophores,	  and	  R0	  is	  the	  distance	  at	  which	  E	  is	  at	  50%	  efficiency.	  Rather	  than	  the	  radiative	  transfer	  commonly	  associated	  with	  fluorescent	  proteins,	  which	  attenuates	  to	  the	  2nd	  power	  with	  distance,	  FRET	  is	  far	  more	  sensitive	  to	  distance	  and	  loses	  efficiency	  to	  the	  6th	  power.	  FRET	  is	  incredibly	  dependent	   on	  maintaining	   a	   distance	   between	   the	   fluorophores	   that	   is	   less	   than	  the	   R0	   and	   is	   consequently	   most	   efficient	   when	   the	   two	   molecules	   are	   directly	  linked	  with	   the	  minimum	  spacer	  distance	  between	   the	   fluorophores	   as	   possible;	  Xia	  and	  Liu	  (2001)	  demonstrated	  that	  an	  increase	  of	  22	  amino	  acid	  residues	  in	  the	  linker	  sequence	  between	  fluorophores	  can	  reduce	  the	  measured	  FRET	  intensity	  by	  >40%.	  Because	   of	   its	   sensitivity	   to	   distance,	   the	   most	   common	   applications	   of	  FRET	   are	   to	   investigate	   the	   colocalisation	   of	   different	   proteins	   to	   cellular	   and	  membrane	  compartments	  and	  their	  interactions,	  acting	  as	  a	  very	  precise	  molecular	  ruler;	   however	   a	   FRET	   approach	   has	   also	   been	   used	   to	   successfully	   develop	   a	  reporter	  of	  caspase-­‐3	  activation	  in	  apoptosis	  (X.	  Xu	  et	  al.	  1998;	  Rehm	  et	  al.	  2002;	  Tian	  et	  al.	  2007).	  Xu	  et	  al.	  (1998)	  have	  developed	  an	  expression	  cassette	  encoding	  a	  CFP	  YFP	  FRET	  pair	   linked	  by	   a	   short	   sequence	   encoding	   the	  human	   caspase-­‐3	  cleavage	   site	   DEVD;	   in	   response	   to	   caspase-­‐3	   activation,	   this	   site	   is	   cleaved	  resulting	  in	  the	  separation	  the	  fluorophore	  pairs	  and	  a	  loss	  of	  FRET.	  In	  this	  study	  I	  aim	  to	  modify	  this	  system	  to	  develop	  a	  reporter	  of	  caspase-­‐1	  activation	  in	  human	  macrophage	   like	   cells,	   and	   to	   further	   expand	   this	   into	   an	   in	   vivo	   reporter	   of	  inflammasome	  function	  in	  a	  transgenic	  zebrafish.	  	  	   In	  designing	  a	  FRET-­‐based	  reporter	  for	  caspase-­‐1	  activity	  it	  is	  important	  to	  consider	   the	   ideal	   conditions	   to	   achieve	   optimal	   energy	   transfer,	   as	   well	   as	   the	  parameters	  required	  in	  order	  that	  it	  is	  detected	  most	  effectively.	  The	  details	  of	  the	  design	  and	  detection	  are	  therefore	  described	  in	  detail	  below.	  	   In	  previous	  studies	  (Morgan	  et	  al.	  2001;	  Tyas	  et	  al.	  2000;	  Rehm	  et	  al.	  2002;	  Tian	  et	   al.	   2007;	  Koopmans	  et	   al.	   2007)	  FRET	  has	  been	  measured	  by	   calculating	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changes	   in	   the	  CFP/YFP	  ratio	   for	  a	  CFP-­‐YFP	  FRET	  pair.	  Resonant	  energy	  used	   to	  excite	  an	  acceptor	  fluorophore	  from	  a	  donor	  excitation	  input	  is	  energy	  not	  released	  as	   visible	   light	   at	   the	   emission	   wavelength	   of	   the	   donor,	   as	   such,	   when	   FRET	  occurs,	  the	  acceptor	  operates	  as	  a	  fluorescent	  quencher	  of	  the	  donor.	  Separation	  of	  the	   fluorophores	   disables	   the	   quencher	   activity	   of	   the	   acceptor	   resulting	   in	   an	  increase	  in	  donor	  emission.	  This	  will	  result	  in	  a	  change	  in	  the	  ratio	  of	  CFP	  to	  YFP	  in	  a	  CFP-­‐YFP	  FRET	  pair	  as	  donor	  emission	  intensity	  increases.	  
 
5.2.	  Results	  
5.2.1	  In	  vitro	  characterisation	  of	  FRET	  DEVD	  	   The	  published	  caspase-­‐3	  apoptosis	  reporter	  (Rehm	  et	  al.	  2002)	  was	  initially	  tested	  in	  order	  to	  establish	  that	  FRET	  measurement	  and	  processing	  was	  possible	  due	   to	   a	   biological	   response,	   using	   the	   equipment	   available.	   HEK293	   cells	   were	  transfected	  with	   the	   caspase-­‐3	  DEVD	  FRET	   reporter	   plasmid	   (Rehm	  et	   al.	   2002)	  and	  a	  plasmid	  encoding	  the	  pro-­‐apoptotic	  protein	  Bcl-­‐2	  associated	  x	  protein	  (BAX)	  a	   kind	   gift	   of	   Dr.	   David	   Huang	   (Eliza	   and	   Walter	   Hall	   Institute,	  Melbourne)(Renshaw	  et	  al.	  2004),	  a	  Bcl-­‐2	  family	  member.	  24	  hour	  treatment	  with	  the	  pan-­‐caspase	  inhibitor	  Q-­‐VD.OPh	  was	  used	  as	  a	  negative	  control.	  24	  hours	  after	  transfection,	   these	   cells	  were	   fixed	   in	  VECTASHIELD®	   (Vector	  Labs)	  and	   imaged.	  Volocity™ was	  used	   to	  generate	  a	   channel	   for	   the	   ratio	  of	   the	  CFP	  channel	   (CFP	  excitation,	  CFP	  Emission)	  to	  the	  YFP	  channel	  (YFP	  excitation,	  YFP	  Emission)	  (ratio	  hereby	   reffered	   to	   as	   C/Y),	   which	   was	   then	   analysed	   by	   using	   a	   measurement	  function	   to	   define	   objects	   of	   cellular	   size	   with	   a	   fluorescent	   intensity	   in	   the	   6th	  percentile	  of	  the	  CFP	  channel.	  These	  parameters	  are	  strict	  enough	  to	  remove	  most	  false	  positives,	  but	  did,	  however,	  remove	  a	  number	  of	  transfected	  cells	  as	  well.	  The	  intensities	  for	  these	  objects	  were	  averaged	  across	  each	  field	  of	  view	  to	  quantify	  the	  C/Y	  for	  each	  treatment	  group.	  This	  protocol	  removes	  any	  data	  not	  defined	  as	  a	  cell	  by	  the	  software	  based	  on	  the	  CFP	  channel,	  which	  tended	  to	  be	  less	  intense	  than	  the	  YFP,	  as	  selecting	  objects	  by	  YFP	  could	  result	  in	  the	  inclusion	  of	  low	  intensity	  cells	  where	  the	  CFP	  emission	  signal	  could	  fall	  below	  the	  threshold	  of	  detection.	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   It	  was	  possible	  to	  further	  refine	  this	  cell	  population	  using	  background	  and	  threshold	   corrections.	   A	   background	   correction	   subtracts	   a	   defined	   background	  signal	   from	   each	   channel	   before	   calculating	   C/Y,	  whereas	   threshold	   alters	   every	  pixel	  falling	  below	  the	  value	  set	  to	  zero,	  effectively	  discounting	  the	  signal	  defined	  as	  background.	  A	  background	  correction	  therefore	  decreases	  the	  entire	  signal	  from	  any	   images,	   including	   signal	   contributing	   to	   FRET	   increasing	   the	   risk	   of	   false	  negatives	   and	   removing	   a	   significant	   amount	   of	   data.	   Conversely	   threshold	  correction	   may	   not	   properly	   correct	   for	   background	   signal	   overlapping	   FRET	  expressing	   cells	   and	   may	   allow	   the	   introduction	   of	   experimenter	   bias	   if	   not	  performed	  correctly.	  With	  regards	  to	  C/Y,	  the	  FRET	  signal	  is	  derived	  as	  change	  in	  the	  fluorescent	  ratio.	  	   The	  data	  were	  corrected	  with	  both	  mechanisms	  and	  plotted	  to	   investigate	  background	  correction	  further.	  In	  uncorrected	  data,	  treatment	  with	  BAX	  increased	  the	   C/Y	   compared	   to	   untreated	   samples	   and	   treatment	   with	   Q-­‐VD.OPh	   (Figure	  5.2A).	  The	  effect	  of	  background	  corrections	  vary;	  correcting	  the	  ratio	  channel	  with	  the	  background	  function	  and	  threshold	  yield	  similar	  results	  (Figure	  5.2	  B	  and	  C),	  however,	   with	   a	   much	   greater	   spread	   of	   values	   and	   consequently	   a	   greater	  standard	  error.	  Technically,	  when	  using	   C/Y,	   threshold	   correction	   is	   not	   necessary	   as	   the	  cells	   imaged	   are	   selected	   by	   the	   software	   based	   on	   their	   size	   and	   fluorophore	  expression,	  thereby	  only	  measuring	  pixels	  in	  cells	  expressing	  the	  FRET	  construct.	  However,	  as	  the	  aim	  is	  to	  develop	  this	  system	  in	  an	  in	  vivo	  model	  it	  is	  necessary	  to	  refine	   the	   generation	   of	   a	   FRET	   channel	   to	   enable	   the	   processing	   of	   FRET	   in	  zebrafish.	  C/Y	  directly	  compares	  donor	  and	  acceptor	  fluorophore	  intensity	  during	  FRET,	  taking	  advantage	  of	  its	  role	  as	  a	  fluorescent	  quencher,	  however	  it	  generates	  an	   aberrant	   signal	   because	   the	   C/Y	   is	   also	   calculated	   for	   non-­‐cell	   containing	  regions.	  Any	  background	  should	  therefore	  be	  corrected	  when	  using	  C/Y.	  This	  can	  be	   seen	   in	   Figure	   5.2	   C	   where	   thresholding,	   mostly	   falling	   at	   a	   very	   low	   level,	  whereas	   background	   correction	   (Figure	   5.2B)	   yields	   a	   result	  much	   closer	   to	   the	  uncorrected	   data.	   Using	   both	   background	   and	   threshold	   correction	   seems	   to	  greatly	   increase	   the	   range	   of	   values	   the	   result	   shown	   by	   a	   threshold	   correction,	  reducing	  most	   data	   points	   to	   below	  0.01	   and	   inverting	   the	   result	   expected	   from	  previous	  studies	  (Rehm	  et	  al.	  2002).	  Clearly,	  the	  spread	  of	  data	  and	  correction	  of	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Figure	   5.2.	   FRET	   signal	   from	   the	   caspase-­‐3	   reporter	   plasmid	   is	   reduced	   in	  
response	   to	  BAX	  overexpression	  when	  expressed	  as	  a	  CFP/YFP	  ratio	   (C/Y).	  HEK293T	   cells	   cotransfected	   with	   the	   FRET	   DEVD	   reporter	   plasmid	   and	  proapoptotic	  protein	  BAX	  show	  an	  increase	  in	  C/Y	  compared	  to	  cells	  treated	  with	  pan-­‐caspase	  inhibitor	  Q-­‐VD.OPh	  (qVD)	  and	  cells	  without	  BAX	  transfection	  (A).	  B,	  C	  and	  D	  are	  the	  same	  data	  showing	  background,	  threshold	  and	  multiple	  methods	  of	  correction	   respectively.	   (n=3,	   3-­‐4	   samples	   per	   experiment.	   Statistics:	   One	   way	  ANOVA	  followed	  by	  Dunnets	  post	  test)	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Figure	   5.3.	   FRET	   signal	   from	   the	   caspase-­‐3	   reporter	   plasmid	   is	   reduced	   in	  
































































most	   values	   to	   below	  0.2	   and	  0.01	  using	   threshold	   and	   combined	   threshold	   and	  background	   correction	   informs	   that	   this	   is	   an	   unviable	   strategy	   for	   generating	   a	  FRET	   channel.	   However,	   a	   background	   correction	   could	   still	   prove	   useful.	   Other	  studies	   (Tyas	   et	   al.	   2000;	  Morgan	   et	   al.	   2001)	   have	   used	   a	   C/Y	   ration	   to	   detect	  FRET,	  however,	  differences	  in	  processing	  from	  these	  these	  groups	  could	  present	  a	  problem.	   In	   these	   studies,	   cells	  were	   annotated	  manually	   rather	   than	   relying	   on	  software	  processing.	  In	  a	  live	  organism	  with	  multiple	  cells	  at	  a	  site	  of	  injury	  over	  a	  long	   timelapse	   microscopy	   aquisition,	   such	   a	   strategy	   is	   unviable,	   so	   other	  mechanisms	  of	  detecting	  FRET	  were	  also	  investigated.	  
	  
5.2.2	  Measures	  of	  FRET	  As	  opposed	   to	  using	  C/Y,	   it	   is	   possible	   to	  make	  a	  more	  direct	  measure	  of	  FRET.	  Youvan	  et	  al.	  (1997)	  have	  developed	  an	  algorithm	  to	  calculate	  netFRET	  (nF).	  Defined	  as:	  	   2                 𝑛𝐹 = 𝐹𝑅𝐸𝑇 − 𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟×𝐴 + 𝐷𝑜𝑛𝑜𝑟×𝐵 	  	  The	  imaging	  parameters	  to	  generate	  nF	  are	  substantially	  different	  from	  those	  used	  to	  measure	  C/Y.	  C/Y	  requires	  the	  acquisition	  of	  images	  of	  CFP	  emission	  following	  CFP	  excitation	  and	  YFP	  emission	  following	  YFP	  excitation	  and	  relies	  entirely	  on	  the	  quenching	  ability	  of	  the	  YFP	  fluorophore	  to	  generate	  a	  ratio,	  which	  is	  then	  altered	  by	  the	  separation	  of	  the	  fluorophores.	  nF	  requires	  the	  addition	  of	  a	  third	  channel,	  that	  being	  YFP	  emission	   following	  CFP	  excitation	  and	   is	  effectively	  a	  more	  direct	  measurement	  of	  the	  FRET	  process	  as	  it	  quantifies	  the	  component	  of	  the	  YFP	  signal	  derived	  from	  the	  resonant	  transfer.	  The	  advantage	  of	  nF	  over	  C/Y	  is	  that	  it	  corrects	  for	   spectral	   overlap	   between	   the	   two	   fluorophores	   more	   effectively,	   necessary	  because	  of	  the	  very	  similar	  spectra	  of	  CFP	  and	  YFP	  (Pawley	  2006).	  In	  vivo,	  nF	  will	  also	  provide	  a	  more	  useful	  visualisation	  of	  FRET	  as	  either	  a	  presence	  or	  absence	  of	  a	   signal	   rather	   than	  an	   increase	   in	   a	   signal,	   this	  will	   be	  discussed	   in	  more	  detail	  later.	  (section	  5.3)	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Figure	   5.4.	   Post-­‐apoptotic	   cellular	   debris	   has	   a	   significant	   amount	   of	   nF	  
signal	  derived	  from	  auto-­‐fluorescence.	  Background	  regions	  selected	  by	  drawing	  ROI	   in	  regions	   lacking	  a	  YFP	  signal	  have	  a	  high	  background	  level	  of	  nF.	  (n=3,	  3-­‐4	  samples	  per	  experiment,	  statistics:	  two	  tailed	  t-­‐test.)	  	  The	   nF	   of	   the	   above	   experiment	   was	   plotted	   and	   background	   and	   threshold	  corrections	   again	   performed	   (Figure	   5.3).	   Like	   C/Y,	   these	   corrections	   must	   be	  carefully	  considered.	  However,	  unlike	  C/Y	  as	   the	  signal	   is	   the	  product	  of	  a	  single	  channel	  with	  subtractions	  to	  account	  for	  spectral	  bleedthrough,	  it	  is	  possible	  that	  the	  best	  correction	  will	  differ	   from	  this	  method	   to	  C/Y.	  Varying	  corrections	  have	  been	  used	  in	  a	  number	  of	  studies,	  however,	  none	  of	  these	  directly	  relate	  to	  a	  in	  vivo	  model.	  Most	  studies	  have	  used	  a	  straight	  background	  correction	  when	  generating	  derivatives	  of	  nF	  (Youvan	  et	  al.	  1997;	  G.	  Gordon	  et	  al.	  1998;	  Z.	  Xia	  &	  Y.	  Liu	  2001),	  however	  have	  concentrated	  on	  single	  cells	  rather	  than	  an	  average	  across	  a	  field	  of	  view.	   In	   this	   instance,	  both	  background	  and	   threshold	  corrections	  give	  results	  as	  expected	   (Figure	  5.3B,C),	   based	  on	   experience	   of	   the	  C/Y	   ratio;	   both	   corrections	  were	  not	  applied	  simultaneously.	  It	  is	  confounding	  that	  applying	  a	  background	  correction	  gives	  the	  inverse	  of	  the	  expected	  results	  (Rehm	  et	  al.	  2002),and	  in	  order	  to	  understand	  this,	   the	  data	  must	  be	  examined	  more	  closely.	  In	  this	  protocol,	  cells	  are	  defined	  and	  selected	  by	  fluorescence	   in	   the	  CFP	  wavelength,	   a	   fluorophore	   significantly	   less	   intense	   than	  YFP	   (Pawley	   2006)	   which	   radiates	   weakly	   above	   the	   high	   background	   of	   the	  

























experiment.	  While	  it	  is	  possible	  to	  capture	  more	  exposed	  images	  of	  CFP	  emission,	  this	   would	   have	   an	   adverse	   effect	   on	   the	   YFP	   fluorophore	   by	   overexposing	   it	  thereby	   making	   a	   reliable	   quantification	   of	   FRET	   impossible,	   therefore	   CFP	  emission	  will	  often	  fall	  below	  a	  level	  of	  detection.	  At	  such	  low	  intensities	  it	  may	  be	  difficult	   to	   distinguish	   between	   cells	   containing	   CFP	   from	   auto-­‐fluorescing	   cell	  debris	  without	  correcting	  for	  background	  in	  the	  other	  channels,	  as	  removal	  of	  cells	  which	   don’t	   fluoresce	   above	   a	   set	   threshold	   in	   the	   YFP	   of	   FRET	   channel	   will	  remove	  these	  data.	  The	  magnitude	  of	  this	  effect	  can	  be	  quantified	  by	  generating	  an	  uncorrected	   nF	   channel	   for	   images	   exposed	   to	   the	   BAX	   apoptotic	   stimulus,	   or	  control	   cells	   and	   quantifying	   the	   nF	   in	   a	   non	   cell	   containing	   region	   (Figure	   5.4)	  quantification	   shows	   a	   significant	   difference	   between	   the	   background	   signal	   of	  control	   and	  apoptotic	   cells	  which	   can	  only	  be	  attributed	   to	   transfection	  with	   the	  BAX	   pro-­‐apoptotic	   protein.	   Plotting	   an	   uncorrected	   nF	   against	   a	   threshold	  corrected	   channel	   shows	   the	   complete	   reversal	   of	   just	   the	   BAX	   treated	   cells,	  demonstrating	  the	  necessity	  of	  correcting	  for	  background	  (Figure	  5.3).	  	  
5.2.3	  Normalising	  FRET	  	   As	  shown	  by	  equation	  2,	  nF	  itself	  is	  dependent	  on	  the	  direct	  intensity	  of	  the	  FRET	   channel	   corrected	   for	   spectral	   bleedthrough	   from	   the	   donor	   and	   acceptor	  channels.	   Thereby,	   an	   increase	   in	   intensity	   of	   the	   fluorophores	   based	   on	   an	  increased	   concentration	   of	   fluorophores	   in	   any	   given	   cell	   increases	   nF;	  whereas	  lower	   concentrations	   of	   fluorophores	   will	   yield	   an	   equivalently	   lower	   nF	   (a	  perceived	  erroneous	  result	  as	  a	  lower	  concentration	  does	  not	  automatically	  imply	  a	   loss	   of	   FRET	   from	   the	   caspase	   reporter).	   Therefore,	   for	   accuracy	   in	   a	   wide	  selection	  of	  cells,	  nF	  must	  be	  corrected	  for	  fluorophore	  concentration.	  Gordon	  et	  al	  (1998)	  propose	  a	  simple	  correction	  based	  on	  dividing	  directly	  by	  the	  intensity	  of	  both	  fluorophores,	  defining	  FRETN	  as:	  	   3                   𝐹𝑅𝐸𝑇𝑁 = 𝐹𝑅𝐸𝑇 − ( 𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟×𝐴 + (𝐷𝑜𝑛𝑜𝑟×𝐵)𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟  ×  𝐷𝑜𝑛𝑜𝑟 = 𝑛𝑓𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟  ×  𝐷𝑜𝑛𝑜𝑟	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Figure	   5.5.	   FRET	   signal	   from	   the	   caspase-­‐3	   reporter	   plasmid	   shows	   no	  

































































Figure	   5.6.	   FRET	   signal	   from	   the	   caspase-­‐3	   reporter	   plasmid	   shows	   no	  
change	   in	   response	   to	  BAX	  overexpression	  when	  expressed	  as	  NFRET	  unless	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correction	   removes	   this	   aberrant	   result,	   yielding	   a	   measurement	   far	   closer	   to	  results	   for	   C/Y	   and	   corrected	   nF,	   whereas	   a	   background	   correction	   greatly	  exacerbates	  this.	  In	  a	  different	  study,	  Xia	  and	  Liu	  (2001)	  propose	  that	  FRETN	  is	  an	  unreliable	  normalisation	   mechanism	   and	   can	   yield	   results	   with	   errors	   of	   more	   than	   80%.	  Instead	  they	  develop	  a	  different	  correction	  mechanism	  to	  account	  for	  fluorophore	  concentration	  named	  NFRET:	  	   4         𝑁𝐹𝑅𝐸𝑇 = 𝐹𝑅𝐸𝑇 − 𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟  ×𝐴 + 𝐷𝑜𝑛𝑜𝑟  ×  𝐵𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟  ×  𝐷𝑜𝑛𝑜𝑟 = 𝑛𝑓𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟  ×  𝐷𝑜𝑛𝑜𝑟	  	  NFRET	  normalises	  by	  the	  square	  of	  acceptor	  and	  donor	  intensity	  and	  analysing	  the	  previous	  data	   this	  way	  yields	   a	   similar	  pattern	   to	   that	   shown	  by	  FRETN,	   though	  with	  a	   smaller	   spread	  of	   results	  and	  a	   closer	   fit	   to	  nF	  and	  C/Y	  data	   (Figure	  5.6).	  However,	   it	   is	  unclear	  whether	   this	   analysis	   is	  necessary.	  Both	  FRETN	  and	  NFRET	  correct	   for	   the	   donor	   and	   acceptor	   concentrations,	   a	   correction	   important	   in	  measuring	  FRET	  interactions	  between	  two	  molecules,	  which	  could	  be	  expressed	  in	  different	  concentrations.	  This	  correction	  is	  unnecessary	  when	  considering	  a	  fusion	  protein	   as	   both	   fluorophores	   will	   be	   expressed	   equimolarly	   before	   caspase-­‐3	  mediated	  cleavage	  and	  the	  subsequent	  loss	  of	  FRET.	  Xia	  and	  Liu	  (2001)	  describe	  a	  further	  normalisation	  method,	  nF/Donor:	  	   5                   𝑁𝐹𝑅𝐸𝑇𝐷𝑜𝑛𝑜𝑟 = 𝐹𝑅𝐸𝑇 − 𝐴𝑐𝑐𝑒𝑝𝑡𝑜𝑟  ×  𝐴 + 𝐷𝑜𝑛𝑜𝑟  𝑥  𝐵𝐷𝑜𝑛𝑜𝑟 = 𝑛𝑓𝐷𝑜𝑛𝑜𝑟	  	  (defined	  incorrectly	  as	  NFRET/Donor	  by	  Volocity)	  which	  they	  quantify	  as	  yielding	  an	  error	  of	  <10%,	  compared	  to	  their	  measured	  error	  of	  <7%	  for	  NFRET.	  When	  plotted,	  nF/Donor	  yields	  results	  remarkably	  consistent	  with	  those	  for	  uncorrected	  nF	  and	  C/Y	  with	  and	  both	  background	  corrections.	  	   In	  in	  vitro	  studies	  using	  cell	  lines,	  transfection	  will	  result	  in	  fluorescent	  cells	  having	   a	   spread	   of	   intensities,	   so	   if	   FRET	   is	   to	   be	   quantified	   its	   necessary	   to	  normalise	  for	  fluorophore	  concentration,	  however,	  from	  the	  processing	  of	  the	  in	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Figure	   5.7.	   FRET	   signal	   from	   the	   caspase-­‐3	   reporter	   plasmid	   shows	   no	  
change	   in	   response	   to	   BAX	   overexpression	   when	   expressed	   as	   nF/Donor	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vitro	  data,	  we	  can	  see	  that	  background	  correction	  substantially	  alters	  the	  results	  of	  the	   experiment.	  Threshold	   corrections	   for	  C/Y	   removes	   a	   large	   amount	  of	   signal	  from	  annotated	  objects.	  Therefore,	  the	  need	  for	  a	  background	  correction	  should	  be	  questioned.	  The	  experimental	  setup	  defines	  objects	  by	  the	  donor	  intensity;	  as	  not	  all	   of	   the	   cells	   in	   the	   experiment	   are	   transfected	  with	   the	   FRET	   reporter,	   only	   a	  proportion	  express	  it,	   these	  must	  therefore	  be	  defined	  by	  Volocity™.	  This	  already	  selects	  out	  non-­‐FRET	  areas,	  which	  is	  the	  function	  of	  the	  background	  and	  threshold	  correction.	   Because	   C/Y	   is	   a	   simple	   division	   and	   Equations	   2-­‐4	   are	   not	   used,	   no	  bleed-­‐through	  between	  channels	   is	  calculated.	  Furthermore,	  as	   this	  data	   is	  based	  on	  a	  ratio	  channel	  and	  the	  reporter	  plasmid	  expresses	  CFP	  and	  YFP	  in	  equimolar	  concentrations	   (as	   these	   proteins	   are	   expressed	   from	   the	   same	   open	   reading	  frame/cDNA).	  	  
5.3	  In	  vivo	  FRET	  
5.3.1	  Measuring	  neutrophil	  apoptosis	  in	  vivo	  using	  FRET	  DEVD	  	   As	  demonstrated,	  the	  reliability	  of	  FRET	  in	  in	  vitro	  cell	  culture	  is	  dependent	  on	  a	  number	  of	  factors;	  background	  correction	  and	  normalisation	  being	  the	  most	  important.	  If	  these	  techniques	  are	  to	  be	  applied	  in	  vivo,	  the	  same	  corrections	  must	  also	  be	  applied.	  Moreover,	  the	  mounting	  of	  live	  embryos	  and	  cells	  is	  substantially	  different	   from	   cell-­‐based	   assays;	   cells	   are	   seeded	   onto	   microscope	   coverglass,	  leaving	   no	   tissue,	   or	   media	   between	   the	   coverglass	   and	   the	   fluorescent	   cells	  resulting	  in	  a	  lightpath	  with	  minimal	  to	  no	  distortion.	  Alternatively,	  zebrafish	  must	  be	  mounted	  in	  agarose	  and	  constitute	  a	  living	  mass	  of	  tissue.	  It	  was	  therefore	  likely	  that	  further	  optimisation	  would	  be	  required	  before	  the	  development	  of	  a	  caspase	  reporter	  in	  vivo.	  	  In	  order	   to	   investigate	   the	   in	  vivo	   activity	  of	  an	  apoptosis	  reporter,	  a	  model	  with	  demonstrated	   apoptosis	   was	   required;	   apoptosis	   has	   been	   proposed	   as	   a	  mechanism	   for	   the	   clearance	   of	   neutrophils	   from	   sites	   of	   injury	   during	   the	  inflammation	   and	   is	   necessary	   for	   its	   successful	   resolution	   (Loynes	   et	   al.	   2010).	  This	  would	  prove	  an	  ideal	  model	  to	  characterise	  a	  FRET	  based	  in	  vivo	  reporter	  of	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apoptosis	   and	   to	   further	   develop	   the	   imaging	   techniques	   necessary	   for	   an	  inflammasome	  reporter.	  To	   generate	   a	   zebrafish	   model	   expressing	   the	   caspase-­‐3	   FRET	   reporter	  previously	   described,	   the	   FRET	   pair	   construct	   was	   targeted	   to	   the	   MPO	   BAC	  (Renshaw	   et	   al.	   2006)	   using	   BAC	   recombineering	   (E.	   Lee	   et	   al.	   2001).	   This	  generated	   a	   vector	   for	   the	   generation	   of	   a	   line	   expressing	   devdFRET	   under	   the	  control	   of	   a	   neutrophil	   specific	   promoter.	   The	   Tg(BACmpo:FRET	   DEVD)sh237	  transgenic	  line	  was	  generated	  using	  this	  construct.	  Expression	  vector	  construction	  and	  line	  generation	  was	  performed	  by	  Catherine	  Loynes.	  
5.3.2	  Acceptor	  Photobleaching	  in	  FRET	  To	  test	  whether	  the	  fluorescent	  signal	  emitted	  from	  these	  cells	  was	  actually	  FRET,	  an	  acceptor	  photobleaching	  experiment	  was	  performed.	  The	  YFP	  acceptor	  protein	  was	  bleached	  using	  a	  spinning	  disc	  confocal	  with	  a	  wavelength	  of	  514nm	  and	  the	  resulting	   fluorescence	   quantified.	   FRET	   was	   lost	   after	   acceptor	   photobleaching	  along	  with	   the	   signal	   from	   the	  YFP	   channel	   (Figure	  5.8).	  As	   FRET	   functions	   as	   a	  fluorescent	   quencher	   it	   is	   expected	   that	   the	   emission	   of	   the	   CFP	  would	   increase	  with	   the	   destruction	   of	   the	   YFP	   fluorophore,	   however	   this	  was	   not	   seen	   (Figure	  5.8).	  A	  fluctuation	  corresponding	  to	  the	  timepoint	  of	  the	  photobleaching	  showed	  a	  slight	  reduction	  in	  intensity	  in	  the	  CFP	  channel,	  which	  could	  indicate	  that	  the	  514	  laser	  line	  may	  have	  bleached	  the	  CFP	  fluorophore	  and	  masked	  any	  increase	  in	  the	  CFP	  emission	  after	  loss	  of	  quenching,	  which	  would	  be	  expected	  given	  the	  spectral	  similarity	  of	  CFP	  and	  YFP.	  This	  hypothesis	  was	  tested	  by	  photobleaching	  the	  YFP	  with	   the	  next	   available	  wavelength,	   561nm,	  which	  would	  have	   less	   overlap	  with	  the	   CFP	   excitation	   frequency,	   so	   would	   not	   be	   expected	   to	   bleach	   CFP;	   but	   this	  failed	  to	  disrupt	  the	  YFP	  fluorophore.	  The	  increase	  in	  fluorescent	  emission	  energy	  of	   the	  CFP	  fluorophore,	  whilst	  significant,	   is	  expected	  to	  be	  spread	  across	  a	   large	  emission	   range,	   and	   the	   increase	   at	   any	   given	   frequency	   is	   predicted	   to	   be	   very	  small	  (Figure	  2B	  in	  Youvan	  et	  al.	  1997)	  (notably	  for	  a	  BFP	  rather	  than	  CFP	  protein)	  so	  may	  fall	  below	  the	  threshold	  of	  detection	  for	  the	  instruments	  used.	  Furthermore	  previous	   studies	   of	   acceptor	   photobleaching	   have	   used	   a	   532nm	   laser	   for	   the	  bleaching	  of	  a	  YFP	  fluorophore,	  equipment	  not	  available	  at	  this	  facility.	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Figure	  5.8.	  bleaching	  of	  the	  acceptor	  fluorophore	  results	  in	  loss	  of	  FRET	  (nF).	  
Tg(BACmpo:FRET	  DEVD)sh237	  embryos	  imaged	  under	  20x	  NA	  0.45	  obejctive	  using	  a	  spinning	  disc	  confocal	  lose	  nF	  signal	  in	  response	  to	  acceptor	  photobleaching	  with	  a	  514nm	  laser.	  
5.3.3	  Isopimpinellin	  induces	  neutrophil	  apoptosis	  in	  the	  resolution	  of	  inflammation	  	  To	   investigate	   the	   functional	   use	   of	   this	   transgenic	   line	   as	   a	   reporter	   of	  apoptosis,	   a	   compound	   implicated	   in	  neutrophil	   apoptosis	  was	  used	   to	   treat	   fish	  post	   injury	   to	   elicit	   an	   accelerated	   resolution	   of	   the	   inflammatory	   response.	   The	  naturally	  occurring	  coumarin	   isopimpinellin	  has	  been	  shown	   to	  have	  anti	   cancer	  properties	   in	   mouse	   experiments	   (Kleiner	   et	   al.	   2001;	   Prince	   et	   al.	   2006).	  Furthermore,	   a	   recently	   performed	   small	   molecule	   screen	   has	   shown	   that	  isopimpinellin	   can	   accelerate	   the	   resolution	   of	   neutrophilic	   inflammation	   in	   a	  zebrafish	   model	   through	   a	   pro-­‐apoptotic	   pathway	   (unpublished	   data,	   Anne	  Robertson).	   The	   action	   of	   isopimpinellin	   on	   Tg(BACmpo:FRET	   DEVD)sh237	  following	   injury	  was	   investigated.	   78	  hpf	   embryos	  were	   injured	   and	  mounted	   in	  agarose	   containing	   25um	   isopimpinellin	   for	   imaging.	   The	   embryos	  were	   imaged	  every	   2.5	   minutes	   for	   11	   hours.	   These	   images	   were	   processed	   using	   nF	   and	  threshold	  correction	  and	  displayed	   in	  a	  merged	  channel	   image	  with	   the	  acceptor	  for	   normalization	   to	   fluorophore	   concentration	   during	   visualisation.	   Unlike	   the	  previously	   described	   normalisation	  methods	   (equations	   3-­‐5,	   Gordon	   et	   al.	   1998;	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Xia	   &	   Liu	   2001),	   nF	   was	   expressed	   overlayed	   on	   the	   acceptor	   image	   for	   each	  timepoint	   in	   the	   acquisition	   to	   enable	   visualisation	   of	   the	   loss	   of	   FRET	   over	   the	  timecourse	   and	   enable	   tracking	   of	   neutrophil	   fate	   after	   the	   loss	   of	   FRET	   (Figure	  5.9).	   Neutrophils	  at	  the	  site	  of	  injury	  can	  be	  seen	  adopting	  an	  apoptotic,	  spherical	  morphology	   at	   which	   point	   the	   FRET	   signal	   is	   lost.	   After	   loss	   of	   FRET,	   YFP	  expression	   remains	   for	   approximately	   5	   minutes	   until	   this	   signal	   is	   lost,	  recapitulating	   the	   morphology	   seen	   by	   Loynes	   et	   al	   (2010)	   during	   neutrophil	  apoptosis.	   After	   the	   loss	   of	   FRET,	   neutrophils	   remain	   for	   5-­‐15	   minutes	   before	  emission	  from	  the	  fluorophores	  is	  lost.	  This	  has	  been	  described	  as	  occurring	  prior	  to	   apoptosis	   as	   neutrophil	   “corpses”	   remain	   after	   loss	   of	   fluorescence	   of	   GFP	  derived	   proteins	   (Loynes	   et	   al.	   2010)	   and	   is	   most	   likely	   due	   to	   changes	   in	   pH	  within	   the	   cell	   denaturing	   these	   fluorophores	   (Pawley	   2006).	   Isopimpinellin	  significantly	  increased	  the	  occurrence	  of	  neutrophil	  apoptosis	  at	  the	  site	  of	  injury	  (Figure	  5.10).	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Figure	   5.10.	   Isopimpinellin	   increases	   neutrophil	   apoptosis	   during	  
inflammation.	  Tg(BACmpo:FRET	  DEVD)sh237	   imaged	  1	  hour	  post	   injury	   show	  a	  greater	  number	  of	  observable	  apoptotic	  events	  when	  treated	  with	   isopimpinellin	  than	  embryos	  treated	  with	  a	  DMSO	  control.	  (n=2,	  10	  fish	  in	  total.	  Unpaired	  t-­‐test.)	  
5.3.3	  Nitroreductase	  converts	  metronidazole	  into	  a	  pro-­‐apoptotic	  metabolite	  As	   an	   additional	   validation	   of	   the	   responsiveness	   of	   the	   in	   vivo	  
Tg(BACmpo:FRET	  DEVD)sh237	   reporter	   to	   apoptosis,	   another	   functional	   test	  was	  developed.	   Nitroreductase,	   the	   protein	   product	   of	   the	   nsfb	   gene	   converts	  metronidazole	  into	  a	  toxic	  metabolite	  (Curado	  et	  al.	  2008;	  X.	  Zhao	  et	  al.	  2009)	  and	  can	  be	  used	  to	  ablate	  specific	  cell	  populations.	  I	  used	  the	  tol2kit	  Gateway™	  system	  (Kwan	  et	  al.	  2007)	  to	  generate	  a	  neutrophil	  specific	  nitroreductase	  mCherry	  fusion	  construct	  by	  combining	  a	  LyzC	  5’	  promoter	  entry	  clone,	  with	  an	  nsfb	  middle	  entry	  clone	   lacking	   a	   stop	   codon	   and	   a	   3’	   mCherry	   entry	   clone	   to	   generate	  
pol2DEST(Lyz:nsfb.mCherry)	   and	   to	   subsequently	   generate	   the	   Tg(Lyz:nsfb-­‐
mCherry)sh260	   transgenic	   line	  enabling	  the	  targeted	  ablation	  of	  neutrophils.	  This	  line	  was	  crossed	  to	  Tg(BACmpo:FRET	  DEVD)sh237.	  Tg(BACmpo:FRET	  DEVD)sh237,	  
Tg(Lyz:nsfb-­‐mCherry)sh260	  embryos	  were	  treated	  with	  metronidazole,	  and	  imaged	  4	   hours	   after	   metronidazole	   treatment	   mounted	   in	   metronidazole	   containing	  agarose.	   An	   nF	   channel	  was	   generated	   for	   this	   acquisition	   and	  merged	  with	   the	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acceptor	   channel	   to	   visualise	   apoptosis	   (Figure	   5.11).	   Over	   this	   timelapse,	  apoptotic	  neutrophils	  are	  clearly	  distinguishable	  by	   their	  morphology;	  as	  well	  as	  loss	   of	   FRET	   and	   nitroreductase.mCherry	   fluorescence.	   The	   complexity	   of	   this	  compound	  zebrafish	   line	  necessitated	   taking	   images	  at	  5	  minute	   intervals	   rather	  than	   the	   2.5	   minute	   intervals	   used	   previously	   (Figure	   5.9)	   due	   to	   the	   time	  necessary	   to	   change	   4	   filter	   sets	   and	   laser	   lines	   rather	   than	   3.	   The	   apoptotic	  process	   occurred	   over	   a	   similar	   duration	   to	   that	   described	   previously	   with	  Isopimpinellin	  treatment.	  The	  key	  to	  successful	  in	  vivo	  FRET	  imaging	  appears	  to	  be	  the	  management	  of	  background	  signal	  and	  the	  acquisition	  of	  images	  using	  the	  correct	  filter	  settings.	  While	   exposure	   was	   kept	   to	   a	   minimum,	   the	   FRET	   reporter	   protein	   was	   less	  susceptible	   to	   bleaching	   in	   vivo	   than	   it	   was	   in	   transfected	   cells.	   However,	   as	  predicted,	   there	  was	   substantially	  more	  background	   signal	   in	   the	   zebrafish,	  with	  significant	  autofluorescence	  in	  the	  CFP	  and	  FRET	  channel	  arising	  from	  the	  pigment	  cells.	   This	  was	   removed	   from	   nF	   images	   by	   increasing	   the	   YFP	   threshold	   as	   the	  autofluorescence	   was	   not	   present	   in	   this	   channel,	   and	   was	   the	   reason	   why	   a	  threshold	   correction	   was	   used	   for	   in	   vivo	   imaging	   in	   this	   study.	   Furthermore,	  necrotic	   tissue	   in	   embryos	   that	   died	   over	   the	   course	   of	   the	   acquisition	  was	   also	  autofluorescent	   and	   generated	   its	   own	   “nF”	   signal	   independent	   of	   a	   fluorophore	  (Figure	  5.12),	  further	  supporting	  the	  use	  of	  a	  correction	  in	  the	  in	  vitro	  experiments	  described	  earlier	  (Figure	  5.4).	  	  	   Tg(BACmpo:FRET	   DEVD)sh237	   successfully	   reports	   on	   apoptosis	   in	   vivo,	  recapitulating	   in	   vivo	   data	   of	   isopimpinellin	   efficacy	   via	   TUNEL	   staining.	   (Anne	  Robertson,	   data	  not	   shown).	   From	   this	  model,	   a	   viable	  methodology	   for	   imaging	  and	  displaying	  FRET	  in	  an	  in	  vivo	  system	  has	  been	  demonstrated.	  From	  this	  point	  it	  was	  possible	  to	  move	  onto	  generating	  an	  in	  vivo	  reporter	  of	  IL-­‐1β	  processing	  using	  caspase-­‐1	  specific	  FRET	  cleavage.	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Figure	  5.12.	  nF	  is	  detected	  from	  autofluorescence	  as	  a	  function	  of	  necrosis.	  A	  proportion	  of	  Tg(BACmpo:FRET	  DEVD)sh237	  embryos	   injured	  72	  hpf	  and	   imaged	  for	  8	  hours	  die	   as	   a	   result	   of	   the	   experimental	   process.	  These	   embryos	   show	  an	  increase	  in	  nF	  (green)	  throughout	  the	  fish	  (B)	  when	  compared	  to	  the	  initial	  1	  hour	  post	   injury	   timepoint	   (A)	   and	   demonstrate	   the	   importance	   of	   considering	   the	  contribution	  autofluorescence	  can	  make	  when	  measuring	  FRET	  in	  a	  live	  organism.	  Scale	  bar	  =	  110	  µm	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5.4	  FRET	  as	  a	  reporter	  of	  caspase-­‐1	  activation	  
5.4.1	  In	  vitro	  testing	  of	  inflammasome	  reporter	  constructs.	  Using	  site	  directed	  mutagenesis,	  the	  caspase-­‐3	  cleavage	  site	  DEVD	  was	  mutated	  to	  the	   caspase-­‐1	   optimal	   cleavage	   site	   WEHD	   (Rano	   et	   al.	   1997):	   primers	   were	  designed	  complementary	  to	  the	  sequence	  on	  either	  side	  of	  the	  DEVD	  cleavage	  site	  with	   the	   centre	   residues	   instead	   encoding	   WEHD.	   These	   primers	   were	   used	   to	  amplify	   the	   FRET	   cassette	   and	   vector	   via	   PCR,	   then	   the	   template	   was	   degraded	  with	  methylated	  DNA	  specific	  restriction	  enzyme	  Dpn1.	  Success	  of	  the	  site	  directed	  mutagenesis	   was	   confirmed	   by	   sequencing.	   An	   additional	   mutant,	   encoding	   the	  caspase-­‐1	  cleavage	  site	  present	  on	  IL-­‐1β,	  YVHD,	  was	  also	  generated.	  	  	  In	   order	   to	   develop	   a	   caspase-­‐1	   FRET	   reporter	   an	   appropriate	   cell	   model	   was	  required.	  Only	  specific	  cell	  types	  are	  responsible	  for	  IL-­‐1β	  processing	  and	  release	  
in	   vivo;	   as	   mentioned	   these	   are	   mainly	   monocytes	   and	   macrophages	   (Dinarello	  1996).	  A	  model	  of	  IL-­‐1β	  processing	  must	  therefore	  be	  as	  close	  to	  these	  cell	  types	  as	  possible	  but	  remain	  amenable	  to	  cell	  culture	  techniques.	  The	  ultimate	  aim	  was	  to	  develop	  this	   into	  an	   in	  vivo	  model,	  but	   in	  vitro	   testing	  was	  required	  as	  a	  proof	  of	  concept	   in	   order	   to	   determine	   whether	   the	   FRET	   reporter	   was	   responsive	   to	  inflammasome	  activation.	  Initially,	  mouse	  RAW264.7	  macrophage	  cells	  were	  used	  as	  a	  model	  of	   inflammasome	  activation,	   these	   cells	   are	  amenable	   to	   transfection,	  but	   retain	   a	  macrophage	   like	   phenotype.	   Shortly	   after	   commencing	   this	   work	   it	  was	  shown	  by	  Pelegrin	  et	  al.	  (2008)	  that	  RAW264.7	  cells	  lack	  the	  ASC	  protein	  and	  are	   unable	   to	   process	   IL-­‐1β,	   so	   were	   unsuitable	   for	   testing	   our	   inflammasome	  reporter.	   Instead,	   the	   human	  monocyte	   cell	   line	  THP-­‐1	  was	   chosen,	   having	   been	  previously	   characterised	   for	   IL-­‐1β	   release	   by	   caspase-­‐1	   inhibitor	   AC-­‐YVAD-­‐CMK	  (YVAD)	  (MacKenzie	  et	  al.	  2001).	  These	  cells	  are	  difficult	  to	  transfect	  and	  a	  number	  of	   transfection	   techniques	   were	   attempted.	   Nucleofection	   (Amaxa)	   proved	   the	  most	   efficient	   method	   of	   transfecting	   THP-­‐1	   cells,	   mirroring	   published	   data	  (Martinet	  et	  al.	  2003),	  however	  the	  maximum	  transfection	  efficiency	  achieved	  was	  5%,	   as	   opposed	   to	   the	   80%	   described.	   It	   was	   found	   that	   transfection	   efficiency	  decreased	  substantially	  as	  a	  function	  of	  passage	  number.	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5.4.2	  FRET	  YVHD	  is	  unable	  to	  detect	  caspase-­‐1	  activation	  in	  transfected	  THP-­‐1	  cells	  in	  
vitro.	  	   It	  was	  confirmed	  that	  FRET	  YVHD	  was	  insensitive	  to	  cleavage	  by	  caspase-­‐3	  using	  the	  previously	  described	  assay	  (Figure	  5.13).	  To	  test	   investigate	  caspase-­‐1	  mediated	  cleavage	  of	  FRET	  YVHD,	  THP-­‐1	  cells	  were	  transfected	   with	   the	   FRET-­‐YVHD	   reporter	   construct	   and	   treated	   with	   PMA	   to	  differentiate	   them	   into	  a	  more	  macrophage	   like,	   adherent	  phenotype,	   responsive	  to	   IL-­‐1	   secretion	   and	   amenable	   to	   imaging.	   The	   cells	   were	   primed	  with	   LPS	   48	  hours	   after	   transfection	   for	   3	   hours	   then	   imaged.	   Cells	   were	   stimulated	   with	  BzATP	   at	   the	   beginning	   of	   image	   acquisition	   in	   order	   to	   activate	   caspase-­‐1	   via	  P2X7	   receptor	   activation.	   The	   cells	   were	   imaged	   for	   20	   minutes	   post	   ATP	  stimulation	  with	  images	  taken	  every	  30	  seconds.	  6	  fields	  of	  view	  were	  imaged	  per	  treatment.	   As	   VolocityTM	   was	   not	   able	   to	   keep	   track	   of	   the	   same	   cells	   over	   the	  timecourse,	   cells	   were	   annotated	   manually	   for	   each	   field	   of	   view	   and	   tracked	  across	  multiple	  time	  points.	  An	  nF/donor	  channel	  was	  generated	  for	  each	  field	  of	  view	  and	  these	  data	  were	  averaged	  per	  field	  of	  view.	  Bleaching	   is	   a	   confounding	   issue	  with	   this	   experiment	   as	   generation	   of	   a	  FRET	  channel	  requires	  taking	  3	  imaged	  for	  each	  frame,	  the	  FRET	  signal	  decreases	  very	  strongly	  for	  all	  channels	  as	  a	  result	  of	  bleaching,	  which	  nF/Donor	  was	  unable	  to	  compensate	  for.	  The	   FRET	   YVHD	   signal	   appeared	   to	   decrease	   significantly	   faster	   than	   in	   the	  controls,	  with	   the	  AC-­‐YVAD-­‐CMK	   treated	   FRET	  YVHD	   signal	   decreasing	   at	   a	   rate	  somewhere	   between	   this	   and	   the	   DEVD	   non	   caspase-­‐1	   cleavable	   control.	   To	   be	  sure	   that	   this	   is	   a	   result	   of	   the	   caspase-­‐1	   cleavage	   the	   experiment	   was	   further	  refined.	  Fluorescent	  exposure	  was	  reduced	  by	  increasing	  the	  time	  between	  image	  acquisition	   to	  2.5	  minutes	   (Figure	  5.15)	  and	  10	  minutes	   (Figure	  5.16).	  Bleaching	  was	   still	   a	   significant	   problem	  at	   2.5	  minutes,	   but	   as	   before,	   nF	   /Donor	   in	   FRET	  YVHD	   decreased	   faster	   than	   in	   other	   treatments,	   implying	   that	   this	   difference	  could	   again	   be	   due	   to	   the	   action	   of	   caspase-­‐1.	   This	   was	   not	   detected	   using	   10	  minute	  intervals	  between	  exposures	  where	  no	  change	  was	  measured.	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Figure	   5.13.	   DEVD	   YVHD	   is	   not	   sensitive	   to	   caspase-­‐3	   activation	   by	  
overexpression	  of	  BAX.	  HEK293T	  cells	  cotransfected	  with	  DEVD	  or	  YVHD	  FRET	  reporter	  plasmids	  and	  BAX	  only	  show	  a	  decrease	  in	  nF	  in	  the	  DEVD	  reporter	  with	  no	  change	  in	  the	  nf	  signal	  from	  the	  YVHD	  reporter	  plasmid.	  Data	  are	  mean	  ±	  SEM	  for	   n=3,	   3-­‐4	   samples	   per	   experiment.	   Statistics:	   One	   way	   ANOVA	   followed	   by	  Boneferroni	  post	  test,	  threshold	  correction	  applied.	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Figure	   5.14.	   Differentiated	   and	   primed	   THP-­‐1	   monocytes	   show	   a	   faster	  
decrease	  in	  nF	  signal	  in	  the	  FRET	  YVHD	  reporter	  when	  stimulated	  with	  ATP.	  THP-­‐1	   monocytes,	   transfected	   with	   DEVD	   or	   YVHD	   reporter	   plasmids	   show	   a	  decrease	   in	   nF	   signal	   due	   to	   overexposure	   and	   photobleaching,	   loss	   of	   FRET	   is	  uninhibited.	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Figure	   5.15	   Differentiated	   and	   primed	   THP-­‐1	   monocytes	   show	   a	   faster	  
decrease	  in	  nF	  signal	  in	  the	  FRET	  YVHD	  reporter	  when	  stimulated	  with	  ATP.	  THP-­‐1	   monocytes,	   transfected	   with	   DEVD	   or	   YVHD	   reporter	   plasmids	   show	   a	  decrease	   in	   nF	   signal	   due	   to	   overexposure	   and	   photobleaching,	   loss	   of	   FRET	   is	  uninhibited	  by	  caspase-­‐1	  inhibitor	  AC-­‐YVAD-­‐CMK	  (YVAD)	  however,	  nF	  signal	  from	  Untreated	   YVHD	   declines	   at	   a	   faster	   rate,	   possibly	   indicating	   inflammasome	  activation.	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Figure	   5.16.	   Differentiated	   and	   primed	   THP-­‐1	   monocytes	   show	   no	   change	  
between	   caspase-­‐3	   and	   caspase-­‐1	   reporters	   when	   imaged	   at	   10	   minute	  
intervals.	   THP-­‐1	  monocytes,	   transfected	  with	  DEVD	  or	   YVHD	   reporter	   plasmids	  show	  no	  change	  in	  nF	  signal	  over	  20	  minutes	  of	  stimulation	  with	  BzATP.	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5.5	  Discussion	  	  
5.5.1	  FRET	  calculation	  methodology.	  The	   hardware	   available	   for	   the	   experimental	   measurement	   of	   FRET	   has	  expanded	   over	   time,	   and	   Xia	   and	   Liu	   (2001)	   have	   described	   the	   use	   of	   three	  different	   acquisition	   systems	   for	   experimental	   use;	   a	   spectrofluorometer,	   a	  widefield	   fluorescence	   microscope	   and	   confocal	   microscopy.	   Microscopy	   was	  described	  as	  more	  effective	  for	  live	  cell	  imaging	  due	  to	  the	  ability	  to	  spatially	  and	  temporally	  define	  FRET	  signals	  with	  a	  greater	  level	  of	  accuracy	  at	  the	  microscopic	  level.	   This	   study	   also	   used	   similar	   light	   microscopy	   techniques	   because	   of	   the	  emphasis	  on	  using	  FRET	  techniques	  at	  the	  cellular	  level.	  However,	  because	  of	  the	  hardware	   limitation,	   the	   software	   available	   for	   processing	   was	   limited	   to	  Volocity™.	  Although	  other	  methodologies	  for	  calculating	  FRET	  exist,	  the	  four	  FRET	  measurements	   presented	   here	   are	   the	   only	   methods	   available	   in	   Volocity™,	   as	  although	  other	  software	  examples,	  such	  as	  PixFRET	  (Feige	  et	  al.	  2005),	  exist,	   the	  necessity	   of	   high	   throughput	   for	   processing	   inflammatory	   timelapse	  microscopy	  required	  the	  use	  of	  Volocity™.	  Although	  described	  methods	  for	  normalising	  FRET	  (G.	  Gordon	  et	  al.	  1998;	  Z.	  Xia	  &	  Y.	  Liu	  2001)	  require	  correction	  for	  the	  concentration	  of	  both	  fluorophores,	  in	  this	  example	  it	  was	  not	  necessary.	  The	  FRET	  cleavage	  reporter	  is	  a	  fusion	  protein	  expressing	  CFP	  and	  YFP	  in	  a	  1:1	  ratio,	  therefore	  the	  concentration	  of	  CFP-­‐YFP	  will	  be	   the	   same.	   However,	   some	   form	   of	   normalisation	   was	   still	   required	   as	   in	  transfected	  cells,	  there	  was	  a	  range	  of	  intensities	  resulting	  from	  the	  transfection	  in	  both	  HEK293T	  cell	  lines	  and	  monocyte	  cell	  lines.	  Although	  from	  the	  experimental	  data,	   it	   was	   clear	   that	   FRETN	   (G.	   Gordon	   et	   al.	   1998)was	   the	   least	   accurate	  methodology	  for	  normalisation.	  	  
5.5.2	  In	  vivo	  FRET	  as	  a	  reporter	  of	  apoptosis	  Normalisation	  was	  less	  of	  an	  issue	  in	  in	  vivo	  zebrafish	  images,	  as	  there	  was	  less	  difference	  in	  intensity	  between	  cells,	  however,	  when	  imaging	  across	  a	  number	  of	  planes,	  error	  could	  still	  be	  introduced	  in	  objects	  appearing	  less	  bright	  if	  falling	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outside	  a	   focal	  plane.	  For	  this	  reason,	  normalisation	  may	  still	  be	  required.	   In	  this	  study,	  in	  vivo	  images	  of	  nF	  were	  expressed	  relative	  to	  their	  acceptor	  fluorescence,	  with	  nF	  shown	  over	  the	  acceptor	  signal.	  Showing	  the	  data	  this	  way	  demonstrates	  that	  the	  FRET	  signal	  is	  lost	  before	  the	  cell	  undergoes	  apoptosis	  as	  the	  YFP	  signal;	  and	  in	  the	  nitroreductase	  example,	  mCherry;	  persists	  after	  the	   loss	  of	  FRET.	  This	  gives	  a	  qualitative	  on/off	  FRET	  signal	  for	  each	  cell,	  which	  can	  be	  quantified	  across	  an	  organism	  by	  considering	  the	  number	  of	  cells	  undergoing	  apoptosis,	  but	  would	  be	  inappropriate	  if	  the	  magnitude	  of	  FRET	  in	  each	  cell	  was	  to	  be	  considered.	  In	  this	  situation,	  normalisation	  by	  nF/Donor	  would	  be	  necessary.	  A	   further	   issue	  with	   the	   in	  vivo	   study	   is	   the	   use	   of	  widefield	  microscopy;	  cells	   falling	  outside	   focal	  planes	  suffer	  optical	  distortion	  and	  appear	  out	  of	   focus,	  which	   makes	   identification	   of	   cells	   difficult.	   Removal	   of	   this	   signal	   would	   be	  possible	  using	  deconvolution,	  a	  function	  present	  in	  the	  Volocity	  software	  package,	  but	  would	  require	  generating	  CFP	  and	  YFP	  beads	  in	  order	  to	  reliably	  measure	  an	  accurate	  Point	   Spread	  Function	   (PSF),	   and	  while	   it	   is	   possible	   to	   calculate	   a	  PSF	  based	   on	   wavelength	   and	   numerical	   aperture,	   this	   results	   in	   a	   less	   accurate	  deconvolution.	  	  As	  shown,	  the	  noise	  of	  a	  system	  has	  a	  large	  impact	  on	  the	  FRET	  signal	  and	  can	   easily	   affect	   the	   experimental	   output.	   It	   was	   unclear	   which	   method	   of	  background	   correction	   was	   most	   accurate	   with	   both	   background	   and	   threshold	  corrections	   yielding	   similar	   results	   with	   respect	   to	   loss	   of	   FRET	   following	   BAX	  transfection,	  however	  both	  demonstrated	  the	  necessity	  of	  a	  correction,	  confirmed	  by	  the	  high	  nF	  background	  signal	  present	   in	  BAX	  treated	  cells.	  Thresholding	  was	  preferentially	   used	   in	   this	   study	   due	   to	   its	   effects	   across	   a	   larger	   number	   of	  normalisation	   methods	   and	   its	   ability	   to	   correct	   both	   FRETN	   and	   NFRET,	  encouraging	   its	   use	   for	   any	   further	   FRET	   experiments	   which	   may	   require	  normalisation	   for	  differing	   fluorophore	  concentrations	  rather	  than	  using	  a	   fusion	  protein,	  though	  this	  may	  not	  be	  appropriate	  for	  in	  vivo	  experiments.	  
In	   vivo	   FRET	   in	   zebrafish,	   may	   introduce	   additional	   challenges	   for	  correcting	   distortion	   and	   background	   signal	   insurmountable	   by	   these	   methods.	  Imaging	  live	  zebrafish	  relies	  on	  visualizing	  cells	  throughout	  the	  embryo,	  a	  system	  with	   changing	   thicknesses	   and	   densities	   throughout	   the	   specimen.	   Due	   to	   their	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migratory	   and	   patrolling	   role,	   neutrophils	   and	  macrophages	   are	   not	   localized	   to	  any	  particular	  site	   in	  the	  fish	  and	  can	  be	  present	   in	  any	  of	   the	  tissues	  at	  a	  site	  of	  interest	   such	   as	   an	   injury.	   Their	   spread	   throughout	   a	   large	   cross	   section	   of	   the	  embryonic	  tissue	  leads	  to	  a	  large	  amount	  of	  optical	  distortion	  due	  to	  the	  difference	  in	  lightpaths	  through	  varying	  thicknesses	  of	  tissue	  resulting	  in	  large	  variations	  in	  the	  signal	  noise	  ratio	  and	  distortion	  for	  cells	  depending	  on	  their	  location	  within	  the	  fish.	   However,	   with	   Volocity™,	   it	   may	   be	   possible	   to	   generate	   a	   background	  correction	  to	  more	  easily	  account	  for	  the	  different	  background	  rather	  than	  relying	  on	  background	  correction	  built	   into	  the	  FRET	  applications.	  Quantitative	  data	  was	  successfully	   obtained	   in	   this	   study	   because	   visualisation	   was	   limited	   to	   a	   small	  area;	  however,	  this	  also	  greatly	  limited	  the	  number	  of	  apoptotic	  events	  visualised.	  To	  increase	  the	  data	  gathering	  ability	  of	  the	  acquisition,	  more	  image	  correction	  is	  necessary.	   Foremost,	   the	   introduction	   of	   deconvolution	   or	   image	   acquisition	  reducing	  the	  unfocused	  signal,	  such	  as	  confocal	  microcopy,	  would	  be	  preferential,	  however	   corrections	   for	   removal	   of	   background	   must	   also	   be	   considered.	   This	  could	  be	  done	  in	  two	  possible	  ways;	  a	  background	  correction	  could	  be	  generated	  from	  wildtype	   embryos.	   Embryos	  would	   be	  mounted	   in	   as	   similar	   a	   position	   as	  possible	  and	  an	  image	  would	  be	  taken	  in	  the	  relevant	  fluorescent	  channels	  at	  the	  same	  exposure	  and	  gain	  settings	  as	   for	   the	  transgenic	  embryos.	  This	  background	  image	  could	  then	  be	  subtracted	  from	  each	  image	  acquired	  in	  the	  transgenic	  fish	  to	  create	   an	   image	   with	   no	   background	   signal.	   The	   major,	   and	   possibly	  insurmountable	   problem	   is	   the	   difficulty	   in	   finding	   fish	   of	   the	   same	   age	   and	  mounting	   them	   in	   exactly	   the	   same	   position,	   though	   at	   lower	   resolutions	   this	  would	  be	  possible.	  An	  alternative	  approach	  would	  be	  to	  use	  the	  first	  image	  in	  the	  sequence	  as	  the	   background	   correction;	   this	   approach	   has	   the	   virtue	   of	   being	   in	   exactly	   the	  same	   fish	   embryo	   and	   having	   the	   same	   fluorescent	   background	   as	   every	   other	  frame	  in	  the	  acquisition,	  however,	  with	  the	  downside	  that	  the	  initial	  frame	  of	  the	  video	  will	   be	   lost,	   and	   that	   any	   cells	   that	   remain	   immotile	  will	   also	  be	   removed,	  furthermore,	   as	   the	   health	   of	   the	   embryo	   changes,	   or	   regeneration	   at	   the	   site	   of	  injury	  begins,	  this	  correction	  would	  lose	  effectiveness.	  	  It	   may	   be	   possible	   to	   remove	   the	   requirement	   for	   as	   much	   background	  correction	  by	  altering	  the	  fluorescent	  properties	  of	  the	  donor.	  As	  described,	  one	  of	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the	  main	   issues	  with	   the	   initial	  pre-­‐correction	  nF	  channel,	  was	   the	  relatively	   low	  intensity	   of	   the	   CFP	   fluorophore.	   If	   this	   could	   be	   replaced	   with	   a	   more	   intense	  fluorophore,	  such	  as	  mTurquoise,	  then	  it	  would	  be	  advantageous	  to	  imaging	  FRET	  (Goedhart	  et	  al.	  2010).	  If	   the	   issues	   surrounding	   optical	   distortion	   and	   autofluorescence	   in	   live	  samples	  can	  be	  resolved,	   then	  FRET	  could	  prove	  a	  very	  powerful	   tool	   to	  provide	  temporal	  resolution	  to	   in	  vivo	   studies	  where	  the	  advantage	  of	  FRET	  as	  an	  almost	  instantaneous	   reporter	   will	   be	   most	   apparent.	   The	   sensitivity	   of	   FRET	   to	  fluorophore	   separation	   distance	   presents	   rapidly	   in	   the	   intensity	   of	   the	   FRET	  signal,	   and	   at	   higher	   resolutions	   it	   may	   be	   possible	   for	   in	   vivo	   experiments	   to	  provide	  subcellular	  spatial	  resolution.	  However,	  the	  imaging	  demands	  of	  FRET	  can	  have	  deleterious	  consequences	  on	  acquired	  data.	  The	  requirement	  for	  3	  separate	  channels	  for	  each	  FRET	  image	  exposes	  specimens	  to	  a	  large	  amount	  of	  energy	  and	  results	  in	  accelerated	  bleaching,	  therefore	  care	  must	  be	  taken	  to	  reduce	  the	  effect	  of	  overexposure	  on	  samples	  wherever	  possible.	  	  
5.5.3	  FRET	  YVHD	  as	  a	  reporter	  of	  inflammasome	  activation.	  A	   major	   problem	   with	   the	   FRET	   approach	   to	   measuring	   inflammasome	  activation	   is	   exposure	   and	   intensity	   of	   the	   light	   used	   in	   acquiring	   the	   images.	  Ferrari	  et	  al.	  (1997)	  show	  that	  up	  to	  80%	  of	  the	  intracellular	  IL-­‐1β	  in	  macrophages	  remains	   uncleaved,	  with	   the	   implication	   that	   the	   scope	   of	   action	   of	   caspase-­‐1	   is	  therefore	   limited	   within	   the	   cell.	   As	   a	   cleavage	   based	   reporter	   of	   caspase-­‐1	  activation	   would	   compete	   with	   native	   IL-­‐1β	   for	   the	   active	   site	   of	   caspase-­‐1,	   we	  would	  expect	  an	  even	  smaller	  percentage	  of	  the	  reporter	  to	  be	  cleaved.	  The	  loss	  of	  FRET	  signal	  from	  such	  cleavage	  events	  may	  be	  very	  low	  and	  technically	  difficult	  to	  isolate	  from	  the	  noise	  of	  the	  system.	  It	  would	  be	  expected	  that	  the	  resulting	  loss	  of	  FRET	   signal	   resulting	   from	   caspase-­‐1	   activation	   would	   be	   smaller	   than	   the	   loss	  resulting	  from	  caspase-­‐3	  mediated	  cleavage	  of	  FRET	  DEVD.	  Nevertheless,	  efforts	  to	  detect	  this	  change	  were	  hampered	  by	  the	  difficulty	  in	  transfecting	  cells	  capable	  of	  activating	   caspase-­‐1	   and	  mediating	   the	  processing	  of	   IL-­‐1β.	   If	   this	   obstacle	  were	  overcome,	  characterising	  a	  FRET	  YVHD	  reporter	  would	  be	  possible.	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With	   the	  publication	  of	  recent	  data	  supporting	  a	  similar	  role	   for	  zebrafish	  caspase-­‐A	  to	  human	  caspase-­‐1	  in	  the	  processing	  of	  IL-­‐1β	  (Vojtech	  et	  al.	  2012),	  and	  my	   generation	   of	   Tg(MPEG1:Gal4.VP16)	   it	   may	   be	   possible	   to	   circumvent	   the	  requirement	   for	   transfectable	   macrophages	   by	   expressing	   the	   construct	   in	   a	  zebrafish	  line.	  The	  development	  of	  a	  real	  time	  inflammasome	  reporter	  remains	  an	  important	  goal	  for	  the	  study	  of	  IL-­‐1β	  processing	  and	  release	  and	  would	  be	  an	  ideal	  tool	  for	  the	  study	  of	  IL-­‐1β	  biology.	  Regardless	  of	  this,	  I	  have	  shown	  here	  the	  characterisation	  of	  an	  in	  vivo,	  real	  time	   caspase-­‐3	   reporter	   in	   zebrafish,	   a	   tool	   which	   could	   be	   important	   for	   the	  temporal	   quantification	   of	   inflammation	   resolution	   in	   neutrophils	   and	   the	  application	   of	   this	   reporter	   for	   anti-­‐inflammatory	   drug	   discovery.	   This	   also	  provides	   an	   important	   proof	   of	   principle	   for	   an	   in	   vivo	   caspase-­‐1	   reporter	   as	   a	  model	  of	  IL-­‐1β	  processing.	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Chapter	  6:	  in	  vivo	  release	  of	  IL-­‐1β	  
6.1	  Introduction	  	   The	   release	   mechanism	   of	   IL-­‐1β	   from	   mammalian	   cells	   is	   a	   poorly	  understood	  and	  there	  have	  been	  a	  number	  of	  pathways	  proposed	  for	  its	  secretion.	  IL-­‐1β	  is	  a	  leaderless	  protein	  that	  does	  not	  follow	  the	  traditional	  Golgi-­‐Endoplasmic	  reticulum	   release	   process	   and	   so	   is	   secreted	   from	   cells	   using	   other	   non-­‐conventional	   pathways.	   Andrei	   et	   al	   (1999,	   2004)	   have	   shown	   that	   IL-­‐1β	   is	  released	   via	   endolysosomal	   related	   organelles	   from	   monocytes,	   whereas	   IL-­‐1β	  release	  via	  membrane	  derived	  microvesicles	  has	  been	   show	  by	  MacKenzie	   et	   al.,	  (2001)	   from	  THP-­‐1	  monocytes,	   Bianco	   et	   al.	   (2005)	   in	  microglia,	   Pizzirani	   et	   al.,	  (2007)	  in	  dendritic	  cells	  and	  Qu	  et	  al.	  (2009)	  in	  murine	  macrophages.	  Qu	  et	  al	  have	  also	   shown	   the	   release	   of	   IL-­‐1β	   from	   via	   smaller	   exosome	   derived	   vesicles	   in	  murine	  macrophages	  (Qu	  et	  al.	  2007;	  Qu	  et	  al.	  2009).	  	  	   The	  proposed	   release	  pathways	   for	   IL-­‐1β	  differ	   according	   to	   the	   cell	   type	  used	  in	  each	  study	  and	  the	  stimuli	  used.	  However,	  none	  of	  these	  studies	  have	  been	  performed	  in	  vivo,	  and	  the	  situation	  in	  a	  living	  system	  may	  be	  different.	  An	  in	  vitro	  methodology	  may	  lead	  to	  an	  incomplete	  understanding	  of	  microvesicle	  biology	  due	  to	   the	   innate	   differences	   these	   systems	   have	   with	   in	   vivo	  models.	   Monocytes,	  macrophage	  and	  related	  cells	  such	  as	  microglia	  exist	  as	  a	  single	  cell	  monolayer	  in	  
in	  vitro	  studies,	  whereas	  in	  vivo	  macrophages	  are	  present	  within	  a	  milieu	  of	  living	  tissue	  and	  as	   such	  we	  can	  expect	   that	   the	  behaviour	  of	   in	  vivo	  microvesicles	  will	  more	  accurately	  represent	  the	  biological	  situation.	  The	  development	  of	  an	   in	  vivo	  model	  of	  IL-­‐1β	  release	  will	  therefore	  provide	  a	  powerful	  tool	  for	  the	  study	  of	  IL-­‐1β	  biology	  and	  provide	  further	  insights	  into	  its	  poorly	  understood	  release	  mechanism,	  as	  well	  as	  allow	  the	  investigation	  of	  vesicle	  targeting	  to	  IL-­‐1β	  sensitive	  cells.	  	   In	   a	   number	   of	   these	   studies,	  mice	   have	   been	   shown	   to	   share	   significant	  homology	   in	   IL-­‐1β	   release	   with	   humans,	   however	   visualizing	   microvesicles	   in	  living	  mouse	  tissue	  would	  be	  nearly	  impossible	  with	  current	  techniques	  due	  to	  the	  lack	   of	   contrast	   and	   resolution.	   However,	   the	   advantages	   of	   the	   zebrafish	   as	   a	  transgenic	   model	   described	   earlier,	   especially	   its	   optical	   transparency,	   make	   it	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ideal	   for	   this	   study.	  The	  ease	  of	  visualizing	   specific	   cell	  populations	   in	  vivo	   using	  fluorescent	  markers	  allows	  the	  targeting	  of	  specific	  cells	  with	  a	  reporter	  of	   IL-­‐1β	  release.	  	   In	  order	   to	  visualise	   the	  release	  of	   IL-­‐1β	   in	  vivo,	   a	   reporter	  would	  have	   to	  mimic	  the	  structure	  and	  sequence	  of	  IL-­‐1β	  to	  interact	  with	  the	  release	  pathway.	  As	  it	  is	  unclear	  which	  part	  of	  IL-­‐1β,	  a	  cytokine	  with	  no	  leader	  sequence,	  is	  responsible	  for	   its	   release,	   and	   also	   what	   mechanism	   the	   release	   pathway	   takes,	   it	   is	   not	  possible	   to	   generate	   an	   artificial	   version	   of	   the	   sequence	   or	   epitope	   to	   use	   as	   a	  reporter.	   Therefore,	   the	   remaining	   option	   is	   to	   fluorescently	   label	   a	   coding	  sequence	   for	   IL-­‐1β	   itself	   in	   order	   to	   create	   a	   fusion	   protein.	   Expression	   of	   this	  reporter	   on	   cells	   capable	   of	   releasing	   IL-­‐1β	  will	   allow	   the	   visualisation	   of	   IL-­‐1β	  release	  via	  tracking	  the	  behaviour	  of	  the	  fusion	  protein.	  Mammalian	  IL-­‐1β	  contains	  an	   N-­‐terminal	   pro-­‐domain;	   therefore	   a	   fluorescent	   label	   of	   bioactive	   IL-­‐1β	   is	  required	   to	   be	   on	   the	  N-­‐terminus.	   There	   is	   also	   a	   possibility	   that	   the	   size	   of	   the	  fluorophore,	   which	   nearly	   doubles	   the	   size	   of	   the	   fusion	   protein,	   may	   interfere	  with	   export	   and	   the	   release	   of	   the	   protein,	   However,	   IL-­‐1β	   containing	   vesicles	  retain	   caspase-­‐1	   activity	   and	   have	   been	   shown	   to	   contain	   inflammasome	  components	  (MacKenzie	  et	  al.	  2001),	  as	  well	  as	  pro-­‐IL-­‐1β	  implying	  that	  the	  size	  of	  these	   vesicles	   is	   already	   large	   enough	   to	   contain	   a	   number	   of	   proteins,	   so	   the	  possibility	  of	  the	  fluorophore	  interacting	  negatively	  with	  the	  secretion	  machinery	  is	  small.	  
6.2	  Results	  
6.2.1	  IL-­‐1β	  release	  from	  differentiated	  THP-­‐1	  monocytes	  	   To	  test	  whether	  a	  EGFP	  tag	  interfered	  with	  the	  secretion	  of	  IL-­‐1β,	  an	  IL-­‐1β-­‐EGFP	   construct	   a	   kind	   gift	   of	   David	   Brough	   (University	   of	   Manchester),	   was	  transfected	   into	   THP-­‐1	   monocytes,	   which	   were	   then	   differentiated	   with	   the	  addition	   of	   phorbol	   12-­‐myristate	   13-­‐acetate	   (PMA)	   (Grahames	   &	   Michel	   1999).	  The	  cells	  were	  primed	  with	  LPS	  and	  stimulated	  with	  BzATP.	  The	  release	  of	   large	  vesicles	  was	  seen	  following	  BzATP	  stimulation	  (Figure	  6.1),	  however	  this	  was	  only	  visible	  on	  overexposed	  cells	  with	  very	  strong	  expression	  of	  the	  plasmid.	  However,	  no	  signal	  was	  seen	  outside	  cells	  with	  a	  lower	  level	  of	  expression	  even	  though	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Figure	  6.1.	  IL-­‐1β.EGFP	  does	  not	  appear	  to	  interfere	  with	  secretion	  machinery	  
in	   differentiated	   THP-­‐1	   monocytes.	   THP-­‐1	  monocytes	   transfected	  with	   an	   IL-­‐1β.EGFP	  fusion	  protein	  encoding	  plasmid	  differentiated	  with	  PMA	  and	  primed	  for	  3	  hours	  with	  LPS	  release	  microvesicles	  containing	   the	   IL-­‐1β	   fusion	  protein	  when	  stimulated	  with	  500	  nM	  BzATP.	  Time	  is	  mm:ss	  from	  start	  of	  imaging,	  scale	  bar	  =	  32	  
µm	  	  blebbing	  was	  apparent,	  which	  was	  likely	  due	  to	  the	  low	  EGFP	  signal	  in	  any	  vesicles	  released	  falling	  below	  the	  detection	  threshold	  during	  imaging.	  
	  
6.2.2	  The	  Tol2kit	  and	  Gateway™	  cloning	  	   In	   this	   study	   the	   primary	   mode	   of	   vector	   construction	   was	   the	   Tol2Kit	  (Kwan	   et	   al.	   2007),	   itself	   	   based	   on	   the	   Gateway™	   recombination	   system	  (Invitrogen)	   (Hartley	   et	   al.	   2000).	   The	   Gateway™	   process	   is	   based	   on	   two	  recombination	   steps,	   a	  BP	   reaction,	   recombining	  AttB	  and	  AttP	   sites;	   and	   the	  LR	  reaction,	   recombining	   AttL	   and	   AttR	   sites	   using	   the	   BP	   and	   LR	   clonase	  recombinase	   enzymes	   respectively.	   This	   is	   a	   very	   powerful	   tool	   for	   generating	  expression	  plasmids	   as	   it	   allows	   a	   single	   clone	   to	  be	  modularly	   constructed	   into	  vectors	   with	   a	   variety	   of	   promoters,	   tags	   and	   reporters.	   The	   empty	   Gateway™	  vectors,	   donor	   plasmids	   and	   destination	   vectors,	   code	   for	   a	   ccdb	   suicide	   gene	  between	   the	   att	   recombination	   sites,	   so	   are	   unable	   to	   propagate	   in	   normal	  competent	   cells	   (Bernard	   &	   Couturier	   1992)(Figure	   6.2	   A).	   Once	   recombination	  occurs,	   the	   gene	   is	   removed	   allowing	   for	   growth	   of	   transformed	   colonies.	  Furthermore,	  donor	  and	  destination	  vectors	  encode	  different	  antibiotic	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Figure	   6.2.	   Using	   Invitrogen’s	   Gateway™	   recombination	   system	   to	   generate	  
expression	   constructs.	   The	   Gateway™	   recombination	   system	   allows	   expression	  systems	  to	  be	  constructed	  from	  two	  simple	  recombination	  reactions.	  A.	  A	  gene	  of	  interest	   is	   amplified	   with	   recombination	   site	   containing	   PCR	   primers	   and	  recombined	  with	   a	   donor	   vector,	   generating	   an	   entry	   clone.	   B.	   5’,	  middle	   and	   3’	  entry	   clones	   are	   combined	   with	   a	   destination	   vector	   to	   generate	   an	   expression	  vector.	   C.	   Kwan	   et	   al	   (2007)	   have	   generated	   destination	   vectors	   for	   easy	  expression	   in	   zebrafish	   by	   adding	   Tol2	   transposable	   elements	   and	   transgenic	  markers.	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resistances,	   ensuring	   that	   during	   LR	   recombination	   only	   recombined	   expression	  vectors	  will	  grow	  on	  appropriate	  selection	  medium	  (Figure	  6.2	  B).	  Kwan	  et	  al.	  (2007)	  used	  this	  system	  to	  generate	  a	  molecular	  biology	  toolkit	  for	   the	   easy	   assembly	   of	   zebrafish	   expression	   vectors	   by	   inserting	   Tol2	  transposable	  elements	  on	  either	  side	  of	  the	  AttL	  recombination	  sites	  of	  the	  attR4-­‐R3	  destination	  vector	  to	  enable	  easy	  transposition	  of	  this	  vector	  into	  the	  zebrafish	  genome.	  Further	   improvements	  were	  made	   to	   this	  vector	  with	   the	   inclusion	  of	  a	  transgenic	  marker,	  allowing	  easy	  identification	  of	  embryos	  with	  transgenes	  by	  the	  presence	  of	  EGFP	  expressed	  under	  a	  cmlc2	  promoter	  in	  the	  heart,	  which	  is	  clearly	  visible	  by	  30	  hpf.	  (Figure	  6.2	  C)	  	   Alongside	  these	  destination	  vectors	  is	  the	  inclusion	  of	  a	  number	  of	  modified	  entry	   clones	   to	   allow	   fluorescent	   labelling	   of	   proteins	   of	   interest	   and	   variable	  strategies	  for	  expression,	  such	  as	  tissue	  specific	  or	  whole	  organism.	  	  
6.2.3	  IL-­‐1β	  strain	  variation.	  Using	   primers	   complementary	   to	   the	   deposited	   zebrafish	   IL-­‐1β	   sequence	  (NM_212844.1),	   the	   coding	   sequence	   for	   zfIL-­‐1β	   was	   amplified	   from	   48	   h	   WIK	  embryos,	  then	  TOPO	  cloned	  and	  sequenced.	  Two	  different	  sequence	  variants	  were	  discovered	   in	   the	   WIK	   strain,	   however	   it	   was	   unclear	   whether	   these	   were	  attributable	  to	  PCR	  error	  or	  strain	  variation.	  These	  sequences	  were	  translated	  and	  aligned	   (Figure	   6.3)	   to	   determine	   where	   the	   differences	   lie.	   There	   were	   five	  instances	  there	  the	  amino	  acid	  sequence	  was	  altered	  between	  the	  two	  sequences,	  so	   the	   structural	   data	   described	   previously	   in	   chapter	   3	  was	   used	   to	   determine	  where	  these	  polymorphisms	  lay	  (Figure	  6.3).	  None	  of	  the	  polymorphisms	  affected	  residues	   that	   were	   directly	   conserved	   between	   human	   and	   zebrafish	   IL-­‐1β,	   but	  some	  did	  overlap	  with	   regions	  of	   secondary	  structure.	  To	   further	   investigate	   the	  source	   of	   the	  polymorphisms,	   the	   two	   alleles	  were	   aligned	   to	   available	   database	  zfIL-­‐1β	   sequences	   (Figure	   6.4).	   There	   was	   only	   one	   instance	   where	   the	  polymorphisms	  did	  not	  align	   to	  a	  deposited	  sequence,	  an	  L/R	  change	  on	  residue	  130.	  These	  differences	  were	  attributed	  to	  strain	  differences	  between	  zebrafish	   in	  Sheffield	  and	  the	  institutions	  where	  these	  sequences	  were	  initially	  cloned.	  Further	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cloning	  from	  AB	  and	  Nacre	  wildtype	  zebrafish	  strains	  only	  detected	  allele	  two.	  As	  this	  variant	  sequence	  shared	  most	  in	  common	  with	  	  
	  
Figure	  6.3.	  IL-­‐1β	  allele	  variations	  in	  Sheffield	  WIK	  wildtype	  zebrafish	  are	  in	  
non	   conserved	   residues.	   Variant	   alleles	   aligned	   and	   structurally	   annotated;	  regions	   predicted	   as	  β-­‐sheets	   using	   Phyre	   (chapter	   3)	   presented	   as	   red	   arrows,	  with	   boxes	   indicating	   conserved	   residues	   between	   Human	   and	   Zebrafish	   IL-­‐1β	  sequences	  show	  that	  allele	  variations	  are	  in	  non	  conserved	  residues	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Figure	   6.4.	   Most	   allele	   variants	   in	   Sheffield	   WIK	   IL-­‐1β 	   genotype	   are	  
conserved	  between	  deposited	  zfIL-­‐1β	  sequences.	  Zebrafish	  WIK	  allele	  variants	  (1,	  2)	  aligned	  to	  deposited	  sequences,	  ESTs	  and	  IMAGE	  clones	  for	  zebrafish	  IL-­‐1β	  (accession	  numbers	   shown)	   show	  most	  polymorphisms	  between	  WIK	  alleles	   are	  shared	  with	  at	  least	  other	  deposited	  IL-­‐1β sequence.	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deposited	  sequences	  and	  between	  strains,	  alongside	  retaining	   the	  Arg	  residue	  as	  described,	  it	  was	  chosen	  as	  the	  basis	  for	  the	  reporter	  constructs.	  
6.2.4	  Fluorescently	  tagged	  IL-­‐1β	  EGFP	  vector	  construction.	  The	  Variant	  2	  IL-­‐1β	  sequence	  was	  amplified	  with	  restriction	  site	  containing	  primers	   and	   ligated	   into	   the	   Gateway™	   pME	   MCS	   entry	   clone,	   which	   was	   then	  combined	   with	   the	   5’	   UAS,	   and	   either	   the	   3’EGFP	   or	   3’	   mCherry	   alongside	   the	  pDestTol2CG2	  destination	  vector	  to	  generate	  expression	  constructs	  for	  IL-­‐1β	  EGFP	  and	  IL-­‐1β	  mCherry	  respectively	  using	  the	  Gateway™	  recombination	  system	  (Kwan	  et	  al.	  2007)	  (Invitrogen).	  The	  constructs	  were	  injected	  into	  Tg(α-­‐Actin:Gal4)	  alongside	  tol2	  mRNA	  to	  visualise	  expression.	  Embryos	  were	  selected	  for	  EGFP	  expression	  in	  heart	  muscle	  from	  the	  cmlc2:EGFP	  transgenesis	  marker	  and	   imaged	   for	  expression	  of	  EGFP	  or	  mCherry	  in	  the	  somite	  muscle	  blocks.	  No	  fluorescent	  expression	  was	  detected	  with	  either	  pDEST(UAS	  MCS	  IL-­‐1β.EGFP)	  or	  pDEST(UAS	  IL-­‐1β.mCherry).	  The	  lack	  of	  expression	  could	  be	  due	  to	  a	  number	  of	  factors.	  Tg(α-­‐Actin:Gal4)	  is	   maintained	   as	   an	   outcross	   from	   the	   original	   line.	   With	   lack	   of	   proper	  maintenance	   and	   screening,	   these	   fish	   are	   a	  mix	   of	   wild	   type	   and	   heterozygous	  gal4	  alleles.	  Therefore,	  only	  25%	  of	  injected	  embryos	  from	  this	  this	  line	  are	  likely	  to	  have	  actin:Gal4	  expression.	  Furthermore,	  PME-­‐MCS	  only	  has	  one	  reading	  frame	  not	   containing	   a	   stop	   codon	   and	   is	   not	   fully	   characterised	   in	   the	   original	   tol2Kit	  publication	   (Kwan	   et	   al.,	   2007),	   so	   its	   possible	   that	   the	   cloned	   IL-­‐1β	   coding	  sequence	  was	   inserted	   incorrectly,	  however,	   it	  was	   later	  confirmed	   to	  be	  correct	  by	  sequencing.	  A	  final	  problem	  was	  that	  using	  the	  pME-­‐MCS	  middle	  entry	  clone	  to	  build	   a	   fusion	   protein	   introduces	   a	   large	   linker	   between	   the	   end	   of	   the	   protein	  coding	   sequence	   and	   the	   initiation	   codon	  of	   the	   fluorophore.	   For	  MCS	   IL-­‐1β	   this	  encoded	  an	  additional	  32	  amino	  acids,	  which	  increase	  the	  size	  of	  the	  IL-­‐1β	  protein	  by	  12%.	  This	  could	  result	  in	  deleterious	  effects	  on	  the	  translation	  and	  expression	  of	  the	  reporter	  protein	  and	  negatively	  affect	  its	  stability.	  	   Instead	  a	  new	  approach	  to	  generate	  the	  IL-­‐1β	  middle	  entry	  clone	  was	  used.	  The	   zfIL-­‐1β	   coding	   sequence	   was	   amplified	   with	   primers	   containing	   attB	  recombination	  sites	  and	  recombined	  with	  the	  attB1-­‐2	  donor	  vector	  (PDONR	  221)	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to	  generate	  pME-­‐zfIL-­‐1β,	  an	  IL-­‐1β	  coding	  sequence	  entry	  clone	  with	  no	  stop	  codon.	  This	   entry	   clone	   was	   used	   to	   generate	   new	   versions	   of	   the	   EGFP	   and	   mCherry	  tagged	   IL-­‐1β	   expression	   vectors	   with	   the	   same	   5’	   and	   3’	   entry	   clone	   and	  destination	   vector	   as	   described	   previously.	   When	   injected	   into	   tg(αActin:Gal4),	  clear	   mosaic	   expression	   of	   both	   EGFP	   and	   mCherry	   can	   be	   seen	   in	   the	   muscle	  tissue	  at	  48	  and	  72	  hpf	  (Figure	  6.5).	  	   I	  proceeded	  to	  test	  this	  construct	  in	  a	  macrophage	  specific	  gal4	  driver	  line.	  
pDEST(UAS:IL-­‐1β.EGFP)	   was	   injected	   into	   Tg(fms:Gal4-­‐VP16)i186;	  
Tg(UAS:nfsB.mCherry)i149	  (Gray	  et	  al.,	  2011)	  and	  the	  resulting	  embryos	  screened	  for	   heart	   marker	   expression.	   The	   resultant	   Tg(fms:Gal4-­‐
VP16)i186;Tg(UAS:nfsB.mCherry)i149	   compound	   transgenic	   expresses	   mCherry	  tagged	   nitroreductase	   in	  macrophages	   and	   a	   subset	   of	   other	   cells.	  Macrophages,	  identified	  by	  expression	  of	  mCherry,	  motility	  and	  morphology	  were	  visualised	  for	  EGFP	  expression,	  but	  none	  was	  detected.	  The	  embryos	  were	  subjected	  to	  injury	  by	  tail	  transection	  to	  recruit	  macrophages	  to	  the	  site	  of	  injury.	  Very	  few	  macrophages	  were	   distinguishable	   by	   mCherry	   expression	   in	   the	   transgenic,	   although	   a	   few	  motile,	  EGFP	  positive	  cells	  were	  visible	  with	  no	  mCherry	  expression	  at	  the	  site	  of	  injury	   (Figure	   6.6).	   Further	   repeats	   of	   this	   experiment	   failed	   to	   detect	   anymore	  EGFP	  expressing	  cells	  and	  few	  mCherry	  labelled	  macrophages	  were	  seen.	  The	   Tg(fms:Gal4.VP16)i186;Tg(UAS:nfsB.mCherry)i149	   has	   persistent	  problems	   with	   detecting	   macrophages	   as	   discussed	   in	   chapter	   4	   and	   so	   poses	  significant	   difficulties	   when	   using	   this	   transgenic	   as	   a	   fluorescent	   macrophage	  marker.	  Furthermore,	  overexpression	  of	  a	  proinflammatory	  cytokine	  in	  a	  number	  of	   additional	   tissues	   such	   as	   xanthophores	   and	   in	   the	   cells	   of	   the	   hindbrain	   as	  driven	  by	  the	  fms	  promoter	  may	  negatively	  effect	  the	  viability	  of	  the	  embryos,	  and	  uncontrolled	   expression	   of	   IL-­‐1β	   in	   these	   tissues	   could	   also	   interfere	  experimentally	  with	   the	  use	  of	   the	  pDEST(UAS:	  IL-­‐1β.EGFP)	   line	   as	   a	   reporter	  by	  inducing	  aberrant	  inflammatory	  responses.	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The	  Tg(fms:Gal4.VP16)i186;Tg(UAS:nfsB.mCherry)i149	   line	  was	  therefore	  found	  to	  be	  unsuitable	  for	  the	  generation	  of	  an	  IL-­‐1β.EGFP	  reporter.	  Instead,	  as	  described	  in	  chapter	   4,	   I	   was	   able	   to	   generate	   an	  mpeg1,	   macrophage	   specific,	   gal4	   driver,	  
Tg(mpeg1:Gal4.VP16)sh256,	  using	  the	  mpeg1	  promoter	  5’	  entry	  clone	  generated	  by	  Ellett	  et	  al.	  (2010).	  This	  approach	  presents	  certain	  advantages	  over	  using	  the	  fms	  promoter	   as	   a	   driver	   for	   an	   IL-­‐1β.EGFP	   fusion	   protein.	   Access	   to	   the	   fms	   as	   a	  macrophage	   specific	   driver	   is	   limited	   to	   the	   Tg(fms:Gal4-­‐
VP16)i186;Tg(UAS:nfsB.mCherry)i149	   compound	   line,	   whereas	   mpeg1	   is	   a	  promoter	  entry	  clone	  compatible	  with	  the	  versatile	  Tol2Kit	  Gateway™	  system.	  This	  presented	   an	   opportunity	   for	  me	   to	   address	   the	   problem	   in	   two	   different	  ways.	  The	  mpeg1	   entry	   clone	   was	   used	   to	   generate	   a	   direct	   driver	   expression	   vector,	  
pDEST(mpeg1:zfIL-­‐1β.EGFP)	   for	   use	   in	   transient	   expression	   experiments	   and	  subsequent	  stable	  zebrafish	  line	  generation.	  	  	   A	   further	   strategy	   was	   also	   developed,	   to	   add	   increase	   the	   likelihood	   of	  developing	   an	   IL-­‐1β	   reporter.	   The	   UAS	   silencing	   issues	   present	   in	   the	   current	  version	  of	  the	  Tol2Kit	  were	  addressed	  with	  the	  generation	  of	  a	  new	  UAS	  5’	  entry	  clone.	  The	  phenomenon	  of	  UAS	  silencing	  has	  previously	  been	  described	   in	  detail	  (Akitake	  et	  al.	  2011)	  and	  is	  primarily	  due	  to	  the	  methylation	  of	  the	  CpG	  rich	  UAS	  repeats	  used	  in	  the	  assembly	  of	  these	  promoters,	  with	  the	  number	  of	  concatemers	  influencing	   the	   methylation	   frequency.	   However,	   Akitake	   et	   al.	   (2011)	   have	  developed	  a	  UAS	  promoter	  system	  based	  on	  4	  non-­‐repeating	  UAS	  sequences.	  This	  new	   UAS	   promoter	   is	   described	   as	   being	   far	   less	   susceptible	   to	   promoter	  methylation	   and	   silencing	   after	   multiple	   generations.	   I	   used	   this	   promoter	  sequence	  to	  generate	  a	  new	  promoter	  entry	  clone	  for	  a	  non-­‐repeating	  UAS	  using	  a	  template	  clone	  kindly	  donated	  by	  Mike	  Parsons	  (Johns	  Hopkins)	  (from	  hereon	  this	  entry	   clone	   is	   referred	   to	   as	   the	  4xUAS	  5’	   entry	   clone).	  This	   construct	   should	  be	  less	   susceptible	   to	   methylation,	   and	   the	   appropriate	   entry	   clone	   was	   used	   to	  generate	  the	  pDEST(4xUAS:IL-­‐1β.EGFP)	  expression	  vector.	  	   The	   direct	   driver	   construct	   was	   used	   in	   the	   rest	   of	   the	   study	   as	   it	   gives	  direct	  control	  over	  the	  expression	  of	  IL-­‐1β.EGFP	  and	  provides	  a	  transgenic	  marker	  for	  the	  selection	  of	  positive	  embryos	  in	  which	  IL-­‐1β.EGFP	  is	  driven	  directly	  by	  the	  
mpeg1	   promoter.	   The	   4xUAS	   construct	   was	   designed	   to	   be	   used	   in	   conjunction	  with	   the	   Tg(mpeg1:Gal4.VP16)sh256	   line	   as	   a	   strategy	   designed	   to	   increase	   the	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likelihood	  of	  success,	  as	  this	  has	  some	  disadvantages	  over	  a	  direct	  driver	  system.	  Although	   the	  original	  non-­‐repeating	  UAS	   sequence	  has	  been	   tested	   for	  promoter	  methylation,	   the	   4xUAS	   entry	   clone	   has	   not,	   and	   therefore	   may	   be	   more	  susceptible	  than	  in	  the	  original	  publication,	  though	  this	  is	  unlikely.	  When	  crossed	  to	  Tg(mpeg1:Gal4.VP16)sh256,	   there	   is	  only	  a	  marker	   for	  one	   transgenic	  allele	  as	  
Tg(mpeg1:Gal4.VP16)sh256	   line	   was	   not	   assembled	   with	   the	   cmlc2:EGFP	  destination	  vector,	  therefore	  it	  is	  expected	  that	  when	  crossed	  to	  heterozygous	  Gal4	  positive	  adults,	  only	  50%	  of	  the	  tg(4xUAS:IL-­‐1β.EGFP)	  embryos	  will	  be	  positive	  for	  the	  Tg(mpeg1:Gal4.VP16)sh256	  allele,	  making	  selection	  and	  experimentation	  more	  difficult.	   However,	   the	  major	   advantages	   of	   this	   construct	   are	   that	   the	   Gal4:UAS	  system	  provides	  an	  amplification	  effect	  for	  the	  promoter	  driving	  the	  Gal4	  protein,	  and	   that	  we	   can	   use	   the	  pDEST(4xUAS:IL-­‐1β.EGFP)	  modularly	   in	   any	  Gal4	   driver	  line	  to	  explore	  IL-­‐1β	  biology	  in	  other	  cell	  types.	  	  
6.2.5	  IL-­‐1β	  reporter	  expression.	  
pDEST(mpeg1:Gal4.VP16)	  was	  injected	  into	  AB	  wildtype	  embryos	  alongside	  tol2	   transposase	  mRNA.	  Embryos	  were	  selected	  by	  heart	  marker	  expression	  and	  imaged	   for	   green	   fluorescence	   in	   cells	  with	  macrophage	  morphology.	   There	  was	  very	   little	   expression	  of	   the	   IL-­‐1β.EGFP	   transgene.	  The	   embryos	  were	   injured	   to	  recruit	  macrophages	  to	  the	  tail	  and	  imaged	  using	  high	  power	  confocal	  microscopy.	  Macrophages	   could	   be	   clearly	   distinguished	   with	   confocal	   imaging	   using	   a	   40x	  objective	   at	   the	   site	   of	   injury.	   Membrane	   blebbing	   could	   be	   seen	   at	   the	   leading	  edges	  of	  the	  macrophages	  as	  they	  moved	  at	  the	  site	  of	  injury	  (Figure	  6.7)	  but	  very	  little	  evidence	  of	  microvesicle	  release	  was	  seen.	  Contrast	  enhancement	  of	  these	  macrophage	  timelapse	  images	  at	  the	  site	  of	  injury	   revealed	   that	   circular	   vesicles	   of	   ≤1	  µm	   could	   be	   seen	   around	   these	   cells	  (Figure	   6.8).	  With	   no	   other	   source	   of	   EGFP	   fluorescence	  within	   the	   embryo,	   the	  origin	  of	  these	  vesicles	  is	  attributable	  to	  the	  IL-­‐1β.EGFP	  expressed	  in	  macrophages.	  Furthermore,	  it	  is	  unlikely	  that	  this	  is	  due	  to	  autofluorescence	  as	  this	  is	  only	  seen	  in	   a	   subset	   of	   the	   cells	   visualised.	   These	   vesicles	   have	   therefore	   been	   described
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as	   IL-­‐1β.EGFP	   containing	   microvesicles,	   although	   further	   work	   is	   required	   to	  confirm	  their	  origin	  and	  biogenesis.	  
	  
6.3	  Discussion	  There	   are	   many	   elements	   of	   the	   IL-­‐1β	   pathway	   that	   remain	   poorly	  understood.	  In	  this	  chapter	  I	  attempted	  to	  address	  the	  gulf	  of	  understanding	  in	  the	  secretion	   of	   IL-­‐1β	   during	   the	   inflammatory	   response	   by	   developing	   an	   in	   vivo	  model	  of	  IL-­‐1β	  release,	  which	  could	  be	  used	  to	  visualise	  this	  response	  in	  a	  whole	  intact	  organism,	  rather	  than	  in	  the	  cell	  culture	  paradigm	  to	  which	  previous	  studies	  have	  been	  restricted.	  Due	  to	  the	  poorly	  understood	  nature	  of	  the	  release	  pathway	  of	  IL-­‐1β,	  an	  in	  
vivo	  reporter	  of	  release	  had	  to	  be	  based	  on	  the	  IL-­‐1β	  sequence	  itself,	  the	  simplest	  method	   to	   design	   such	   a	   reporter	   being	   to	   label	   IL-­‐1β	   with	   a	   fluorophore.	   The	  EGFP	  label	  has	  been	  shown	  to	  not	  interfere	  with	  release	  of	  IL-­‐1β	  so	  was	  predicted	  to	  serve	  as	  an	  adequate	  reporter	  of	  secretion.	  	  	   	  
6.3.1	  Gateway™	  and	  the	  Tol2kit	  for	  vector	  construction.	  The	  use	  of	  Gateway™	  to	  generate	  these	  reporters	  allowed	  the	  construction	  of	   a	   number	   of	   vectors	   from	   the	   same	   basic	   template.	   Here,	   IL-­‐1β.EGFP	   and	  mCherry	  driven	  by	  UAS,	  mpeg1	  and	  4xUAS	  were	  all	  generated	  from	  a	  single	  middle	  entry	   clone	  of	   zfIL-­‐1β.	  Throughout	   this	   study,	   the	  Gateway™	  system	  provided	  an	  ideal	   solution	   for	   generating	   expression	   vectors	   and	   allowed	   their	   adaptation	   to	  using	   different	   promoters,	   which	   would	   have	   required	   a	   substantial	   change	   in	  strategy	   if	   using	   traditional	   cloning	   methods.	   However,	   the	   tol2	   kit	   can	   cause	  problems	   if	   used	   for	   generating	   fusion	   constructs.	   In	   the	   initial	   attempt	   at	  generating	  a	  fusion	  vector,	  the	  linker	  between	  the	  IL-­‐1β	  coding	  sequence	  and	  the	  EGFP	  start	  site	  added	  41	  amino	  acids	  in	  total,	  which	  proved	  to	  be	  deleterious	  for	  protein	  expression.	  By	  cloning	  zfIL-­‐1β	  directly	  into	  an	  entry	  clone,	  this	  linker	  was	  reduced	  to	  a	  size	  of	  9	  amino	  acids,	   the	  minimum	  possible	  due	  to	  the	   inclusion	  of	  the	   Att	   recombination	   sites	   between	   the	   two	   entry	   clones.	   This	   construct	   was	  shown	  to	  express	  well	  in	  vivo,	  however,	  with	  no	  comparison,	  it	  is	  unclear	  whether	  this	  construct	  would	  be	  more	  stable	  or	  have	  a	  stronger	  signal	  without	  this	  linker.	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   The	  tol2	  kit	  based	  on	  Invitrogen’s	  Gateway™	  system	  is	  an	  incredibly	  useful	  tool	  for	  the	  generation	  of	  transgenics.	  There	  is	  a	  sufficient	  range	  of	  available	  entry	  clones	  to	  generate	  an	  array	  of	  expression	  vectors,	  however	  over	  the	  course	  of	  the	  project	  I	  have	  observed	  a	  few	  problems	  that	  I	  have	  tried	  to	  improve	  upon.	  One	  of	  the	  easiest	  methods	  for	  making	  a	  middle	  entry	  clone	  from	  an	  existing	  expression	  construct	  is	  to	  use	  the	  middle	  entry	  MCS	  plasmid	  to	  generate	  a	  clone	  of	  your	  gene	  of	   interest	   in	   a	   Gateway™	   compatible	   format.	   However,	   a	   number	   of	   problems	  were	  encountered	  in	  the	  use	  of	  the	  original	  PME-­‐MCS.	  The	  first	  was	  in	  the	  cloning	  error	   that	   leads	   to	   the	  addition	  of	  a	  stop	  site	   in	   two	  out	  of	   three	  reading	   frames,	  and	  the	  second	  was	  the	  presence	  of	  an	  M13	  primer	  site	  after	  the	  att	  recombination	  sites.	  The	  presence	  of	  an	  additional	  primer	  site	  disrupts	  the	  ease	  of	  sequencing	  a	  Gateway™	  entry	  clone	  as	  all	  clones	  have	  been	  designed	  with	  M13F	  and	  M13R	  sites	  before	   the	   5’	   att	   site	   and	   behind	   the	   3’	   att	   site	   both	   reading	   into	   the	   construct.	  Gateway™	   entry	   clones	   are	   usually	   easily	   sequenced,	   but	   the	   presence	   of	   an	  additional	   M13F	   site	   in	   the	   Gateway™	   insert	   between	   the	   attp1	   and	   attp2	   sites	  interferes	  with	  this	  functionality.	  The	  pME-­‐MCS	  entry	  clone	  was	  itself	  added	  to	  the	  tol2kit	   as	   an	   afterthought	   (Chien	   et	   al,	  http://chien.neuro.utah.edu/tol2kitwiki/index.php/Main_Page),	  as	  the	  generation	  of	   entry	   clones	   from	   PCR	   products	   with	   ATT	   site	   containing	   primers	   is	   much	  simpler	   than	   using	   a	   traditional	   cloning	   vector	   such	   as	   TOPO	   to	   amplify	   a	   given	  sequence,	  then	  using	  restriction	  site	  primers	  to	  insert	  it	  into	  pME-­‐MCS.	  	  	   Though	   an	   MCS	   plasmid	   is	   not	   essential,	   it	   can	   be	   useful	   to	   generate	  constructs	   from	   existing	   plasmids	   without	   BP	   clonase,	   and	   in	   situations	   where	  maintaining	  a	  reading	   frame,	  such	  as	  when	  generating	   fusion	  constructs,	   it	   is	  not	  required.	  The	  PCS2	  plasmid	  family	  is	  often	  used	  to	  make	  mRNA	  for	  overexpression	  in	   fish,	   and	  we	   found	   that	   by	   using	  AttB	   primers	   designed	   for	   either	   side	   of	   the	  PCS2+	  multiple	  cloning	  site,	  we	  could	  very	  easily	  generate	  entry	  clones	  for	  coding	  sequences	  from	  existing	  mRNA	  generation	  constructs.	  These	  clones	  lack	  the	  issues	  with	   the	   pME-­‐MCS	   constructs	   described	   above	   and	   allowed	   the	   generation	   of	   a	  PCS2+	  multiple	  cloning	  site	  entry	  clone	  which	  can	  be	  used	  to	  generate	  new	  entry	  clones	  entirely	  via	  restriction	  digest.	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As	   described,	   a	   recently	   discovered	   problem	   with	   Gal4/UAS	   expression	  system	   in	   zebrafish	   is	   the	   methylation	   mediated	   silencing	   of	   the	   UAS	   promoter	  sequence	  (Akitake	  et	  al.	  2011).	  The	  5’	  UAS	  clone	  provided	  in	  the	  initial	  release	  of	  the	   tol2	   kit	   is	   a	   10x	   repeating	   concatamer	   construct	   and	   remains	   prone	   to	  silencing.	   I	   used	   the	   4x	   non-­‐repeating	   sequence	   described	   to	   generate	   a	  theoretically	  methylation-­‐resistant	   entry	   clone	  which	   should	   prove	   a	   useful	   tool	  for	  exploiting	  the	  Gal4/UAS	  system	  using	  Gateway™.	  	  
6.3.2	  Macrophage	  promoters	  A	  major	  problem	  with	   the	   generation	  of	   the	   IL-­‐1β-­‐EGFP	   reporter	  was	   the	  lack	   of	   a	   reliable	  macrophage	   specific	   Gal4	   driver	   line	   or	  macrophage	   promoter	  with	  which	  to	  express	  the	  zfIL-­‐1β	  EGFP	  fusion	  protein.	  The	  fms	  promoter	  (Gray	  et	  al.	  2011)	  expressed	  in	  too	  wide	  a	  population	  of	  cells	  and	  caused	  concerns	  for	  the	  viability	  and	  reliability	  of	  results	  recorded	  in	  embryos	  with	  overexpression	  of	  zfIL-­‐1β.EGFP	   in	   so	  many	  different	   cell	   types.	  Human	   IL-­‐1β	  has	   a	   very	  broad	   range	  of	  effects	  and	  overexpression	  in	  tissues	  without	  the	  internal	  machinery	  to	  process	  IL-­‐1β	   could	   lead	   to	   deleterious	   effects	   for	   the	   health	   of	   the	   zebrafish.	   These	   issues	  were	   compounded	  by	   the	   availability	  of	   this	   line	  only	   as	   a	   compound	   transgenic	  with	   Tg(UAS:nsfB.mCherry)i149,	   a	   line	   with	   significant	   UAS	   methylation	   and	  promoter	  silencing.	  The	   publication	   of	   the	  much	  more	  macrophage	   specific	   promoter,	  mpeg1	  (Ellett	  et	  al.	  2010),	  and	  its	  available	  format	  as	  an	  entry	  clone	  compatible	  with	  the	  Tol2kit	   system	   used	   to	   generate	   the	   IL-­‐1β	   expression	   vectors	   allowed	   the	  expression	   of	   zfIL-­‐1β.EGFP	   in	   a	   much	   more	   macrophage	   specific	   manner,	   and	  furthermore	  allowed	  a	  variety	  of	  strategies	  for	  reporter	  expression	  to	  increase	  the	  chances	  of	  success.	  	   Though	   putative	   macrophage	   derived	   microvesicles	   have	   been	   imaged	  around	  mpeg1:zfIL-­‐1β.EGFP	  positive	   cells	   close	   to	   the	   site	  of	   injury,	   they	  are	  not	  conclusively	  attributable	  as	  the	  microvesicles	  described	  in	  previous	  studies	  of	  IL-­‐1β	   release	   from	   cells.	   In	   order	   to	   visualise	   the	   release	   of	   vesicles	   from	   cells,	   a	  higher	  resolution	  approach	  is	  required.	  These	  microvesicles,	  described	  as	  between	  0.1	  and	  1	  µM,	  exist	  at	   the	   limit	  of	  conventional	   fluorescence	  microscopy,	  and	  the	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images	  presented	  here	  were	  recorded	  at	  an	  NA	  of	  1.3	  in	  using	  a	  Nipkow	  Spinning	  disc	   confocal,	   close	   to	   the	   state-­‐of-­‐the-­‐art	   for	   rapid	   live	   imaging.	   Though	   higher	  resolution	  approaches	  exist	  for	  fluorescence	  microscopy,	  they	  are	  limited	  in	  their	  application	  to	  this	  study.	  Super-­‐resolution	  microscopes	  could	  provide	  the	  requisite	  resolution,	   as	   could	   high-­‐end	   confocal	   microscopes.	   However	   these	   systems	   are	  mostly	   too	   slow	   for	   imaging	  of	   a	  mechanism	  described	   as	   occurring	  over	   such	   a	  short	   timeframe.	   This	   limitation	   must	   therefore	   be	   addressed	   using	   a	   method	  compatible	  with	  the	  current	  imaging	  system.	  The	   tol2kit	   provides	   a	   ready	  mechanism	   that	   could	   be	   used	   to	   overcome	  this	  challenge.	  If	  the	  membrane	  of	  the	  IL-­‐1β.EGFP	  positive	  cells	  could	  be	  visualised,	  separately	   from	   the	   reporter,	   it	  may	  be	   possible	   to	   distinguish	   the	   IL-­‐1β	   release	  events	  during	  a	  microscopy	  acquisition.	  If	  IL-­‐1β.EGFP	  cells	  were	  also	  labeled	  with	  a	  membrane	  mCherry	  then	  the	  simultaneous	  expression	  of	  both	  transgenes	  would	  allow	   the	   visualization	   of	   events	   at	   the	   cell	   surface,	   and	  would	   also	   allow	   easier	  tracking	  of	  these	  vesicles	  following	  stimulation.	  An	   expression	   vector	   for	   a	   membrane	   localized	   mCherry	   would	   not	   be	  technically	  challenging	  to	  generate.	  The	  tol2kit	  includes	  an	  mCherry	  vector	  with	  an	  in-­‐frame	  membrane	  localization	  sequence,	  the	  latest	  version	  of	  which	  is	  available	  for	  use.	  Construction	  of	   the	  vector	  would	  simply	   involve	  combining	   this	  with	   the	  correct	   promoter	   for	   the	   expression	   system	   used,	   either	   mpeg1	   or	   4xUAS.	  However,	  the	  construct	  may	  be	  more	  reliable	  if	  a	  non	  Gateway™	  system	  were	  used	  for	  expression.	  If	  this	  membrane	  fluorophore	  was	  combined	  in	  a	  single	  expression	  vector	   with	   the	   zfIL-­‐1β.EGFP	   fusion	   protein	   and	   mpeg1	   as	   a	   direct	   driving	  promoter	   then	  only	  a	  single	  allele	  would	  need	  to	  be	  generated	  to	  yield	  a	  useable	  transgenic	   line.	   This	   would	   make	   animal	   husbandry	   and	   stock	   maintenance	  significantly	   easier	   and	   cheaper	   and	   would	   allow	   the	   reduction	   of	   inbreeding	  within	  the	  fish	  stock	  to	  enhance	  animal	  welfare.	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Chapter	  7:	  Discussion	  In	   this	   thesis	   I	   aimed	   to	   develop	   a	   zebrafish	   model	   of	   IL-­‐1β	   biology.	   Initially	   I	  investigated	  the	  function	  of	  IL-­‐1β	  in	  zebrafish	  to	  verify	  the	  suitability	  of	  the	  species	  for	   this	  purpose.	  The	  predicted	  structure	  of	  zebrafish	   IL-­‐1β	   is	  very	  similar	   to	   the	  crystal	   structure	   of	   human	   IL-­‐1β	   as	   shown	   using	   three	   different	   methods	   for	  structural	  prediction,	  I-­‐TASSER,	  Phyre	  and	  RaptorX.	  IL-­‐1β	  mRNA	  was	  shown	  to	  be	  induced	   in	   response	   to	   injury,	   and	   treatment	   of	   zebrafish	   larvae	   with	   IL-­‐1β	  pathway	  inhibitors	  reduced	  NF-­‐kB	  activation	  and	  leukocyte	  recruitment	  to	  the	  site	  of	  injury,	  however	  one	  major	  question	  was	  not	  addressed.	  There	  is	  considerable	  disagreement	  in	  the	  literature	  over	  the	  evolutionary	  conservation	   of	   IL-­‐1β.	   Initial	   studies	   of	   IL-­‐1β	   outside	   the	   mammalian	   class	  indicated	  the	  lack	  of	  a	  consensus	  caspase	  cleavage	  site	  on	  fish,	  birds	  and	  Xenopus	  (Bird,	   Zou,	   et	   al.	   2002).	   However,	   processing	   of	   these	   IL-­‐1β	   proteins	   by	   non	  mammalian	   vertebrates	   was	   observed	   from	   the	   earliest	   experiments	   of	   IL-­‐1β	  biology	  when	   Auron	   et	   al.	   (1984)	   demonstrated	   that	   Xenopus	   oocytes	   produced	  biologically	  active	   IL-­‐1β	  after	   injection	  with	   the	  human	  mRNA	  sequence.	  Further	  evidence	   for	   IL-­‐1β	   processing	   outside	   the	   mammalian	   lineage	   has	   been	  demonstrated	   in	   seabream	   (Angosto	   et	   al.	   2012),	   but	   was	   shown	   to	   be	  independent	  of	  caspase-­‐1.	  Conversely	  a	  recent	  study	  showd	  that	  zebrafish	  IL-­‐1β	  is	  cleaved	  by	  zebrafish	  caspase-­‐1	  equivalents	  caspase-­‐A	  and	  caspase-­‐B	  (Vojtech	  et	  al.	  2012).	   Zou	   et	   al.	   (1999)	   investigated	   trout	   IL-­‐1β,	   and	   showed	   no	   evidence	   of	   a	  Caspase-­‐1	   cleavage	   site,	   but	   performed	   no	   functional	   tests.	   From	   the	   literature,	  there	  are	  few	  pieces	  of	  evidence	  describing	  the	  cleavage	  of	  IL-­‐1β	  in	  teleost	  fish,	  and	  the	  two	  key	  studies	  in	  the	  area,	  Angosto	  et	  al.	  (2012),	  and	  Vojtech	  et	  al.	  (Vojtech	  et	  al.	   2012),	   disagree	   on	   the	   subject.	   A	   key	   factor	   in	   this	   disagreement	   is	   the	  evolutionary	  distance	  between	  seabream	  and	  zebrafish	  (Sarropoulou	  et	  al.	  2007),	  and	  clear	  differences	  in	  the	  structure	  of	  their	  domains	  (López-­‐Castejón	  et	  al.	  2008).	  López-­‐Castejón	  et	  al	  (2008)	  characterise	  the	  seabream	  caspase-­‐1	  as	  more	  closely	  related	  to	  human	  caspase-­‐1	  based	  largely	  on	  the	  CARD	  domain,	  however,	  a	  closer	  look	  at	   these	   caspase	   sequences	  with	   the	  CARD	  domain	   removed	   shows	  a	   lesser	  distance	  between	  zebrafish	  and	  human	  caspase-­‐1	   than	  seabream	  caspase-­‐1.	  This	  implies	   closer	   homology	   between	   the	   active	   regions	   of	   human	   caspase-­‐1	   and	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caspase-­‐A,	  which	  may	  explain	  the	  difference	  in	  IL-­‐1β	  cleavage	  potential	  described	  (Angosto	  et	  al.	  2012;	  Vojtech	  et	  al.	  2012)	  (Figure	  3.7).	  	   In	   this	   study	   I	   found	   that	   based	   on	   structure	   prediction	   software,	   human	  and	  zebrafish	  IL-­‐1β	  share	  remarkable	  structural	  similarity	  in	  the	  region	  equivalent	  to	   bioactive	   IL-­‐1β.	   The	   structural	   similarity	   of	   the	   pro	   domain	   region	   is	   poorer,	  however,	  this	  is	  expected,	  as	  the	  function	  of	  this	  domain	  appears	  to	  be	  masking	  IL-­‐1β	   bioactivity.	   Further	   pathway	   conservation	   was	   found	   in	   relation	   to	  inflammatory	   caspase	   structure,	   and	   with	   regard	   to	   IL-­‐1β	   functional	   assays.	  caspase-­‐1	  antagonists	  had	  a	  negative	  effect	  on	  inflammatory	  assays	  measuring	  NF-­‐kB	   activation	   and	   leukocyte	   recruitment,	   and	   IL-­‐1β	   was	   shown	   to	   be	   highly	  induced	   in	   response	   to	   inflammatory	   insult	   via	   injury.	   P2X7	   inhibition	   had	   a	  similar	   effect	   on	   inflammatory	   function,	   demonstrating	   that	   these	   results	   were	  likely	  based	  on	  response	  from	  similar	  pathways.	  	  The	   structural	   similarity	   and	   evidence	   of	   cleavage	   (Vojtech	   et	   al.	   2012),	  indicate	   an	   evolutionary	   importance	   placed	   on	   IL-­‐1β	   as	   a	   regulator	   of	  inflammation,	  highlighted	  by	   increasing	  complexity	  during	  mammalian	  evolution,	  which	   has	   served	   to	   intensify	   this	   role.	   These	   data	   support	   the	   need	   for	   further	  study	   and	   characterisation	   of	   IL-­‐1β	   as	   a	   key	   mediator	   of	   inflammation	  demonstrated	  by	  its	  role	  in	  so	  many	  inflammatory	  diseases	  (Dinarello	  2011a)	  and	  the	   effects	   that	   anti	   IL-­‐1β	   therapies	   have	   so	   far	   produced	   (Dinarello	   2011b;	  Dinarello	  et	  al.	  2012).	  Unfortunately,	   such	   treatments	   have	   thus	   far	   taken	   the	   form	   of	   protein	  based	  therapies	  such	  as	  recombinant	  IL-­‐1RA	  antagonist	  Anakinra,	  Decoy	  receptor	  based	   Rilonocept	   (Terkeltaub	   et	   al.	   2009)	   and	   monoclonal	   anti	   IL-­‐1β	   antibody	  Canakinumab	  (Dhimolea	  2010).	  Protein	  therapies	  tend	  to	  be	  more	  expensive,	  have	  a	   shorter	   half-­‐life	   and	   require	   intravenous	   administration;	   undesirable	   qualities	  for	  the	  treatment	  of	  such	  a	  broad	  range	  of	  diseases.	  And	  it	  is	  our	  hope	  that	  with	  a	  better	   understanding	   of	   IL-­‐1β	   biology,	   a	  more	   effective	   small	  molecule	   inhibitor	  could	  be	  found.	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The	  objectives	  of	  the	  study	  define	  the	  choice	  of	  model	  used	  for	  the	  investigation	  of	  IL-­‐1β	  biology.	  Our	  understanding	  of	  IL-­‐1β	  biology	  has	  improved	  significantly	  from	  the	  use	  of	   in	  vitro	   study	   in	   cell	   culture,	   alongside	  mouse	  models	   and	  histological	  studie	  which	  have	  allowed	  a	  more	  systemic	  approach.	  However,	  with	  these	  models	  it	  would	   be	   very	   difficult	   to	   establish	   the	   in	  vivo	  mechanisms	   of	   IL-­‐1β	   secretion,	  and	   their	   downstream	   function.	   It	   was	   therefore	   a	   further	   aim	   of	   this	   study	   to	  develop	  reporters	  of	   these	  release	  pathways	   for	  use	   in	  an	   in	  vivo	   investigation	  of	  this	  pathway	  amenable	  to	  chemical	  and	  genetic	  manipulation.	  	   To	   achieve	   these	   aims,	   the	   zebrafish	   presents	   an	   ideal	   model.	   The	  transparency	  of	   the	  zebrafish	  allows	   the	  use	  of	   fluorescent	   reporters	  acting	  on	  a	  temporal	  and	  spatial	   level	  with	  minimum	  of	   interference	   in	  how	   these	  pathways	  function	  in	  a	   living	  organism,	  yet	   its	  genetic	  tractability	  allows	  these	  reporters	  to	  be	  readily	  established.	  I	  have	  approached	  the	  development	  of	  an	  IL-­‐1β	  model	  by	  investigating	  the	  use	   of	   reporters	   linked	   to	   some	   of	   the	   more	   confounding	   questions	   of	   IL-­‐1β	  biology;	  the	  development	  of	  FRET	  as	  a	  reporter	  of	  IL-­‐1β	  processing	  is	  an	  effort	  to	  investigate	   the	  activation	  of	  caspase-­‐1	  on	  a	   temporal	  scale.	  To	  date	  my	  efforts	   to	  develop	  a	  caspase-­‐1	  reporter	  have	  been	  limited,	  primarily	  by	  the	  lack	  of	  a	  reliably	  transfectable	  human	  macrophage	  model	  has	  restricted	  microscopy	  measurements.	  Despite	   this	   the	   in	  vivo	  measurement	   of	   FRET	  was	   achieved;	   I	   have	   successfully	  characterised	  the	  use	  of	  the	  Tg(BACmpo:FRET	  DEVD)i237	  as	  a	  reporter	  caspase-­‐3	  apoptosis	   in	   vivo,	   a	   tool	   which	   should	   prove	  more	   flexible	   than	   TUNEL	   staining	  only	   useable	   on	   fixed	   specimens,	   providing	   a	   temporal	   readout	   of	   neutrophil	  apoptosis.	   This	   reporter	   can	   easily	   be	   incorporated	   into	   other	   tissues	   under	   the	  control	  of	  a	  UAS	  sequence	  or	  other	  promoters.	  However,	  in	  order	  to	  characterise	  a	  reporter	  for	  caspase-­‐1,	  I	  would	  require	  a	  more	  amenable	  cell	  line	  or	  a	  better	  mode	  of	   transfection,	   such	   as	   polymersome	   based	  methods.	   Further	   improvements	   to	  this	   reporter	   could	   be	  made	   by	   using	   a	  more	   effective	   set	   of	   fluorophores;	   CFP	  emission	   is	   less	   intense	   than	   YFP	   and	   allowances	   have	   to	   be	   made	   for	   this	   in	  designing	   experiments.	  With	   a	   brighter	   blue	   fluorophore,	   FRET	   in	  vivo	  would	  be	  easier	  to	  perform,	  as	  described	  by	  Goedhart	  et	  al.,	  (2010)	  who	  have	  developed	  the	  more	   intense	   and	   photostable	   CFP	   variant	  mTurquoise,	   as	  well	   as	   the	   improved	  mTurquoise	  2	  (Goedhart	  et	  al.	  2012).	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A	   further	  problem	  with	  using	  CFP/YFP	  as	  a	  reporter	  of	  caspase	  activation	  (Tyas	  et	  al.	  2000;	  Rehm	  et	  al.	  2002)	  is	  the	  sensitivity	  of	  YFP	  to	  pH	  changes	  (Llopis	  et	  al.	  1998).	  A	  more	  photostable	  replacement	  would	  be	  the	  EYFP	  derivative	  Venus,	  shown	  to	  be	  more	  effective	  in	  the	  study	  of	  apoptosis	  (K.	  Takemoto	  et	  al.	  2003).	  	  	   One	   of	   the	  most	   intriguing	   aspects	   of	   IL-­‐1β	   research	   is	   in	   understanding	  unconventional	   release	   of	   this	   cytokine	   from	   monocytic	   cells,	   and	   the	   possible	  involvement	   of	   the	   same	   pathway	   as	   a	   more	   general	   release	   mechanism	   for	  leaderless	  proteins.	  As	  I	  have	  discussed	  previously,	  there	  is	  much	  evidence	  to	  link	  IL-­‐1β	   processing	   to	   its	   secretion;	   having	   a	   live	   reporter	   of	   caspase-­‐1	   activation	  would	   provide	   the	   opportunity	   to	   gain	   new	   insight	   to	   this	   pathway.	   Measuring	  such	  secretory	  mechanisms	  and	  vesicle	  biogenesis	  would	  require	  novel	  specialised	  reporters.	  The	  molecular	  machinery	  of	   the	   secretion	  pathway	   is	   currently	  unknown,	  and	   as	   such	  we	   are	  missing	   a	   big	   part	   of	   the	   larger	   picture	   of	   vesicle	   biology,	   a	  pathway	  demonstrated	  to	  be	  important	  in	  significantly	  more	  than	  IL-­‐1β	  secretion.	  As	   the	   pathway	   remains	   mechanistically	   opaque,	   my	   last	   aim	   was	   to	   develop	   a	  reporter	  of	  IL-­‐1β	  release.	  It	  was	  necessary	  to	  base	  my	  reporter	  on	  a	  protein	  known	  to	  utilise	  this	  leaderless	  secretory	  pathway;	  IL-­‐1β.	  It	  is	  unknown	  which	  part	  of	  IL-­‐1β	  structure	  is	  necessary	  for	  its	  secretion,	  and	  whether	  any	  accessory	  proteins	  are	  perhaps	  responsible	  This	  lack	  of	  knowledge	  mandated	  the	  use	  of	  the	  entire	  IL-­‐1β	  sequence	  in	  reporter	  construction,	  which	  was	  then	  labelled	  with	  a	  fluorophore	  for	  
in	  vivo	   visualisation.	  Using	   this	   reporter,	   I	  have	  recorded	   the	   first	  putative	  visual	  evidence	  in	  vivo	  of	  IL-­‐1β	  containing	  microvesicles	  produced	  in	  response	  to	  injury.	  At	   present	   there	   are	   some	   limitations	   in	   the	   use	   of	   this	   reporter	   and	   the	  interpretations	  that	  can	  be	  accurately	  made	  from	  the	  imaging	  data.	  It	  is	  currently	  impossible	   to	   achieve	   the	   resolution	   necessary	   to	   visualise	   release	   events	  themselves	   due	   to	   the	   lack	   of	   visible	  membrane	   interaction.	   In	   order	   to	   use	   this	  reporter	  to	  successfully	  investigate	  mechanisms	  of	  release	  it	  is	  therefore	  necessary	  to	  use	  it	  alongside	  a	  membrane	  label.	  	  	   These	   reporters	   would	   be	   impossible	   to	   develop	   in	   a	   mouse	   or	   cell	   line	  model	   and	   here	   we	   can	   clearly	   see	   the	   advantages	   of	   zebrafish	   for	   this	   kind	   of	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research.	   It	   is	   important	   to	   note	   that	   although	   zebrafish	   are	   a	   useful	  model,	   any	  discoveries	  made	  will	  still	  need	  to	  be	  validated	  in	  a	  mammalian	  model	  if	  they	  are	  to	  be	  applied	  in	  a	  therapeutic	  setting.	  Therefore	  zebrafish	  should	  be	  used	  not	  as	  a	  model	  in	  isolation,	  but	  alongside	  mammalian	  models	  such	  as	  mouse	  or	  cell	  culture	  techniques.	  	  
7.2	  Future	  work	  The	  validation	  of	   IL-­‐1beta	   function	   in	   the	   zebrafish	   and	   the	   generation	  of	  reporter	  lines	  to	  measure	  inflammasome	  activation,	  IL-­‐1β	  secretion	  and	  targeting	  now	  offer	   the	  opportunity	   to	  dissect	   the	  biological	  mechanisms	  underlying	   these	  processes,	   and	   to	   screen	   for	   small	   molecular	   inhibitors	   of	   these	   pathways.	  However,	  I	  feel	  the	  limitations	  of	  the	  model	  should	  first	  be	  addressed.	  In	   order	   to	   develop	   my	   FRET	   reporters	   further	   it	   is	   necessary	   to	   use	   a	  mammalian	   tissue	   culture	   model	   more	   amenable	   to	   reporter	   expression.	   This	  study	  has	  demonstrated	  the	  inefficiency	  of	  transfection	  in	  THP-­‐1	  cells,	  and	  with	  the	  recently	  published	  study	  demonstrating	  the	  ability	  of	  caspase-­‐A	  to	  process	  native	  IL-­‐1β	  (Vojtech	  et	  al.	  2012),	  it	  may	  prove	  more	  effective	  to	  generate	  this	  tool	  in	  vivo	  than	   relying	   on	   cell	   culture.	   Using	   the	   data	   recently	   published	   by	   Vojtech	   et	   al.	  (Vojtech	   et	   al.	   2012),	   it	   will	   be	   possible	   to	   use	   site	   directed	   mutagenesis	   to	  generate	   a	   caspase	   A	   specific	   FRET	   reporter,	   however,	   in	   its	   initial	   discovery,	  Masumoto	  et	  al	   (2003)	  describe	  caspase-­‐A	  to	  be	  specific	   to	  caspase-­‐1	  substrates,	  so	  perhaps	  a	  strategy	  incorporating	  both	  caspase-­‐A	  site	  NVVD	  and	  caspase-­‐1	  site	  YVHD	   would	   be	   more	   prudent.	   This	   assay	   could	   then	   be	   used	   to	   investigate	  caspase-­‐A	   activation	   in	  vivo	   and	   further	   characterise	   its	   substrate	   specificity	   and	  mechanism	   of	   activation	   via	   the	   use	   of	   morpholino	   knockdown	   and	   mutant	  generation	   strategies,	   as	   well	   as	   small	   molecule	   inhibition.	   Developing	   this	  reporter	   in	  human	  cell	   lines	  will,	  however,	  prove	  more	   technically	  demanding.	   It	  would	   be	   necessary	   to	   use	   a	  macrophage	  model	  more	   amenable	   to	   transfection	  and	  imaging.	  In	   order,	   to	   more	   robustly	   observe	   FRET	   events	   related	   to	   caspase-­‐1	  activation	  it	  would	  also	  be	  necessary	  to	  modify	  the	  FRET	  reporter	  with	  the	  latest	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CFP/YFP	   fluorophores,	   mTurquoise	   2	   and	   Venus	   for	   enhanced	   photo-­‐	   and	   pH	  stability.	  From	   the	   Tg(BACmpo:FRET	   DEVD)sh237	   line,	   it	   is	   possible	   to	   see	   how	   a	  FRET	  based	  reporter	  could	  be	  used	  as	  the	  foundation	  of	  a	  small	  molecule	  inhibitor	  screen,	  however,	  the	  technique	  is	  difficult	  and	  both	  research-­‐time	  and	  computing-­‐resource	   intensive	   and	   we	   found	   that	   it	   is	   more	   useful	   in	   confirming	   the	  mechanism	   of	   inflammation	   resolution	   enhancing	   compounds	   than	   it	   could	   as	  being	  the	  basis	  of	  a	  screen.	  This	   limitation	   could	   be	   reversed	   in	   vitro,	   and	   recently	   Compan	   et	   al.,	  (2012)	   have	   described	   an	   IL-­‐1β	   processing	   reporter	   based	   on	   a	   very	   similar	  principle.	   Compan	   et	   al.,	   (2012)	   have	   developed	   an	   IL-­‐1β	  molecule	  with	   a	   BRET	  reporter	   (Bioluminescent	  Resonance	  Energy	  Transfer)	  with	  both	  advantages	  and	  disadvantages	   over	   a	   FRET	   based	   system.	   BRET	   uses	   a	   luciferase	   mediated	  reaction	  as	  a	  fluorescent	  donor	  to	  stimulate	  an	  acceptor	  fluorophore,	  and	  therefore	  does	   not	   require	   fluorescent	   excitation	   making	   it	   less	   susceptible	   to	  photobleaching	   and	   spectral	   bleedthrough.	   This	   is	   a	   very	   viable	   system	   for	   cell	  based	   assays,	   however	   is	   less	   useful	   in	   vivo	   because	   of	   its	   dependence	   on	   the	  availability	   of	   a	   luciferase	   substrate.	   In	   essence	   though,	   a	   cell	   based	   resonance	  reporter	   is	  more	   amenable	   to	   small	  molecule	   screens	   due	   to	   less	   intense	   image	  processing	   requirements	   and	   lower	   susceptibility	   to	   image	   distortion	   through	  living	  tissue.	  Although	  data	  gathered	  from	  these	  screens	  should	  also	  be	  validated	  in	  a	  living	  model	  for	  a	  clearer	  mechanistic	  insight.	  	  The	  improvement	  of	  the	  zebrafish	  IL-­‐1β	  fusion	  protein	  into	  a	  more	  reliable	  reporter	   of	   release	   will	   be	   simpler.	   This	   would	   require	   the	   generation	   of	   a	  macrophage	   mCherry	   membrane	   tag,	   something	   achievable	   with	   the	   Tol2Kit	  (Kwan	  et	  al.	  2007)and	  the	  mpeg1	  promoter	  entry	  clone	  (Ellett	  et	  al.	  2010)	  and	  the	  subsequent	   generation	   of	   the	   transgenic	   zebrafish	   line.	   This	   also	   provides	   an	  exciting	   opportunity	   for	   a	   more	   reliable	   and	   higher	   resolution	   reporter.	   The	  literature	   on	   IL-­‐1β	   release	   tells	   us	   that	   without	   inflammatory	   stimuli,	   IL-­‐1β	   is	  subject	   to	   constant	   degradation	   in	   lysosomes	   (Saitoh	   et	   al.	   2008;	   Harris	   et	   al.	  2011),	   therefore	   I	   would	   predict	   that	   IL-­‐1β.EGFP	   will	   not	   provide	   a	   constant	  fluorescent	  signal.	  With	   the	  use	  of	  a	  Viral	  2A	  sequence	   (Provost	  &	  Rhee	  2007)	   it	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would	  be	  possible	  to	  generate	  a	  bicistronic	  expression	  construct	  encoding	  both	  the	  IL-­‐1β	  fusion	  protein	  and	  the	  necessary	  membrane	  label	  (Figure	  7.1).	  The	  virtue	  of	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such	   a	   construct	   is	   that	   both	   proteins	   will	   be	   translated	   equimolarly,	  therefore	   in	   any	   macrophage	   labelled	   with	   a	   red	   membrane,	   the	   IL-­‐1β	   fusion	  protein	  would	  also	  be	  expressed.	  Under	  these	  circumstances,	  it	  would	  be	  possible	  to	   investigate	   the	   stability	   of	   IL-­‐1β.EGFP	   in	   response	   to	   inflammatory	   stimuli,	   as	  the	  presence	  of	  a	  membrane	  label	  will	  indicate	  expression	  of	  the	  gene;	  and	  also	  to	  enable	  the	  visualisation	  of	  membrane-­‐derived	  microvesicles	  release	  events	  due	  to	  the	   higher	   contrast	   provided	   by	   the	   membrane	   label.	   The	   presence	   of	   these	  fluorophores	  will	   also	   enable	   easier	   tracking	  of	   vesicle	   trafficking	   to	   target	   cells,	  and	  give	  more	  insight	  as	  to	  the	  events	  responsible	  for	  the	  release	  of	  microvesicular	  contents.	  	   My	   initial	  hypotheses	  were	   that	   the	  ESCRT	  pathway	   is	   responsible	   for	   the	  biogenesis	  of	  membrane-­‐derived	  microvesicles	  and	  that	  this	  pathway	  was	  coupled	  to	  caspase-­‐1	  via	  Rab	  adaptor	  proteins.	  We	  now	  have	  the	  tools	  to	  investigate	  these	  hypotheses	  through	  the	  use	  of	  knockdown	  technology.	  The	  Zebrafish	  homologue	  of	  ESCRT	  I	  subunit	  protein	  Tsg101	  (accession:	  NP_001002089.1)	  shares	  84%	  identity	  with	   the	   human	   protein	   (accession:	   Q99816.2)	   and	   provides	   an	   ideal	   target	   for	  morpholino	  knockdown	   in	   the	   zebrafish,	  however,	   the	  high	   conservation	   implies	  its	  evolutionary	  importance	  and	  creates	  concern	  that	  this	  would	  have	  a	  deleterious	  effect	   on	   a	   number	   of	   other	   pathways.	   Perhaps	   a	   more	   appropriate	   target	   for	  knockdown	   would	   be	   adaptor	   protein	   Rab39a	   (accession:	   NP_059986.1)	   which	  shares	   59%	   identity	   to	   the	   zebrafish	   (accession:	   NP_998207.1).	   Rab39a	   has	  already	  been	  linked	  to	  IL-­‐1β	  release	  via	  caspase-­‐1,	  but	  its	  mechanism	  of	  action	  is	  unclear	  (C.	  Becker	  et	  al.	  2009).	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7.3	  Thesis	  summary	  In	  summary,	  in	  this	  thesis	  I	  have	  demonstrated	  the	  utility	  of	  zebrafish	  in	  the	  study	  of	  IL-­‐1β	  through	  the	  validation	  of	  zebrafish	  IL-­‐1	  biology	  justifying	  the	  development	  of	   fluorescent	   reporters	   and	   transgenic	   lines	   investigating	   IL-­‐1β	   biology.	   I	  undertook	   a	   bioinformatics	   study	   of	   IL-­‐1β	   biology,	   gaining	   insight	   into	   the	  structure	  of	  IL-­‐1β	  and	  possible	  evolutionary	  implications	  in	  IL-­‐1β.	  I	  developed	  and	  generated	  a	  number	  of	  reporter	   lines	   from	  both	  my	  own	  constructs	  and	  those	  of	  collaborators	  enabling	  better	  characterisation	  of	  innate	  immunity	  in	  the	  zebrafish.	  This	   enabled	  me	   to	  undertake	   a	   study	  of	   the	   effects	   of	   known	  mammalian	   IL-­‐1β	  pathway	   inhibitors	   in	   zebrafish	   to	   determine	   the	   effects	   they	   had	   on	   inhibiting	  inflammation	   in	   the	   zebrafish,	   alongside	   characterising	   zebrafish	   IL-­‐1β	   mRNA	  induction.	   Some	   of	   the	   reporter	   lines	   I	   have	   generated	   have	   also	   benefitted	   our	  collaborators	   in	   the	   wider	   community.	   I	   have	   developed	   a	   methodology	   for	  reporting	  in	  vivo	  apoptosis	  using	  a	  FRET	  based	  reporter	  through	  the	  adaptation	  of	  available	  software	  and	  microscopy	  equipment	  allowing	  better	  characterisation	  of	  a	  pro-­‐resolution	  compound,	  Isopimpinellin,	  in	  inflammation.	  I	  have	  also	  generated	  a	  reporter	   of	   IL-­‐1β	   release	   and	   observed	   the	   first	   putative	   microvesicle	   release	  events	   from	   macrophages	   in	   response	   to	   inflammatory	   insult.	   These	   tools	   now	  provide	  us	  with	  the	  opportunity	  to	  identify	  the	  biological	  mechanism	  underlying	  Il-­‐1β	  secretion	  in	  vivo,	  and	  to	  screen	  for	  small	  molecule	  inhibitors	  of	  these	  pathways.	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